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ABSTRACT
GENE REGULATORY MECHANISMS DRIVING TEMPORAL DYNAMICS OF
LINEAGE SPECIFIC DIFFERENTIATION IN THE CRANIAL NEURAL CREST
by
Maria Rose Replogle

The University of Wisconsin-Milwaukee, 2020
Under the Supervision of Ava J. Udvadia, PhD

Genetic and environmental perturbations impacting neural crest (NC) development
can result in pleiotropic structural and functional birth defects, many of which are
associated with pediatric syndromes. As developmental precursors, the NC has the
unique capacity to give rise to a diverse array of ectodermal and mesoectodermal cell
types, from neurons and glia of the peripheral nervous system to the cartilage and bone
of the face. In order to transition from a multipotent progenitor to a specific cell type, NC
cells must undergo a series of dynamic morphological and behavioral transformations
that gradually unfold over time. However, the NC is rare and transient cell population, and
the genetic programming that governs the transition through the intermediate stages of
differentiation toward a specific cell fate remain poorly understood. In order to investigate
the temporal regulation of this process we established a robust in vitro model system of
mammalian cranial and trunk NC cell differentiation. Systematic characterization of
directed differentiation along the neural and chondrogenic lineages revealed
reproducible, temporal benchmarks indicative of the intermediate stages underlying the
progression, many of which mimic those described in vivo. Using this culture system, we

ii

explicitly interrogated cranial NC cells to uncover the dynamic gene expression changes
that occur as the multipotent progenitors transition over time to become peripheral
neurons or cartilage matrix-producing chondrocytes. Our analysis revealed that cranial
NC cell diversification toward either cell type is mediated through gradual coordination of
both common and lineage-specific programming, as well as concurrent suppression of
competing

cell

fates.

We

further

identified

distinct

transcriptional

signatures

corresponding to the intermediate state, as well as putative regulators that govern the
overall progression in a stage-specific and time-sensitive manner. These data serve as a
powerful tool for discovering previously unappreciated mechanisms contributing to cell
fate acquisition in the NC, and novel molecular targets of genetic and environmental
factors that contribute to NC-related birth defects and disorders.
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For Daddy
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CHAPTER I

General Introduction

The neural crest (NC) comprises a transient, multipotent progenitor population that
uniquely contributes to a wide variety of tissues and structures in vertebrate animals. NC
cells were originally described by Wilhem His in 1868 as a band of cells derived from the
ectodermal germ layer in a distinct region arising at the interface between the neural plate
and the presumptive epidermis. During gastrulation, inductive cues subsequently activate
a cascade of transcriptional events leading to NC specification, and subsequent
delamination from the neuroepithelial border territory. Underlying this event is the
epithelial-to-mesenchymal transition (EMT), which endows NC cells with their extensive
migratory properties. Depending on where they originate from along the anterior-posterior
axis of the embryo, migratory NC cells are directed along established pathways defined
by environmental cues to their final site of arrest. A defining feature of the NC is the
potential to generate a diverse array of cell types, including ectodermal derivatives, such
as the neurons and glia of the peripheral nervous system (PNS), to mesoectodermal
derivatives, such as the cartilage, bone, and connective tissues of the face and throat (Le
Douarin, 1982). Given its broad developmental potential, the NC is often referred to as
the “fourth germ layer” (Hall, 2000), and it is regarded as a significant evolutionary driver
underlying the formation of articulated jaws, and cephalic sensory organs in the vertebrate
head (Gans and Northcutt, 1883).
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Over the past century, the NC has been the subject of extensive study, and debate,
especially upon discovering that mesenchymal tissues and structures could be produced
from the ectoderm (eg. Landacre, 1921; Platt, 1883, 1887). Advances in experimental
techniques, such as ablation and cell-tracking using vital dyes, performed across a
multiple model organisms helped to confirm early discoveries regarding the contribution
of the NC during development (eg. Dushane, 1938; Hörstadius and Sellman, 1941; Twitty
and Bodenstein, 1941). In particular, pioneering transplantation experiments using quailchick chimeras enabled tracing of avian NC cells as they migrated throughout the embryo,
and identification of distinct cell fates along the anterior-posterior axis (Le Douarin, 1982).
Concurrently, our understanding of NC development in mammalian embryos was greatly
facilitated by the advent of the Cre-LoxP reporter system (Sauer and Henderson, 1988),
in which expression of a fluorescent or LacZ reporter containing loxP-flanked stop
cassettes is driven by tissue-specific expression of Cre recombinase. Transgenic mouse
lines harboring Cre-LoxP reporter alleles driven by NC-specific promoters (Wnt1-cre,
Danielian et al., 1998; P0-cre, Yamauchi et al., 1999; Sox9-cre, Akiyama et al., 2005;
Sox10-cre, Matsuoka et al., 2005) provided in vivo lineage-tracing and visualization of
migratory pathways, as well as the ability to genetically manipulate and purify NC cells.
Furthermore, methods for isolating, expanding and differentiating avian (Baroffio et al.,
1991; Calloni et al., 2009; Cohen and Konigsberg, 1975; Etchevers, 2011; Kerosuo et al.,
2015; Sieber- Blum and Cohen, 1980; Trentin et al., 2004) and rodent (Bixby et al., 2002;
Etchevers, 2011; Ishii et al., 2012; Maurer et al., 2007; Pfaltzgraff et al., 2012; Stemple
and Anderson, 1992) NC cells in vitro provided a platform for dissecting mechanisms
contributing to multipotency and differentiation potential.

2

To date, the NC continues to be one of the most studied progenitor population in
the developing vertebrate embryo as it is an attractive model for uncovering the
mechanisms driving multipotency and self-renewal, EMT, migration and guidance, and
cell fate acquisition. In addition, understanding the molecular mechanisms mediating the
progressive stages of NC cell development is extremely valuable, particularly for
therapeutic purposes. For instance, genetic or environmental factors impacting proper
NC development can result in pleiotropic structural and functional anomalies (Bolande,
1997), which can manifest as pediatric syndromes or disorders characterized by variable
phenotypes and severities (Noack Watt and Trainor, 2014). Studies of NC growth and
differentiation expand upon our knowledge of the etiology underlying many NC-related
malformations, and enable development of novel diagnostic tools, treatments and
therapies. Additionally, disruption of NC cell development can even lead to a
predisposition to highly aggressive cancers, such as neuroblastoma, glioblastoma, and
melanoma. During metastasis, cancerous cells will undergo EMT upon leaving the
primary tumor, thus acquiring migratory abilities that allow them to travel long distances
in the body. It is thought that cancerous cells utilize similar mechanisms employed by the
NC cells during development (Keruso and Bronner-Fraser, 2012; Theveneau and Mayor,
2012), and therefore the NC acts as a good model for studying cancer progression
(Hanahan and Weinberg, 2011).
Underlying the remarkable properties of the NC is a temporal cascade of extrinsic
and intrinsic influences that together regulate NC development from induction to
specification to migration and, finally, lineage diversification. Recent information inferred
from genome-wide analyses and gene perturbation studies have led to the identification
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of transcriptional and epigenetic inputs that contribute to the different steps (Meulemans
and Bronner-Fraser, 2004; Sauka-Spengler and Bronner-Fraser, 2008; Simões-Costa et
al., 2014). Culmination of this information has led to the assembly of a gene regulatory
network (GRN) orchestrating the progression of NC cell development (Fig. 1; reviewed in
Martik and Bronner, 2017). Each step in the GRN is characterized by a gene expression
module comprised of positive and repressive gene regulatory interactions that noedt only
drive the associated process, but activate the expression downstream gene batteries
encoding regulators that initiate the next step. In this way the GRN acts as a feed-forward
loop, which when coupled with the combined action of several signaling pathways, is
capable of executing precise morphological, behavioral and physiological outputs
(Davidson, 2010).
Currently, most of the regulatory information compiled focuses on NC cell
induction, specification and migration. While modules for various NC derivatives have
been formulated, the information is restricted to genetic control of the terminally
differentiated state. However, differentiation is a dynamic, multistep process where
multipotent

NC

progenitors

gradually

acquire

morphological

and

behavioral

characteristics necessary for cell type-specific function. Thus, we are currently lacking
modules that represent the initiation of lineage-specific programming and the subsequent
progression through the intermediate stages of differentiation toward a particular cell type.
This absence of information precludes our ability to determine how genetic or
environmental insult might accelerate or delay the differentiation process, resulting in NCrelated defects and disorders.
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Figure 1: Overview of the current gene regulatory network (GRN) governing neural crest cell
development. Cumulative information gathered from genome-wide analyses and gene perturbation studies
across various vertebrate models has led to the assembly of a putative GRN for the different phases of NC
cell development (reviewed Martik and Bronner, 2017). Each module comprises transcription factors that
participate in cross-regulatory and auto-regulatory interactions to govern gene expression associated with
a particular phase, but also drive initiation of the next phase. Reciprocal signaling interactions in the
ectoderm lead to the activation of neural plate border specifiers, which define the neural plate border
domain, and control downstream expression of NC specifiers (Groves and LaBonne, 2014; Meulemans and
Bronner-Fraser, 2004; Prasad et al., 2012). NC specifiers endow cells within the neural plate border with
an identity indicative of premigratory NC precursors (Aybar et al., 2003; Dottori et al., 2001; Khudyakov and
Bronner-Fraser, 2009). Stabilization of the NC specification module results in the activation of the EMT
effector program, which enables premigratory NC cells to delaminate from the neural plate border territory
and become motile (Barriga et al., 2013; Cano et al., 2000; Cheung et al., 2005; Simões-Costa et al., 2014).
Migratory NC cells undergo differentiation in to various NC cell derivatives. While differentiation modules
for various cell types have been formulated (Akiyama et al., 2002; Kim et al., 1998; Lee et al., 2000;
Marmigère and Ernfors, 2007; Morikawa et al., 2009; Murisier et al., 2007; Stolt and Wegner, 2016), the
information is limited to the genes involved in maintaining the terminally differentiated state. Consequently,
the transcriptional programming governing the initial transition towards a specific cell type, and the
regulatory factors driving the subsequent progression through the intermediate stages of differentiation into
that cell type are not well understood.
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The overall purpose of the research presented in this dissertation was to expand
our understanding of the intrinsic programming governing the temporal progression of NC
cell differentiation. To achieve this, our goal was to first establish a robust culture system
modelling the intermediate stages of mammalian differentiation along ectodermal and
mesoectodermal lineages. With this tool in hand, we next sought to identify mechanisms
that regulate the timing of NC cell differentiation in order to begin filling in the missing
modules in the current GRN regarding the intermediate stages of this process, and
increase our overall understanding of the genetic regulation of NC cell diversification. In
this chapter, we present a brief overview of NC development, with a particular focus on
our current understanding of the programming controlling terminal differentiation.

Overview of NC cell development
Formation of the NC: Induction and Specification
During gastrulation NC cells are induced in the ectodermal germ layer in a region
that lies at the edge of what will become the central nervous system (CNS) and epidermis,
called the neural plate border (NPB). Establishment of the NPB occurs in a series of steps
mediated by reciprocal signaling interactions between the neural and non-neural
ectoderm, as well as the underlying paraxial mesoderm (Groves and LaBonne, 2014;
Prasad et al., 2012). The first step involves the dynamic interplay between three major
signaling pathways: WNT, BMP and FGF, although Notch and retinoic acid activity also
contribute to defining the NPB domain. While the sources of these signals and
contribution to NPB induction might vary between species, the consensus model indicates
that intermediate WNT and BMP levels, combined with FGF signals secreted from the
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paraxial mesoderm, are necessary to define the NPB domain from which the NC cells are
formed.
Stabilization of morphogen gradients activate a transcriptional circuit in the NPB
that leads to the expression of NPB specifiers: TFAP2, Msx1, Zic1, Pax3/7, Dlx5/6, and
others (Meulemans and Bronner-Fraser, 2004). Coordination of gene activation depends
on differential enhancer activity in response to WNT, BMP and FGF activity (Garnett et
al., 2012). At first, the expression of these genes across the domain is not uniform, and
NPB cells are capable of contributing to neural, NC and placodal cell fates (Roellig et al.,
2017). However, initiation of positive feedback loops within the module, and continued
cross-regulatory interactions between the NPB and neighboring territories, serve to
sharpen the boundaries of each distinct domain, thus separating the future NC from other
cell fates (Matsuo-Takasaki et al., 2005; Nikitina et al., 2008; McLarren et al., 2003).
Refinement of the NPB region also potentiates expression of key regulators which drive
NC specification, such as Msx1, Pax3/7 and TFAP2.
Initiation of NC specification occurs at the late gastrula stage with the expression
of Ets1, FoxD3, Snail1, and Snail2 (also known as Slug) (Khudyakov and Bronner-Fraser,
2009), all of which are direct transcriptional targets of NPB specifiers. These
transcriptional regulators are responsible for activating a suite of NC specifier genes that
together solidify NC cell fate. In this regulatory program, FoxD3 activates Sox10
expression in mouse NC (Dottori et al., 2001), while Snail1 and Snail2 promote
expression of Twist1 and Sox9 in frog NC (Aybar et al., 2003). In addition, NC specifiers
interact with one another in cross-regulatory and auto-regulatory loops in order to promote
robust maintenance of the transcriptional circuitry. The period of NC specification is
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relatively short, concluding when the neural folds begin to elevate as the neural tube
closes during the process of neurulation. At this stage of development, premigratory NC
precursors exhibit a distinct regulatory state characterized by expression of a full
complement of NC specifier genes: cMyc, Ets1, FoxD3, Id, Pax3/7, Snail1/2, SoxE factors
(Sox 8/9/10), TFAP2a, and Twist.
Stabilization of the specification program serves as a catalyst for activation of the
EMT effector program, which enables NC cells to delaminate from the NPB and become
invasive. As such, NC specifiers are known to play direct role in regulating cell-cell
interactions and cytoskeletal changes required for EMT. In addition, many continue to be
expressed in migratory NC, and are required for downstream lineage diversification. For
instance, Sox10 expression persists in cells that contribute to peripheral neurons and glia,
as well as melanoblasts (Aoki et al., 2003; Kim et al., 2003), whereas Sox9 regulates
differentiation of cartilage-matrix producing chondrocytes in the head (Lefebrvre et
al.,1997). Moreover, SoxE factors have been shown to be crucial for maintaining
multipotent potential and survival of the NC (Haldin and LaBonne, 2010). Similarly, other
specifiers are also known to be involved in regulating stem cell characteristics and
differentiation potential. Clonal analysis of NC stem cells (NCSCs) isolated from FoxD3
mutant mice display a severe reduction in self-renewal, and the ability to give rise to
neurons, glia and melanocytes (Mundell and Labosky, 2011), indicating a role for FoxD3
in maintaining stem cell-like characteristics, and modulating cell fate choice by preserving
neural potential. Additionally, cMyc has been shown to regulate the timing of
differentiation through repression of its downstream target, Id3 (Light et al., 2005), thus
preventing premature cell fate decisions. Persistent expression of Id3 in NC cells causes
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ectopic Sox10 expression, thus promoting a neural phenotype in cells that would have
normally adopted a chondrocyte cell fate. These studies demonstrate an essential role
for NC specifiers in establishing a progenitor state during the early stages of NC
development through maintenance of stem cell-like properties, such as self-renewal and
multipotent potential, but also in the timely activation of downstream programming
associated with migration and differentiation.

Mechanisms of NC migration
Delamination and epithelial-to-mesenchymal transition
Once specified, NC cells undergo a series of cellular changes in order to physically
separate from the neuroectoderm, and become motile. This multistep process is mediated
by an EMT effector program which coordinates signaling and transcriptional inputs to
regulate dramatic changes in cell-cell adhesion, cell-extracellular matrix (ECM)
interactions, and cytoskeletal architecture, allowing the NC cells to become less adhesive
and more motile. While all NC cells undergo EMT, the timing of delamination is different
depending on species. For instance, delamination occurs before the neural tube has
closed completely in mouse and Xenopus (Hörstadius, 1950), but after neural tube
closure in chick (Duband and Thiery, 1982). The axial origin along the length of the
embryo also contributes to subtle variations in how this process unfolds. Cephalic NC
cells tend to emerge as a collective, and delamination is not coupled with cell cycle
(Theveneau et al., 2007). In contrast, posterior trunk NC cells emerge progressively over
time, and delamination is linked with G1/S phase transitions in the cell cycle (Kalcheim
and Burstyn-Cohen, 2005; Thiery et al., 1982). One explanation for these variations
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include spatiotemporal differences in the upstream regulators responsible for triggering
EMT along the anterior-posterior axis of the embryo, such as BMP and WNT signals. In
addition, there are differences in transcription factors expressed in the NC at each axial
level that may account for differences in behavior. For instance, Ets1 is only expressed
in the cephalic NC and contributes to the collective dispersion observed during NC
delamination in the head (Theveneau et al., 2007). Nevertheless, many of the major
transcriptional regulators that drive EMT, and therefore contribute to the overall
morphological changes necessary for delamination, and subsequent migration, are
conserved across species. These aspects are briefly highlighted in this section.
While residing in the NPB, premigratory NC cells exist in a polarized, epithelial
sheet, and are tightly associated with one another through adherens junctions. One of the
first events to occur during EMT is the dissolution of these cell-cell interactions to promote
a more motile state. This involves a switch in cadherin-based cell adhesion from type I
cadherins (E-cadherin, N-cadherin), which promote strong cell-cell interactions and
stabilization of an epithelial phenotype, to type II cadherins (Cadherins 6b/7/11), which
are associated with increased motility (Obrink, 1986). NC specifiers, Snail1 and Snail2
are well-characterized mediators of cadherin-switching, and function as transcriptional
repressors that downregulate type I cadherins, most notably E-cadherin (Cano et al.,
2000). Other NC specifiers work cooperatively with Snail factors to facilitate cadherinswitching, either through upregulation or downregulation of type I and type II cadherins,
including FoxD3, Sox10 and Twist1 (Barriga et al., 2013; Cheung et al., 2005), thus
shifting the balance toward reducing overall cell adhesion.
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Concurrently, to fully detach from the neuroepithelium, delaminating NC cells must
decrease their adhesion to the ECM that comprises the basement membrane. This is
achieved by either reducing cell-ECM interactions or remodeling the ECM, and both can
be modulated by metalloproteases (MMP), tissue inhibitors of MMPs (TIMP), and
disintegrin and metalloproteases (ADAM). For instance, ADAM10 and ADAM13, are
proteases that cleave the extracellular domains of transmembrane proteins associated
with ECM, and play important roles in ECM remodeling. ADAM proteases are expressed
in cranial NC cells and have been shown to cleave fibronectin substrates during initial
emigration from the neuroectoderm (Alfandari et al., 2001). Interestingly, this same study
also found that ADAM-mediated ECM remodeling was important for downstream
migration in a stream-dependent manner, and proposed a model in which the first cranial
NC cells to emerge might leave a path of remodeled ECM behind them that subsequent
cells could follow. In addition, ADAM proteases are capable of cleaving the extracellular
domain of cadherin proteins (McCusker et al., 2009), further reducing cell-cell adhesion
leading to detachment and dispersal.
Snail factors, particularly Snail2, also appear to promote cell dispersion by
controlling actin dynamics through upregulation of RhoB, a member of the Rho family of
GTPases (del Barrio and Nieto, 2002), and inhibition of RhoB activity prevents NC cell
delamination from chick neural tube explants (Liu and Jessell, 1998). Subcellular
localization and levels of Rho activity have the ability to regulate actin polymerization and
actin-mediated attachment to the cell membrane, thus facilitating cell dispersion (Sit and
Manser, 2011). Accordingly, a more recent study using Rho biosensors to track in vivo
dynamics in live zebrafish found Rho and Rho-kinase (ROCK) signaling to be enriched
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apically in delaminating NC cells (Clay and Halloran, 2013). This led to changes in
filamentous actin (F-actin) localization, actomyosin contractility and tension that resulted
in apical detachment from the neuroepithelium, and cell retraction toward the basal
lamina. Retracting cells also exhibited a blebbing phenotype with Rho activity restricted
to the protruding edge, resulting in initial forward motility upon detachment from the
neuroepithelium. Together, the EMT effector program, driven by NC specifiers can
regulate diverse downstream outputs that orchestrate cellular changes necessary to
transform tightly adherent, epithelial cells into loose, motile cells that are capable of
undergoing directed migration.

NC migration and guidance
Following EMT, NC cells invade the space between the epidermal layer and the
underlying mesenchyme, and migrate throughout the embryo guided along stereotypical
pathways by external guidance cues. As a whole the NC can be divided into
subpopulations based on their site of origination along the anterior-posterior body axis:
cranial, vagal, trunk, and sacral. NC cells in each subpopulation initially emerge as a
sheet-like wave, but are quickly divided into distinct streams depending on their axial
origin. In addition, the distinct microenvironments and signals that the NC cells encounter
as they migrate, as well as their final destination, have the ability to influence their cell
fate. Cranial NC, which only migrate throughout the embryonic head, emerge from the
hindbrain (rhombomere segments r1-r7) and are divided into 3 streams: (1) cells
emerging from r1 and r2 will migrate to the frontonasal process and first pharyngeal arch
where they form the skeletal elements of the face, and bones of the ear, (2) cells from r4
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populate the second pharyngeal arch, giving rise to the cartilage of the neck, and (3) cells
emerging from r6 populate the third and fourth pharyngeal arches, where they contribute
to forming the thymus, parathyroid and thyroid glands (Le Lievre and Le Douarin, 1975).
In addition, a subset of NC cells from r6, termed the cardiac NC, will continue to migrate
toward the heart where they contribute to parts of the septum of the outflow tract (Waldo
et al., 1998). The vagal NC, a transitional population found between the cranial and trunk
NC, emerges from the hindbrain region adjacent to somites 1-7 and contributes to the
smooth muscle that lines the aortic arch arteries and portions of the enteric nervous
system, among other derivatives (Hutchins et al., 2018). The trunk NC emerges between
somites 8-27, and splits into 2 discrete streams: (1) a dorsolateral stream in which NC
cells move between the epidermis and the somites to colonize skin and hair follicles,
giving rise to melanocytes, and (2) a ventral stream in which migration is restricted to the
anterior portion of the somites. The NC cells that migrate along the ventral pathway
contribute to sympathetic and dorsal root ganglia, adrenomedullary cells, and Schwann
cells (Le Douarin and Teillet, 1974). Lastly, the sacral NC, which contributes to the enteric
nervous system, arises posterior of somite 28 (Pomeranz et al. 1991).
Migratory routes are defined by positive and negative guidance cues, as well as
permissive ECM molecules, which ensure that the NC cells remain on track. We will briefly
focus on these guidance mechanisms in the cranial and trunk NC as it is most relevant to
the work presented in this dissertation. In the head, cranial NC cells are directed into three
distinct streams by establishing NC-free zones adjacent to r3 and r5. This is achieved
through the inhibitory action of eph/ephrins and semaphorin/neuropilin/plexin signaling
pathways. In mouse, cranial NC cells express a complex combination of ephrins and Eph
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receptors (Davy et al., 2004), which when coupled with ephrin and Eph receptor
distribution in the surrounding mesenchyme results in a “code” that promotes proper
cranial NC patterning by preventing the streams from mixing (Baker and Antin, 2003).
Cranial NC cells also express neuropilins 1 and 2, and plexinA, which are receptors
sensitive to class3-semaphorin ligands secreted from surrounding tissues, specifically r3,
r5 and the otic vesicle, which also acts as a physical barrier influencing migratory
patterning (Eickholt et al., 1999; Gammill et al., 2007). Both signaling pathways contribute
to maintaining NC-free zones by causing cell protrusions to collapse upon contact, and
disruption of signaling leads to ectopic migration outside the specified routes.
While negative guidance cues keep the streams distinct, a variety of positive
regulators direct the cranial NC cells toward their final destinations. Some of the most
characterized include FGF, VEGF, PDGF signaling, all of which have been implicated in
driving the migratory NC toward the frontonasal process, and into the pharyngeal arches
(Kubota and Ito, 2000; McLennan et al., 2010; Sato et al., 2011; Smith and Tallquist,
2010; Trokovic et al., 2005). Another positive regulator is the chemokine Stromal cellderived factor 1 (SDF1, also known as CXCL12), which is secreted by the pharyngeal
endoderm and the epibranchial placodes (Olesnicky Killian et al., 2009; Theveneau et al.,
2010). In vivo and in vitro studies have shown that binding of SDF1 to its receptor,
CXCR4, is sufficient to attract cranial NC cells as they migrate ventrally away from the
neuroectoderm and into the pharyngeal arches during migration in Xenopus (Theveneau
et al., 2010). In addition, SDF1/CXCR4 signaling serves to stabilizes cell protrusions
through activation of Rac1, a small GTPase, thus promoting directed migration.
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In trunk NC cells, directed migration along the ventral pathway is controlled by
negative regulators expressed on the posterior portion of the somites, which serves to
restrict movement along the anterior half. Establishing this NC-free zone is mediated by
the similar signaling pathways as described for the cranial NC, including Eph/ephrin and
neuropilin/semaphorin signaling. Trunk NC cells express EphA/B receptors, and
neuropilin1/2, while the posterior half of the somites expresses Ephrin-B ligands, and
Semaphorin F. Disruption of these signaling cues leads to unsegmented migration and
fusion of the peripheral ganglia (Baker and Antin, 2003; De Bellard et al., 2002; Gammill
et al., 2006; Schwarz et al., 2009) Slit/Robo signaling also ensures that the migratory cells
are guided along their respective pathways by selectively preventing trunk NC from
entering the gut, while concurrently allowing the vagal NC passage (De Bellard et al.,
2003). Finally, trunk NC cells are responsive to SDF1/CXCR4 signaling, but in a speciesspecific manner as trunk NC cells expressing CXCR4 give rise to dorsal root ganglia in
the mouse (Belmadani et al., 2005), but sympathetic ganglia in chick (Kasemeier-Kulesa
et al., 2010), and in both cases, of SDF1/CXCR4 lead to aberrant ganglia formation.
Eph/ephrin, Slit/Robo, and endothelin signaling regulate trunk NC cells as they
migrate along the dorsolateral pathway. Trunk NC cells exhibit differential expression of
Eph, Robo and endothelin receptors depending on the timing of emigration from the
neural tube, which dictates if they continue along the dorsolateral or ventral path (Harris
et al., 2008; Jia et al., 2005; Pla et al., 2005; Santiago and Erickson, 2002). The first wave
of trunk NC cells tend to express EphB3, Robo1/2, and endothelin receptor B, and are
forced toward the ventral pathway, where they will contribute to neural derivatives.
However, trunk NC precursors in subsequent waves express EphB2 and endothelin
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receptor B, which respond positively to surrounding ephrin and endothelin signals, thus
promoting continued migration along the dorsolateral pathway. These NC cells will go on
to colonize the skin giving rise to melanocytes. Although, species-specific variation in
determining pathway preference has been observed. For instance, melanocyte
precursors in zebrafish and frog can travel along either the dorsolateral or ventral
pathway, indicating that there are a portion of trunk NC cells that may be controlled by
other unidentified guidance cues (Collazo et al., 1993).
While guidance cues help to establish a defined route, positive and negative
guidance cues alone are not enough to account for the high degree of directionality
observed during NC cell migration. As a collective, NC precursors will migrate in chains
or as clusters of cells, and directionality is mediated through transient cell-cell interactions
in a process known as contact inhibition of locomotion (CIL). During CIL, collision between
two cells leads to retraction of protrusions at the site of contact. This results in a shift in
cell polarity that restricts more stable protrusions to a new leading edge within the cell,
thus providing the means to elicit a change in direction (Mayor and Carmona-Fontaine,
2010). This process relies on homotypic binding of N-cadherin and reciprocal noncanonical Wnt/PCP signaling at the site of contact, which control the activity of small
GTPases Rac1 and RhoA. Collision activates RhoA and inhibits Rac1, thus resulting in
cytoskeletal rearrangement and cell repolarization (Carmona-Fontaine et al., 2008;
Theveneau et al., 2010). RhoA activity is associated with the back or trailing edge of a
cell, where it controls stress fiber contractility associated with focal adhesions. In contrast,
Rac1 is crucial for stabilizing the dynamics of the actin cytoskeleton at the front or leading
edge of a cell (Ridley and Hall, 1992). The combined action of both RhoA and Rac1 are
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required for directed migration, and if either are disrupted CIL is inhibited and cells
produce ectopic protrusions. In that light, CIL also mediates cell dispersion by preventing
migrating NC cells from overlapping one another.
Furthermore, the dispersive effect of CIL is counteracted by a process known as
co-attraction. In this mechanism, migrating NC cells secrete complement factor C3a, but
also express its receptor, C3aR. Reciprocal, paracrine signaling produces a localized C3
gradient that pulls migratory NC cells toward one another. Binding of C3a to its receptor
activates Rac1, thus repolarizing the cells and establishing a new leading edge. This
changes the direction of the cells such that they move back toward the collective
(Carmona-Fontaine et al., 2008). In this way, migratory NC cells never stray too far away
from their respective stream, and are able to maintain a collective state as they migrate
throughout the embryo. When taken as a whole, robust directed migration in the NC is
mediated by the combined efforts of cell dispersion and co-attraction, as well as repulsive
and permissive environmental guidance cues. Together these mechanism drive migratory
NC cells toward their final sites of arrest within the embryo, where they ultimately
differentiate into a variety of derivatives.

Diversification in the NC
Cell fate determination in the NC is a multistep process that unfolds gradually over
time, in which NC cells undergo a series of morphological and behavioral transformations
to attain cell type-specific function. While NC cells are exposed to a variety of cues during
migration that may bias differentiation capacity toward a particular cell fate, several
studies have shown that a majority of the NC cells remain multipotent up until this point,
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both in vitro (Baroffio et al., 1991; Bronner-Fraser and Fraser, 1988; Sieber-Blum and
Cohen, 1980; Trentin et al., 2004), and in vivo (Baggiolini et al., 2015; Bronner-Fraser
and Fraser, 1988, 1989; McKinney et al., 2013; Serbedzija et al., 1990). How NC cells
lose their multipotent potential as they undergo differentiation continues to be an area of
active investigation.
As migrating NC cells begin to colonize regions of the embryo, they will transition
from migratory streams to forming cell aggregates, which interact with surrounding cell
populations to form various tissues and structures (Bronner and Le Douarin, 2012). As a
whole, the NC has the remarkable capacity to give rise to a multitude of diverse cell types.
However, specific derivatives are predominantly determined by where NC cells originated
from along the length of the embryo, with exception of melanocytes, which are derived at
all axial levels (Le Douarin, 1982).
Cranial NC cells give rise to a larger diversity of differentiated cell types compared
to other NC cell populations, and are considered a major contributor to the formation of
the vertebrate head. The cranial NC cells uniquely give rise to cartilage and bone that
comprise the craniofacial skeleton, including the upper and lower jaw (Couly et al., 1998),
bones in the middle ear (Anthwal and Thompson, 2016) and odontoblasts of the dental
papilla (Chai et al., 2000). In addition, they contribute to connective tissues, such as the
stroma of the thymus, parathyroid and thyroid glands (Le Lievre and Le Douarin, 1975),
and the cornea endothelial and stromal cells of the eye, as well as the ciliary muscles of
the anterior segment (Gage et al., 2005). They also give rise to the adipocytes of the face
and neck (Billion et al., 2007), and the smooth muscle cells that line the blood vessels
found in the face and forebrain (Etchevers et al., 2001). Lastly, cranial NC cells also
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contribute to some of the cranial ganglia (superior and jugular ganglia, Thompson et al.,
2010; ciliary ganglion, Lee et al., 2003) and portions of the facial, trigeminal,
glossopharyngeal and vagal nerves, as well as the glial cells that myelinate them (Couly
et al., 1998).
Trunk NC cells contribute to the different types of dorsal root ganglia, together
enabling sensation of touch, temperature, and pain stimuli, and proprioception. They also
give rise the sympathetic and parasympathetic ganglia, Schwann cells, and
adrenomedullary cells (Le Douarin and Teillet, 1974). Finally, the vagal NC cells
contribute to portions of the heart and enteric nerves of the gut (Hutchins et al., 2018),
while sacral NC largely contribute to the enteric nervous system (Pomeranz et al. 1991).
Distinct gene regulatory modules associated with different NC cell derivatives have
been established. Our current understanding of these circuits is centered around the
contribution of NC specifiers, for instance Sox10 for the neural lineages, and Sox9 for
chondrogenesis, and known signaling inputs from surrounding tissues. However, they are
incomplete, as many questions still remain concerning the direct regulatory interactions
that mediate the transition toward a particular cell fate (Betancur et al., 2010; Meulemans
and Bronner-Fraser, 2004). In the sections that follow we will briefly discuss some of the
regulatory mechanisms that contribute to the differentiation of ectodermal and
mesoectodermal derivatives, with a specific focus on peripheral gangliogenesis, and the
formation of the craniofacial skeleton.
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Peripheral neurogenesis
NC cells give rise to components of the PNS, which include sensory and autonomic
neurons, including sympathetic and parasympathetic ganglia, as well as Schwann cells.
In general, sensory neurons function to sense external stimuli, such as touch, pain and
temperature, and relay that information to the CNS. During sensory neurogenesis in
dorsal root ganglia, migratory trunk NC cells undergo differentiation in three waves, where
each give rise to a different sensory neuron subtype. In the first wave, trunk NC cells form
large diameter proprioceptive and mechanoreceptive neurons, which sense touch, limb
movements and position. These neurons express the neurotrophic tyrosine receptors
TrkB (NTRK2) and TrkC (NTRK3), and respond to neurotrophic factors brain-derived
neurotrophic factor (BDNF) and Neurotrophin 3 (NT-3) for survival. The second wave
produces small diameter nociceptive neurons, responsible for sensing pain, as well as
more TrkB/TrkC neurons. Based on their expression of TrkA (NTRK1), nociceptive
neurons can be classified as peptidergic (TrkA+) or non-peptidergic (TrkA-).
In the mouse, waves of neuronal differentiation begin at E8.5, but full maturation
of the neurons doesn’t occur until much later in embryonic development. During that time
the various subtypes are further specified through activation of a cascade of
transcriptional regulators driven by WNT signaling (Ikeya et al., 1997). First, neurogenin1
and 2 (Ngn1/2) are expressed, which bias the neurons along the sensory lineage, rather
than the autonomic lineage (Perez et al., 1999; Zirlinger et al., 2002). Ngn1 appears to
specify TrkA+ neurons, although it has been shown to play minor roles in specification of
the other neuronal cell types, as well. Ngn2 is expressed predominantly in TrkB+/TrkC+
cells, albeit transiently, as it is downregulated over time. Ngn1/2 activates expression of
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the Neuronal Differentiation (NeuroD) family of transcription factors, as well as Forkhead
Box S1 (Foxs1), Brain-Specific Homeobox/POU Domain Protein 3A (Brn3a), RuntRelated Transcription Factor 1 or 3 (Runx1/3) and Ret Proto-Oncogene (Ret), which
promote terminal differentiation depending on the levels of Runx1/3 and Ret. Specifically,
TrkB+/TrkC+ cells will become mechanoreceptive in the presence of Runx3 and Ret, but
low levels of Ret specify the proprioceptive cell fate. Finally, diversification into TrkA+
peptidergic neurons requires Ret, but expression of Ret and Runx1 promotes generation
of TrkA- non-peptidergic neurons (reviewed in Marmigère and Ernfors, 2007).
Moreover, studies have showed that as Ngn factors are increasingly expressed,
Sox10, which was expressed in the migratory NC, is downregulated (Zirlinger et al.,
2002). Sox10 expression is not necessary for dorsal root gangliogenesis, but does play
a crucial role in the development of Schwann cells. Schwann cells not only myelinate the
dorsal root ganglia, but they provide trophic support essential for survival. Accordingly,
dorsal root ganglion formation occurs normally in Sox10-null mice, however the neurons
undergo apoptosis shortly thereafter (McKeown et al., 2005; Sonnenberg-Riethmacher et
al., 2001). Thus, activation of Ngn promotes sensory neuron differentiation by activating
a downstream cascade of gene expression events leading to subtype specification, and
by repressing competing fate programming.
Sympathetic ganglia, on the other hand, are responsible for maintaining
homeostasis by regulating hormone release, heart rate and blood pressure. In the trunk,
BMP signaling cooperates with Sox10 to induce a sympathetic cell fate through induction
of Achaete-Scute Family BHLH Transcription Factor 1 (Ascl1) and Paired Mesoderm
Homeobox Protein 2B (Phox2b) (Kim et al., 2003; Morikawa et al., 2009). These
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transcriptional regulators activate Paired Mesoderm Homeobox Protein 2A (Phox2a),
GATA Binding Protein 2 and 3 (GATA2/3), Heart And Neural Crest Derivatives Expressed
2 (Hand2), and Insulinoma-Associated Protein 1 (Insm1), which cross-regulate each other
to mediate survival and further differentiation (Huber, 2006; Rohrer, 2011). Mature
sympathetic neurons express TFAP2a, which interacts with Phox2b to activate tyrosine
hydroxylase (TH), and dopamine beta hydroxylase (Kim et al., 1998), leading to
production of norepinephrine, which contributes to activation of the “flight-or-fight”
response in times of stress.
Currently, much of our understanding of the GRN underlying peripheral
gangliogenesis is derived from studies of trunk NC (Betencur et al., 2010), and we have
limited information about the mechanisms that drive this process in the head. Cranial NC
cells contribute sensory neurons to the proximal ganglia of the facial, glossopharyngeal
and vagal nerves, as well as the trigeminal ganglia in conjunction with placodal cells
(D’Amico-Martel and Noden, 1983). Projections from the cranial NC-derived ganglia
innervate the spinal trigeminal tract (Harlow et al., 2011; Harlow and Barlow, 2007), in
order to relay sensory information regarding touch, pain, and temperature. In that light,
cranial ganglia are similar to dorsal root ganglia in the trunk, and therefore may share
similar mechanisms during differentiation in the head.
It has been shown that proper cranial ganglia assembly requires the interaction
between migrating cranial NC cells and placodal cells (reviewed in Steventon et
al., 2014). During gastrulation, placodal cells are induced in a domain adjacent to the NC
within in the neuroectoderm. As development progresses, the ectoderm thickens and
invaginates to form cranial placodes that contribute to sensory neurons and paired
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sensory organs. Studies have shown that ablation of premigratory NC cells abolishes
placode formation, and a loss of placodal ectoderm inhibits NC cell migration (Theveneau
et al., 2013). In addition, migrating NC cells appear to form a tunnel through which
placodal neuroblast cells will travel just prior to coalescence, and ablating the cranial NC
results in displaced ganglia and abnormal projections to the CNS (Begbie and Graham,
2001). Finally, altered cranial NC migration in mice due to a loss of neuropilin2 results in
fusion of ganglia, and ectopic neuron formation (Schwarz et al., 2008). Therefore, it is
thought that the cranial NC cells provide a scaffold for integrating the two populations
together to mediate proper condensation and positioning in order to facilitate full ganglion
assembly.

Chondrogenesis in the cranial NC
During facial skeletogenesis, the streams of migrating cranial NC cells first
colonize the frontonasal prominence and pharyngeal arches, then differentiate to form
specific types of cartilage that eventually contribute to the skeletal elements of the face
and throat (reviewed in D’Souza et al., 2010). NC cells that migrate into the frontonasal
prominence give rise to the skeletal elements of the forehead, nose, upper lip and primary
palate. Those that migrate into the first pharyngeal arch are separated into the maxillary
and mandibular prominences, which contribute to the formation of the upper and lower
jaw, respectively, among other elements. NC cells within the mandibular prominence form
the Meckel’s cartilages, which provide a scaffold for development of the lower jaw, and
the malleus and incus of the ear. Those that migrate into the second arch contribute to
the stapes of the ear, in addition to the hyoid bone, in conjunction with NC cells found
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within the third pharyngeal arch. Finally, NC cells that migrate into the fourth pharyngeal
arch give rise the thyroid cartilage.
Once migrating cells are recruited to sites of prospective skeletal element
formation, chondrogenic differentiation unfolds in a series of well-described steps
(reviewed in Bobick et al., 2009; Ray and Chapman, 2015). First, progenitor cells, which
are initially dispersed and randomly organized, quickly aggregate to form condensations.
Aggregation is mediated by increased cell-cell interactions, and changes in cell shape in
which migrating cells will exchange their stellate, motile morphology for a cuboidal one,
indicative of the chondroprogenitor state. Together, these changes trigger overt
chondrogenic differentiation characterized by increased production of cartilage-specific
matrix molecules, including various types of collagen, and proteoglycans, such as
aggrecan. As chondrocytes mature they continue to synthesize and remodel the ECM,
thus contributing to the integrity of the cartilaginous framework. In addition, cranial NC
cells can give rise to osteogenic cells fates in response to signals derived from the
pharyngeal epithelia (Hall, 1980).
Finally, craniofacial bone formation in the head occurs through both endochondral
and intramembranous processes (reviewed in D’Souza et al., 2010). Ossification of the
hyoid and thyroid cartilages, and bones of the ear occur through an endochondral process
in which mature chondrocytes differentiate toward a terminal hypertrophic state and
undergo apoptosis, thus allowing infiltration of osteoblasts that facilitate bone
mineralization (Mackie et al., 2008). In contrast, the mandible and other facial skeletal
elements undergo intramembranous ossification. Concerning mandible development
specifically, a portion of NC cells differentiate into osteoblasts which lay down a
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mineralized bone matrix that surrounds and replaces the Meckel’s cartilages (Bhaskar et
al. 1953; Chai et al., 2000; Funato et al., 2009; Radlanski et al., 2003; Tomo et al., 1997).
However, secondary mandibular condylar cartilages, which serve as a growth center for
the mandible at later stages of development, undergo endochondral ossification
(Silbermann and Frommer, 1972).
Controlling chondrogenesis in the cranial NC is a transcriptional circuit regulated
by the NC specifier, Sox9. In mouse, Sox9 regulates the expression of Sox5 and Sox6
(Akiyama et al., 2002), which then cooperate with Sox9 to directly activate the expression
of collagen type 2a1 (Col2a1) and aggrecan (Bell et al., 1997; Lefebvre et al., 1998; Ng
et al., 1997). Sox9 transcriptional activity is dependent on histone acetyltransferase
CREB-binding protein (CBP)/p300 (Tsuda et al., 2003), and maximal expression is
mediated through synergistic binding of not one, but multiple enhancers often located far
upstream of the target gene (Liu and Lefebvre, 2015). In addition, Sox9-mediated gene
expression can be enhanced through interactions with additional binding partners, such
as SMAD3, a transcriptional mediator of TGFβ signaling pathway (Furumatsu et al.,
2005). Moreover, the Sox9 and Sox5/6 trio has also been shown to regulate a number of
other genes involved in chondrogenesis, including ECM components, Col9a2 and
Col11a2 (Bi et al., 1999), and may be involved in repressing genes associated with the
hypertrophic state, such as Col10a1 (Wang et al., 2013) and Runx2 (Liu and Lefebvre,
2015). Consequently, a loss of Sox9 in in murine cranial NC cells results in a reduction in
the ability to form chondrogenic nodules, increased expression of hypertrophic markers
Runx2 and Col10a1, and severe craniofacial defects due to an absence of endochondral
cartilage and bone elements in the face (Mori-Akiyama et al., 2003).
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Other transcription factors involved in regulating chondrogenesis are the Runtrelated transcription factors Runx1 and Runx2. While both Runx1 and Runx2 transcription
factors are known to regulate chondrogenesis during skeletal development, they do so in
a stage-specific manner. Runx1 is highly expressed in mesenchymal condensations
observed early in the differentiation process (Wang et al., 2005), and enhances cartilage
matrix production in cooperation with Sox9 (Yano et al., 2019). In addition, Runx1
expression suppresses the hypertrophic state, partly through its repression of Bapx1 (also
known as Nkx3.2; Yano et al., 2019), thus supporting the continued maintenance of the
pre-hypertrophic state. In contrast, Runx2 plays an essential role in promoting the
terminal hypertrophic state by directly activating osteocalcin (Ducy et al., 1997), Col10a1
(Li et al., 2011), and MMP13 (Hirata et al., 2012), all of which are involved in ECM
remodeling and mineralization associated with bone formation. Accordingly, terminal
differentiation was delayed in Runx2 knockout mice, and this was coupled with a complete
loss of hypertrophic chondrocytes (Yoshida et al., 2004).
One common theme inherent to the transcriptional network underlying
chondrogenesis is the reciprocal antagonism that exists between the factors associated
with either the pre-hypertrophic or hypertrophic state. While we have a fundamental
understanding of a handful of regulators that control the early and terminal stages of
chondrogenesis, we currently lack information regarding regulation of the intermediate
pre-hypertrophic state - the factors that maintain it, thus preserving the integrity of the
cartilaginous framework, and those that might shift the balance toward chondrocyte
hypertrophy and bone formation. In the developing embryo, chondrocytes differentiate
and mature over time and the progression through each step depends on the interplay
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between cell-intrinsic programming and external signaling. Discovering the transcriptional
regulators, and upstream signaling inputs, driving the intermediate stages would not only
yield a more comprehensive understanding of the GRN driving chondrogenic
differentiation, but it would provide insight into how misregulation of these factors
contribute to the formation of cranial NC-related craniofacial defects.

Thesis statement:
The current regulatory paradigms for NC differentiation along the ectodermal and
mesoectodermal lineages focus primarily on the terminally differentiated state while
overlooking the intermediate stages of the process (reviewed in Martik and Bronner,
2017). Moreover, much of our knowledge regarding the overall transcriptomic control of
peripheral gangliogenesis or chondrogenesis is not obtained from the cranial NC, but from
similar cell types, such as dorsal root ganglia derived from the trunk NC, or
chondrogenesis in mesoderm-derived stem cells or tissues. One possible explanation for
this gap in knowledge is that the cranial NC is a rare and transient population of cells, and
the intermediate stages of differentiation are difficult to capture in vivo.
While methods for isolating and expanding NC cells in vitro have been developed,
characterization of the cultures is limited to validation of cell identity and differentiation
potential, and therefore lacking pertinent information regarding how NC cells differentiate
into a particular cell type over time. In order to address essential questions regarding the
molecular mechanisms that govern this time-sensitive and stepwise process, we
established a culture system modeling the temporal progression of mammalian NC cell
differentiation. We present a detailed characterization of the morphological and
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behavioral changes that occur as NC cells differentiate along the neural and
chondrogenic lineages. The temporal benchmarks that constitute each differentiation
timeline allowed for detection and enrichment of cells within the intermediate stages of
differentiation, thus enabling dissection of the transcriptional programming underlying
their progression.
Using this culture system, we explicitly interrogated cranial NC cells to uncover the
dynamic gene expression changes that occur over the course of neurogenesis and
chondrogenesis. Our analysis revealed distinct transcriptional signatures corresponding
to the intermediate stages, as well as putative regulators that drive the differentiation
process over time. We also demonstrate that despite being two very different cell types,
peripheral neurons and cartilage-matrix producing chondrocytes share many features in
common, including morphological and behavioral changes during differentiation, and the
transcriptional programming that governs key biological processes and pathways
underlying those changes. These results provide crucial insight into the mechanisms that
drive neurogenesis and chondrogenesis in the developing head. In addition, the work
presented here serves as a platform to uncover novel cellular and molecular mechanisms
that contribute to the etiology and pathogenesis of cranial NC-related structural and
functional birth defects and disorders.
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Chapter II

Materials and Methods

Experimental animals
All animal procedures were conducted according to NIH's Guide for the Care and
Use of Laboratory Animals and approved by the Institutional Animal Care and Use
Committee (IACUC) at the University of Wisconsin-Milwaukee. Sox9-cre mice, in which
an IRES-Cre-pA cassette was inserted within the 3’UTR of the endogenous Sox9 gene,
were a kind gift from Dr. Benoit de Crombrugghe (Akiyama et al., 2005). B6.129X1Gt(ROSA)26Sor

tm1(EYFP)Cos

/J mice (Srinivas et al., 2001), henceforth designated as

R26R-EYFP, were obtained from Jackson Laboratory (Bar Harbor, ME). Timed matings
between homozygous mice from each strain were conducted to produce Sox9cre; R26REYFP embryos. The presence of a vaginal plug on the following morning was counted as
embryonic day (E) 0.5.

Neural crest cell culture
Primary cranial and trunk NC cells were cultured using protocols adapted and
modified from Stemple and Anderson, 1992; Bixby et al., 2002; Ishii et al., 2012.

Basal medium
The basal medium was prepared as previously described (Bixby et al., 2002).
Basal medium comprised: Dulbecco’s Modified Eagle’s Medium (DMEM)- Low glucose,
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pyruvate (Gibco), 30% Neurobasal-A Medium (Gibco), 15% Chick embryo extract
(prepared as described in (Stemple and Anderson, 1992), 55 mM 2-mercaptoethanol
(Gibco), 1% N2 supplement (Gibco), 2% B27 supplement (Gibco), 100 U/mL penicillin
and 100 µg/mL streptomycin (Corning). Basal medium was sterile filtered (0.22 µm pore
size) and supplemented with 25 ng/mL recombinant human basic fibroblast growth factor
(bFGF; R&D Systems), 20 ng/mL recombinant human insulin-like growth factor 1 (IGF1;
Gibco) and 35 ng/mL retinoic acid (Sigma).

Isolation and expansion
Cranial or trunk tissues were specifically dissected from at minimum 6 Sox9cre;
R26R-EYFP mouse embryos at E9.5. Cranial tissues were dissected rostral of the otic
vesicle, excluding the pharyngeal arches and frontonasal process, and trunk tissues were
dissected between somite 8 and somite 24 to avoid isolation of the vagal NC. Dissection
of cranial or trunk tissues took place in ice cold phosphate-buffered saline (PBS) with no
calcium and magnesium. Upon dissociation, four cranial or trunk tissues were pooled into
one well of a 24-well plate, and tissues were enzymatically digested in 400 uL Accumax
(STEMCELL Technologies) for no more than 15 minutes with agitation on a nutator.
Reactions were quenched in 10% heat inactivated fetal calf serum (HI-FCS; Gemini BioProducts) in DMEM (Gibco), and pelleted at 300g for 5 minutes. After aspirating the
supernatant, cell pellets were resuspended in 250 uL fresh 10% HI-FCS/DMEM. Cranial
or trunk cell suspensions were subjected to fluorescence activated cell sorting (FACS;
BD FACSAria III flow cytometer, equipped with a 70 μm nozzle) in order to isolate EYFPpositive cranial or trunk NC cells.
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Live, EYFP-positive cranial or trunk NC cells were grown in basal medium at 37ºC,
5% CO2 on tissue culture-treated plates/flasks coated with 50 µg/mL Poly-D-Lysine
(Sigma) and 150 µg/mL Fibronectin (Akron Biotechnology). Cells were seeded at 30,000
cells/cm2 and passaged every 4 days. Approximately half of the basal medium was
exchanged every other day. Primary cells isolated via FACS were defined as passage 0
(P0), and each cycle of trypsinization and re-seeding was considered to be an additional
passage.
For subculturing, cells were rinsed with PBS and treated with 0.25% trypsin-EDTA
(Gibco) at 37°C for 3 min. Cells were neutralized in 10% HI-FCS (Gemini Bio-Products)
in DMEM and counted prior to re-seeding onto freshly coated plates/flasks. Cultures were
typically diluted 2 to 3 times with a target seeding density of 30,000 cells/cm2. Under these
conditions, the primary cranial and trunk NC cells maintained logarithmic growth for an
extended period of time.

Quantification of doubling time
Doubling time was determined as cells were passaged every 4 days (96 hours)
over the course of a 20-day period. At each passage, cells were initially seeded at a
density of 30,000 cells/cm2, then after 4 days, cells were detached and final, live cell
counts were determined using the Trypan Blue exclusion method. Initial and final cell
concentrations at each passage were calculated by normalizing against surface area.
Doubling time at each passage was determined using an online doubling time calculator
(Roth, 2006).
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Differentiation of NC cultures
For all derivatives, cultured cells were expanded for 3 passages prior to
differentiation. Each differentiation experiment was carried out in duplicate and repeated
using at minimum three independent cell isolates, for a total of six replicates.

Generation of neuronal cells
Primary cranial or trunk NC cells were seeded at 10,000 cells/cm2 onto tissue
culture-treated glass slides coated with 50 µg/mL Poly-D-Lysine (Sigma) and 10 µg/mL
Laminin (Corning). Cells were grown in neuronal differentiation medium: Neurobasal-A
medium (Gibco), 2 mM GlutaMAX (Gibco), 2% SM1 neuronal supplement (STEMCELL
Technologies), 100 U/mL penicillin and 100 µg/mL streptomycin (Corning). Medium was
sterile filtered, then supplemented with 100 ng/mL mouse nerve growth factor 2.5S (NGF;
MilliporeSigma) and 50 ng/mL recombinant human neurotrophin-3 (NT3; MilliporeSigma).
Half the medium was exchanged every other day.

Generation of glial cells
Primary cranial or trunk NC cells were seeded at 12,000 cells/cm2 onto tissue
culture-treated glass slides coated with 50 µg/mL Poly-D-Lysine (Sigma) and 10 µg/mL
Laminin (Sigma). Cells were grown in glial differentiation medium, as previously described
(Ishii et al., 2012): DMEM/F12 (Gibco), 1% HI-FCS (Gemini Bio-Products), 2 mM
GlutaMAX (Gibco), 2% B27 supplement (Gibco), 100U/mL penicillin and 100 µg/mL
streptomycin (Corning). Medium was sterile filtered, then supplemented with 50 ng/mL
recombinant human bone morphogenetic protein 2 (BMP2; Gibco) and 50 ng/mL
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recombinant human leukemia inhibitory factor (LIF; MilliporeSigma). Half the medium was
exchanged every other day.

Generation of chondrocytes
Chondrogenic differentiation was induced using methods adapted from those
previously described (Ishii et al., 2012). Primary cranial or trunk NC cells were initially
cultured as a monolayer (30,000 cells/cm2) on tissue culture-treated plates coated with
50 µg/mL Poly-D-Lysine (Sigma) and 150 µg/mL Fibronectin (Akron Biotechnology). Cells
were grown for 3 days in osteogenic differentiation medium: a-MEM (Corning), 10% HIFCS

(Gemini

Bio-Products),

0.1

µM

Dexamethasone

(Sigma),

10

mM

β-

glycerophosphate (Sigma), 50 µg/mL L-ascorbic acid (Sigma), 100 U/mL penicillin and
100 µg/mL streptomycin (Corning). Medium was sterile filtered, then supplemented with
100 ng/mL recombinant human bone morphogenetic protein 2 (BMP2; Gibco). Then on
Day 4, cells were harvested and cultured as a micromass (Zhang et al., 2010). Briefly,
cells were resuspended at 2x107 cells/mL in a 10 µL droplet. One droplet was placed in
the center of each well in a 4-well plate. Cells were allowed to adhere at 37°C for 1 hour,
prior to the addition of 400 µL chondrogenic differentiation medium (Ishii et al., 2012): aMEM (Corning), 5% HI-FCS (Gemini Bio-Products), 0.1 µM Dexamethasone (Sigma),
50µg/mL L-ascorbic acid (Sigma), 1% ITS+ Premix (Corning), 1mM sodium pyruvate
(Gibco), 100 U/mL penicillin and 100 µg/mL streptomycin (Corning). Medium was sterile
filtered, then supplemented with 10 ng/mL recombinant human bone morphogenetic
protein 2 (BMP2; Gibco) and 10 ng/mL human recombinant transforming growth factorbeta 3 (TGF-b3; Invitrogen). Half the medium was exchanged every other day.
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Generation of smooth muscle cells
Primary cranial or trunk NC cells were seeded at 30,000 cells/cm2 onto tissue
culture-treated plates coated with 50 µg/mL Poly-D-Lysine (Sigma) and 150 µg/mL
Fibronectin (Akron Biotechnology). Cells were grown in smooth muscle differentiation
medium for 7 days, as previously described (Ishii et al., 2012): DMEM (Gibco), 10% HIFCS (Gemini Bio-Products),100U/mL penicillin and 100µg/mL streptomycin (Corning).
Medium was sterile filtered prior to use. Half the medium was exchanged the day after
seeding, then the medium remained unchanged for the duration of the 7-day
differentiation process.

Generation of adipocytes
Primary cranial or trunk NC cells were seeded at 50,000 cells/cm2 onto tissue
culture-treated plates coated with 50 µg/mL Poly-D-Lysine (Sigma) and 150 µg/mL
Fibronectin (Akron Biotechnology). Cells were expanded in basal medium for 3 days to
achieve 80-90% confluency, prior to culturing in Complete MesenCultTM Adipogenic
Medium (Mouse; STEMCELL Technologies) for an additional 14 days. Half the medium
was exchanged every 3 days.

Generation of melanocytes
Melanogenic differentiation was induced using a method adapted from those
previously described (Maurer et al., 2007). Primary cranial or trunk NC cells were seeded
at 20,000 cells/cm2 onto tissue culture-treated plates coated with 50 µg/mL Poly-D-Lysine
(Sigma) and 150 µg/mL Fibronectin (Akron Biotechnology). Cells were grown for 10 days
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in melanogenic differentiation medium: Dulbecco’s Modified Eagle’s Medium (DMEM)Low glucose, pyruvate (Gibco), 2% Chick embryo extract (prepared as described in
Stemple and Anderson, 1992), 10% HI-FCS (Gemini Bio-Products), 1% N2 supplement
(Gibco), 2% B27 supplement (Gibco), 100 U/mL penicillin and 100 µg/mL streptomycin
(Corning). Medium was sterile filtered and supplemented with 1 ng/mL recombinant
human basic fibroblast growth factor (bFGF; R&D Systems), 10 ng/mL recombinant
human insulin-like growth factor 1 (IGF1; Gibco) and 100nM Endothelin 3 (ET3; Sigma).
Half the medium was exchanged every other day.

Gene expression analysis by qRT-PCR
Quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) was
performed to assess the relative expression of several markers against their expression
in the reference tissue (Fig 3: AP-2a, Snail1, Sox9, Nestin: whole/unsorted E9.5 mouse
embryo; Sox10: adult murine brain; Fig. 23: undifferentiated cranial NC). Gapdh was used
as a housekeeping gene in all experiments. Primers were both designed and checked for
specificity using Primer-BLAST (NCBI), then empirically validated prior to use (Table 1).
Total RNA was extracted using the RNeasy Micro kit, which included a DNasetreatment step (Qiagen). RNA concentration and purity were quantified using QuBit
fluorometer (Invitrogen) and NanoDrop ND2000 spectrophotometer (Thermo Scientific),
respectively. RNA integrity was determined using a 2100 Bioanalyzer (Agilent). Only
samples with RNA integrity numbers (RIN) of 8.0 or greater were used for downstream
analysis. A mixed primer strategy (Oligo dT20 and Random Primer) was used to generate
cDNA from 250 ng of high-quality RNA from each sample using the qScript Flex cDNA
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Synthesis kit (Quantabio), following the manufacture’s protocol. cDNA used as a template
in a 20 µL reaction containing 10 µL Fast SYBR Green Master Mix (Applied Biosciences)
and 125 nmol forward and reverse primers. All qRT-PCR reactions were performed in
duplicate on CFX96 Touch Real-Time PCR Detection System (BioRad). Reactions were
amplified using a 2-stage protocol: 95°C for 5 min, followed by 34 cycles of 95°C for 15 s,
and 60°C for 1 min. After the last cycle, a melt-curve was generated in order to verify that
amplification produced a single, specific product. Fold change in gene expression relative
to the reference tissue was calculated for each primer set using the [2-ΔΔCt] method (Livak
and Schmittgen, 2001).

Mesodermal gene expression analysis by RT-PCR
The expression of pan-mesodermal marker, brachyury (T), and axial mesoderm
marker, Tbx6, was assessed in cultured cranial and trunk NC cells using reverse
transcriptase-PCR (RT-PCR). NC markers, Snail1 and Sox9, and housekeeping gene,
Gapdh, served as positive controls. Primers were both designed and checked for
specificity using Primer-BLAST (NCBI), then empirically validated prior to use (Table 1).
Total RNA was isolated from cultured cranial and trunk NC cells after three
passages, or from whole/unsorted E9.5 mouse embryos. RNA was extracted and quality
was assessed prior to transcribing cDNA using 250 ng of high-quality RNA, as described
above. cDNA was diluted 1:2 prior to being used as a template in a 20 µL reaction
containing 10 µL 2X GoTaq® Green Master Mix (Promega) and 500 nmol forward and
reverse primers. Reactions were amplified on Mastercycler® Gradient thermal cycler
(Eppendorf) using the following protocol: 95°C for 2 min, followed by 30 cycles of 95°C
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for 1 min, 60°C for 1 min, and 72°C for 1 min, with a final extension step of 72°C for
10 min. Gene expression was assessed by standard gel electrophoresis. Images were
taken upon ultraviolet transillumination (UVP) using a Camedia Wide Zoom 5.1Mp digital
camera (Olympus), and processed using Photoshop Elements 2018 software (Adobe).
Table 1. qRT-PCR primers
Table 1. qRT-PCR primers
Gene
Brachyury (T)
Cabin1

NCBI Gene ID

Primer sequence

Accession number

Forward

Reverse

20997

NM_009309.2

5'-CCAGCTCTAAGGAACCACCG-3'

5'-AAAGAACTGAGCTCCCAGCC-3'

104248

NM_172549.3

5'-GCTCTCCTACACCTCTGTGACC-3'

5'-CTTTGCTGTCTCTCCACTTTCC-3'

12824

NM_001113515.2

5'-TGGTGCTCGGGGTAACGAT-3'

5'-GGCTCCAGGAATACCATCAGT-3'

NM_010057.2

5'-CCGAACTGGCTGCTTCCTTA-3'

5'-CAGAAACGTCCCACACTGGA-3'

Gapdh

13396
14433

Hand2

15111

NM_001289726.1
NM_010402.4

5'-GCTCATGACCACAGTCCATGC-3'
5'-CACCAGCTACATCGCCTACC-3'

5'-GTTGGGATAGGGCCTCTCTTG-3'
5'-CTGTCCGGCCTTTGGTTTTC-3'

MEF2C

17260
18008
20613

NM_001170537.1

5'-GTGGTTTCCGTAGCAACTCC-3'

5'-AACTGACTGAGGGCAGATGG-3'

Nestin
Snail1

NM_016701.3.1

5'-AACAGAGATTGGAAGGCCGC-3'

5'-GCCACTTCCAGACTAAGGGAC-3'

NM_011427.2.1

5'-CTGCACGACCTGTGGAAAG-3'

5'-GCCTGGCACTGGTATCTCTT-3'

Sox10

20665

NM_011437.1.1

5'-TTCAGGCTCACTACAAGAGTGC-3'

5'-ATTACCTCGTGGCTGATCTCC-3'

Sox9

20682

Tbx6

21389
21418

NM_011448.4.1
NM_011538.2
NM_001122948.1.1

5'-AGTCGGTGAAGAACGGACAA-3'
5'-TGAAGATCGCAGCCAATCCC-3'
5'-CACTCCTTACCTCACGCCAT-3'

5'-CCCTCTCGCTTCAGATCAACT-3'
5'-TGAAAAGCGGCAGGGTGTAG-3'
5'-GCCACCGTGACCTTGTACTT-3'

Col2a1
Dlx6

TFAP2a

Figure legend:
Table 1. All
primers
were designed
to span
intron and
a 150-300
base pair
amplicon
Primer-BLAST
Table
1. All primers
were
designed
to span
ananintron
andproduce
produce
a 150-300
base
pairusing
amplicon
using(NCBI).
werePrimers
tested via RT-PCR
to ensure
amplification
a single
product.
Primer-BLASTPrimers
(NCBI).
were tested
via
RT-PCRofto
ensure
amplification of a single product.

Immunocytochemistry
NOTE:
To find Accession number and Gene ID
go to https://www.ncbi.nlm.nih.gov/nuccore
type in name of gene and species (mouse)
click on transcript used to make primers from list
Accession number is under name of gene at top of page
Gene ID is listed under "GeneID", search and you will find it

Cultures were fixed with 4% paraformaldehyde for 30 minutes at room temperature

and washed three times with PBS prior to immunostaining. Cultures were then washed
two times with PBS with 0.1% Tween 20 (PBST, Sigma), blocked in 5% normal goat
serum (Gibco)/PBST for 1 hour and incubated with primary antibodies overnight at 4ºC.
The cultures were washed three times with PBST prior to incubation with fluorophoreconjugated secondary antibodies for 1 hour at room temperature. After incubation
cultures were washed an additional six time in PBST to reduce non-specific background,
followed by two washes in PBS in preparation for either 4,6-diamidino-2-phenylindole
(DAPI) staining, or coverslipping with Vectasheild mounting medium (Vector
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Laboratories). Cultures counterstained with DAPI were incubated with 300 nM DAPI
dilactate (Invitrogen) in PBS for 4 minutes, then rinsed with PBS several times prior to
imaging. Primary and secondary antibodies can be found on Table 2.
Single focal plane images were acquired with a Zeiss AxioZoom.V16 fluorescence
stereomicroscope equipped with an Orca R2 CCD camera, a Zeiss ApoTome, and
appropriate filter sets. The objective (PlanNeoFluar Z 2.3x size) on the AxioZoom.V16
has a 0.57 numerical aperture (NA). Fluorescent images were pseudocolored, as
indicated in figure legends, merged using ZEN 2011 software (Zeiss), and exported to
TIFF format using AxioVisionSE64 rel 4.9.1. (Zeiss). Overlapping images were taken in
order to obtain a representative field of view of the entire culturing surface (1 cm2 in an 8well slide). Images were aligned and stitched using the open source Fiji software
(Preibisch et al., 2009). All images were processed using Photoshop Elements 2018
software (Adobe) using Photoshop Elements 2018 software (Adobe).

Alcian blue staining
Chondrogenic micromass cultures were fixed with 4% paraformaldehyde for 30
minutes at room temperature and washed three times with PBS prior to incubation with a
0.1% solution of Alcian blue 8GX (Sigma) dissolved in acidic ethanol (5% concentrated
hydrochloric acid, 70% ethanol) overnight at 4ºC. After incubation, cultures were
destained in acidic ethanol, washed with distilled water and imaged using light
microscopy. All images were processed using Photoshop Elements 2018 software
(Adobe).
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Table
Primary
and secondary
used for immunocytochemistry
Table 2.2.
Primary
and secondary
antibodiesantibodies
used for immunocytochemisrty
Primary antibodies
Antibody

Species

Dilution

Vendor

Catalog number

aSMA
Cabin1

mouse
rabbit

1:500
1:500

eBiosciences
Abcam

14-9760-80
ab3349

Col2a1

rabbit

1:500

Abcam

ab34712

ErbB3

mouse

1:500

Thermo Fisher Scientific

MA1-860

GFAP

mouse

1:1000

Sigma

G3893

HuC/D

mouse

1:1000

Invitrogen

A-21271

MEF2C
TUJ1

mouse
mouse

1:500
1:500

Thermo Fisher Scientific
STEMCELL Technologies

MA5-17119
60052

Fluorophore-conjugated secondary antibodies
Antibody

Species

Dilution

Vendor

Catalog number

AlexaFluor 546

goat

1:1000

Invitrogen

A11030 or A11035

AlexaFluor 633

goat

1:1000

Invitrogen

A21052 or A21071

Abbreviations: αSMA, alpha smooth muscle actin; Cabin1, calcineurin binding protein 1; Col2a1, collagen,
type II, alpha 1; ErbB3, erb-b2 receptor tyrosine kinase 3; GFAP, glial fibrillary acidic protein; HuC/D, ELAVlike RNA binding proteins; MEF2, myocyte enhancer factor 2; TUJ1, neuron-specific class III β-tubulin.

Quantification of nodule number
Figure legend:

Table 1. All primers were designed to span an intron and produce a 150-300 base pair amplicon using Primer-BLAS

Primersimages
were tested
RT-PCR
to ensure
amplification
a single
product.
Overlapping
of via
Alcian
blue
stained
culturesofwere
taken
in order to obtain a

representative field of view of the entire culturing surface of a well (2 cm2) in a 4-well plate.
Four images from each well were aligned and stitched using the open source Hugin
NOTE:
software
(d’Angelo, 2007). Nodule number was determined at each time point in duplicate

To find Accession number and Gene ID
go to https://www.ncbi.nlm.nih.gov/nuccore
using
the particle
analysis
in ImageJ (Schneider et al., 2012). The results from three
type in name
of gene and
species tool
(mouse)
click on transcript used to make primers from list
Accession number independent
is under name ofcultures
gene at topwere
of page
used to calculate the average number of nodules at each time
Gene ID is listed under "GeneID", search and you will find it

point.

Alcian blue extraction
Cartilage-matrix accumulation was assessed by extracting specifically bound
Alcian blue dye from the micromass cultures, as previously described (Paulsen et al.,
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1988). Micromass cultures were solubilized in 4 M guanidine hydrochloric acid, pH 5.8
(GuHCl) overnight at 4ºC. Following incubation, absorbance at 600nm was measured
using a spectrometer (Eppendorf BioPhotometer). Absorbance values were normalized
against those measured at Day 0. The results from three independent cultures were used
to determine the net amount of cartilage-matrix present at each time point.

Oil red O staining
Adipogenic differentiation was assessed by staining with Oil Red O (Humason,
1962; Thermo Fisher Scientific). Cultures were fixed with 4% paraformaldehyde at room
temperature for 30 minutes, washed three times with PBS, then incubated in 60%
isopropanol for 2 minutes. Cultures were then incubated with a 3:2 solution of 30% Oil
red O dissolved in isopropanol:deionized water for 5 minutes at room temperature. After
incubation, the cultures were washed with distilled water and imaged using light
microscopy. Overlapping images were taken in order to obtain a representative field of
view of the entire culturing surface of a well (2 cm2) in a 4-well plate. In this case, four
images from each well were aligned and stitched using the open source Hugin software
(d’Angelo, 2007). All images were processed using Photoshop Elements 2018 software
(Adobe).

L-DOPA reaction assay
Melanogenic differentiation was assessed by 3,4-Dihydroxy-L-phenylalanine (LDOPA) reaction assay (Tsuchiyama et al., 2013). Briefly, primary cells were fixed with 4%
paraformaldehyde at room temperature for 30 minutes, washed three times with PBS,
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then incubated with 5 mM L-DOPA (Sigma) in PBS at 37°C for 8 hours in the dark. After
incubation, the cells were washed with distilled water and imaged using light microscopy.
Overlapping images were taken in order to obtain a representative field of view of the
entire culturing surface of a well (2 cm2) in a 4-well plate. In this case, four images from
each well were aligned and stitched using the open source Hugin software (d’Angelo,
2007). All images were processed using Photoshop Elements 2018 software (Adobe).

HuC/D localization
Images of neurons differentiated from cranial and trunk NC cultures subjected to
HuC/D immunofluorescence staining as described above were quantified with respect to
the percentage of neurons extending HuC/D positive neurites. Five images were obtained
from differentiated cultures in each biological replicate, and each image was separately
analyzed by two blinded observers. Cells with neurites were identified in the green
channel (EYFP). These cells were then assessed for HuC/D expression in the red
channel to calculate the percentage of neurons with HuC/D in processes. Each dot
represents one observation of one image, color-coded by biological replicate and
observer.

Assessing Cabin1 nuclear localization
Nuclear localization was quantified using images of cranial NC cultures fixed at
several time points over the course of chondrogenesis (Undifferentiated (Day 0), and after
4 and 14 days in chondrogenic differentiation medium), and subjected to Cabin1/DAPI
immunofluorescence staining, as described above. At each time point, four representative
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images were taken per well in duplicate. Each image was then divided equally into four
fields of view using Photoshop Elements 2018 software (Adobe). Mean fluorescence
intensity (MFI) of Cabin1 staining within the nuclei in each field of view was obtained using
the particle analysis tool in Fiji (Schindelin et al, 2012), a distribution of ImageJ (Schneider
et al., 2012). Specifically, fields of view taken in the blue channel (DAPI) were used to
count and outline total nuclei. Nuclei outlines were then overlaid onto the corresponding
field of view taken in the red channel (Cabin1) to calculate MFI per nuclei. Each dot
represents MFI within one nucleus, color-coded by biological isolate.

Co-immunoprecipitation and immunoblotting
Nuclear lysates were extracted from cranial NC cells cultured in basal medium for
three passages. Total protein was determined using a DC protein assay (BioRad). 50 μg
of protein, prepared in 16.7 mM Tris-HCl (pH 8.1, Invitrogen), 1.1% Triton X-100 (Sigma),
0.01% SDS (Invitrogen), 167 mM NaCl (Thermo Fisher Scientific), and 1X protease
inhibitor (Thermo Fisher Scientific), was incubated overnight with 10 μg of either Cabin1
(Abcam, ab3349) or MEF2C (Santa Cruz Biotechnology, sc-365862) antibody in the
presence of 50uL protein A dynabeads (Invitrogen). Beads were collected magnetically
and protein complexes were eluted in 2x Laemmli buffer (BioRad) with 55 mM 2mercaptoethanol (1:20, Gibco) at 95°C for 5 minutes. In addition, 50ug of nuclear lysate
was prepared in a similar solution and denatured at 95°C for 5 minutes.
All lysates were resolved using SDS-Page. Proteins were separated on 7.5% MiniPROTEAN TGX Stain-Free gels (Bio-Rad) using the PowerPac Basic apparatus (BioRad)
for 1 hour at 150V. Proteins were transferred to 0.2 μm PVDF membranes (Thermo Fisher
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Scientific) for 1 hour at 100V. Membranes were blocked in 5% milk in tris-buffered saline
(TBS) with 0.05% Tween 20 (TBST), and then incubated overnight at 4°C with an
antibody against Cabin1 (1:1000, Abcam, ab3349) or MEF2C (1:1000, Thermo Fisher
Scientific, #MA5-17119). Membranes were then washed several times in TBST prior to a
1 hour and 30 minute incubation with the corresponding secondary antibody conjugated
with horseradish peroxidase (1:2000, Cell Signaling Technologies, Mouse Anti-Rabbit
IgG (Light-Chain Specific) (D4W3E) mAb (HRP Conjugate) #93702; Rabbit Anti-Mouse
IgG (Light Chain Specific) (D3V2A) mAb (HRP Conjugate) #58802). Membranes were
again washed several times in TBST, and stored in TBS until imaged. Proteins were
detected using Clarity Western ECL Chemiluminescent Substrate (BioRad) on a Syngene
G:BOX XT4: Chemiluminescence and Fluorescence Imaging System with GeneSys
software (Syngene). Images were processed using Photoshop Elements 2018 software
(Adobe).

Statistical Analyses
All statistical analyses and graphical representations for the data presented were
computed using GraphPad Prism, Version 7.0b for Mac OS X (GraphPad Software, La
Jolla, CA, USA, http://www.graphpad.com). Significant differences between groups were
determined using either repeated measures one-way analysis of variance (ANOVA; Figs.
2, 24), two-way ANOVA (Figs. 3, 8, 20), or unpaired t-tests (Fig. 23), as indicated.
Comparisons between means were carried out using Tukey's post hoc multiple
comparison test. Results are reported as mean ± SEM (Figs. 2, 3, 8, 23, 24) or as the
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grand mean across replicates (Fig. 20). For all experiments, p values < 0.05 were
considered statistically significant.

RNA-seq data generation
Cell isolation
Temporal changes in gene expression as cultured primary murine cranial NC cells
differentiated over time into either neurons or chondrocytes were identified using RNAseq. Undifferentiated cranial NC cells were expanded for three passages (12 days in
culture) prior to being grown under either neuronal or chondrogenic differentiation
conditions, as described above. Gene expression was interrogated in undifferentiated
cranial NC cells, and in differentiating cultures at two time points: (1) an early time point
representing a population of intermediate cells (Day 2 and Day 4 for neurogenesis and
chondrogenesis, respectively), and (2) a late time point representing a population of
differentiated cells (Day 6 and Day 14 for neurogenesis and chondrogenesis,
respectively).
Specific methods were employed to enrich for intermediate progenitors or
differentiated cells at each time point. For neurogenesis FACS (BD FACSAria III flow
cytometer, equipped with a 100 μm nozzle) was used to exclude already differentiated
neuronal cells at Day 2, which have a notably smaller cell size compared to the rest of
the cells exposed to differentiation conditions, thus enabling enrichment of an
intermediate cell population. FACS was utilized again at Day 6 to isolate differentiated
peripheral neurons employing the same size differences. For chondrogenesis, whole
cultures were processed at Day 4 as they were enriched for chondroprogenitors, which
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display the characteristic cuboidal morphology. Enrichment of differentiated chondrocytes
at Day 14 was carried out by picking individual chondrogenic nodules from our cultures.
These nodules, which contain condensed, differentiated chondrocytes, were readily
visualized throughout the cultures without the need for additional staining, and nodules
were easily lysed in preparation for RNA extraction.

RNA isolation
Total RNA was extracted from differentiating neurons or chondrocytes at the early
and late time points, and from an equivalent sample of undifferentiated cranial NC cells
set aside prior to differentiation as a control using the using the RNeasy Micro kit, which
included a DNase-treatment step (Qiagen). RNA concentration and purity were quantified
using QuBit fluorometer (Invitrogen) and NanoDrop ND2000 spectrophotometer (Thermo
Scientific), respectively. RNA integrity was determined using a 2100 Bioanalyzer
(Agilent). Only samples with RNA integrity numbers (RIN) of 8.0 or greater were used for
downstream analysis. To increase RNA yield from sorted neurogenic samples
specifically, RNA amplification was performed using the MessageAmp™ II aRNA
Amplification Kit (Ambion), following the manufacture’s protocol. Briefly, 133 ng of RNA
from each time point was reverse transcribed to produce single-stranded cDNA using a
T7 Oligo (dT) primer. After second strand synthesis and purification, the double-stranded
cDNA was used as a template for in vitro transcription with T7 RNA polymerase to
generate multiple copies of amplified RNA. Amplified RNA was purified using an RNA
clean and concentrator kit (Zymo Research) following the manufacture’s protocol, and
quality tested as described above, prior to being submitted for sequencing.
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Library preparation and sequencing
For each lineage, three biological replicates from each time point were sent to
University of Wisconsin Biotechnology Center (UWBC) for library preparation and
sequencing. cDNA libraries were generated using TruSeq Stranded Total RNA Sample
Prep Kits, (Illumina), which included an rRNA suppression step. Each cDNA library was
indexed for multiplexing, and subsequently sequenced on one lane of a S1 flow cell of
the Illumina NovaSeq device. Libraries were sequenced at 100 bp, and yielded 48 million
paired-end reads/sample.

Bioinformatic analysis
Bioinformatics analysis closely followed the approach from Dhara et al. (2019).
Briefly, after merging technical replicates of RNA-seq samples across lanes, adapter
sequences were trimmed (TrimGalore v0.4.4, --stringency 3 -q 20, paired-end mode) and
sequence quality was assessed (FastQC v0.11.5). The Kallisto pipeline (Bray et al., 2016)
was used to perform pseudoalignment against the mouse transcriptome (GRCm38.p6
Mus musculus assembly, Genome Reference Consortium Mouse Build 38, patch release
6, annotation). Kallisto was also used to quantify transcript abundances using 500
bootstrap samples, which controls for variability in estimates due to read alignment.
Differentially expressed (DE) transcripts were identified using Sleuth (v0.29.0;
Pimentel e al., 2017). A “full” model, including a factor for each time point, was estimated
for each transcript, and a Wald test was calculated for each coefficient to identify
significant differences using the undifferentiated cranial NC cells as the baseline. The
Benjamini-Hochberg (Benjamini and Hochberg, 1995) approach was used in order to
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control the false discovery rate (FDR) at 5% within each comparison. Beta values from
the model were used as a biased estimator of log-fold change. Expression heatmaps
were generated based on Z-scores calculated for log transcripts per million [TPM]
estimates using ComplexHeatmap (v1.17.1; Gu et al., 2016). Transcript clusters were
identified using the K-means algorithm, and hierarchical clustering (Euclidean distance,
complete linkage) was used to organize transcripts within clusters. Temporal clusters
were analyzed for enrichment of molecular and functional gene networks within the DE
gene sets (FDR<0.05) at each time point using PantherGO (Version 14.1, released 201903-12; Mi et al., 2013, Thomas et al., 2003), ShinyGO (v0.61, Ge et al., 2020) and gprofiler
(Raudvere et al., 2019) open source tools.
DE transcription factors at each time point were derived by comparing the overall
list of DE genes to a recently published comprehensive list of known human transcription
factors (Lambert et al., 2018). Identified transcription factors were clustered based on
their temporal differential gene expression profiles, and functional relationships between
the temporally clustered genes were inferred using PantherGO (Version 14.1, released
2019-03-12; Mi et al., 2013, Thomas et al., 2003), ShinyGO (v0.61, Ge et al., 2020) and
gprofiler (Raudvere et al., 2019) open source tools.
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CHAPTER III

Establishment of a murine culture system modeling the temporal progression of
cranial and trunk neural crest cell differentiation1

Abstract
The neural crest (NC) is a transient population of embryonic progenitor cells that
are implicated in a diverse range of congenital birth defects and pediatric syndromes. The
broad spectrum of NC-related disorders can be attributed to the wide variety of
differentiated cell types arising from the NC. In vitro models of NC cell development
provide a powerful platform for testing the relative contributions of intrinsic and extrinsic
factors mediating NC differentiation under normal and pathogenic conditions. Although
differentiation is a dynamic process that unfolds over time, until recently, we lacked a welldefined chronology that characterizes the in vitro progression of NC differentiation
towards specific cell fates. In this chapter, we present optimized culture conditions for
expansion of primary murine NC cells that give rise to both ectodermal and
mesoectodermal derivatives, even after multiple passages. Significantly, we have also
established highly reproducible timelines that include distinct intermediate stages for
lineage-specific NC differentiation in vitro. Specifically, our results define characteristic

1

This chapter is a modified version of the published manuscript. Supplementary information can be found in
Appendices A-G.
Replogle, M.R., Sreevidya, V.S., Lee, V.M., Laiosa, M.D., Svoboda, K.R., Udvadia, A.J., 2018. Establishment of a
murine culture system for modeling the temporal progression of cranial and trunk neural crest cell differentiation. Dis
Model Mech 11.
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changes in cell morphology and behavior that track the temporal progression of NC cells
as they differentiate along the neuronal, glial, and chondrogenic lineages in vitro. These
benchmarks constitute a chronological baseline for assessing how genetic or
environmental disruptions may facilitate or impede NC differentiation. Introducing a
temporal dimension substantially increases the power of this platform for screening drugs
or chemicals for developmental toxicity or therapeutic potential.

Introduction
As developmental precursors, the neural crest (NC) uniquely contributes to a wide
variety of tissues and structures in vertebrate animals. Differences in spatiotemporal
patterning during development direct the transition from multipotent, embryonic
progenitor through the eventual acquisition of specific cell fates. Some of the factors
influencing NC cell differentiation in vivo include the site of origination along the anteriorposterior neuraxis, the timing of emigration, the migratory pathway, and the final sites of
arrest within the embryo (reviewed in Betancur et al., 2010; Bhatt et al., 2013; SimõesCosta and Bronner, 2015). The remarkable plasticity of the NC allows it to give rise to cell
types as diverse in structure and function as neurons of the peripheral nervous system
and cartilage-matrix producing cells found within cephalic structures (Le Douarin, 1982).
Given their broad contribution to a range of tissues, disruption in any stage of NC cell
development can result in pleiotropic structural and functional anomalies (Bolande, 1997).
Thus, understanding the molecular mechanisms that regulate the normal growth and
differentiation of the NC is necessary for fully comprehending the etiology underlying a
plethora of birth defects.
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The ability to manipulate isolated NC cells in vitro is highly advantageous,
particularly for the purpose of testing the relative contributions of intrinsic and extrinsic
factors mediating self-renewal and differentiation. For example, in vivo, the cranial NC
normally gives rise to differentiated cells of both ectodermal and mesoectodermal cell
fates, while trunk NC produces mainly ectodermal derivatives. However, directed
differentiation of trunk NC in vitro demonstrates that trunk NC cells have the capacity to
give rise to both ectodermal and mesoectodermal cell types (recently reviewed in Dupin
et al., 2018). Direct comparisons of the two cell populations in vitro, would allow us to
tease apart any intrinsic differences in cell behavior or response to environmental cues.
In addition, in vitro models of NC development are beneficial for elucidating proteinprotein and protein-gene interactions that regulate the transcriptional programs
underlying NC growth and differentiation along distinct lineages. In such studies, in vitro
expansion of the NC is valuable as the number of NC cells per developing embryo is very
low in comparison to the millions of cells needed to investigate molecular function using
biochemical assays, such as co-immunoprecipitation and ChIP-seq analysis.
While methods for isolating, expanding and differentiating both avian (Baroffio et
al., 1991; Calloni et al., 2009; Cohen and Konigsberg, 1975; Etchevers, 2011; Kerosuo
et al., 2015; Sieber-Blum and Cohen, 1980; Trentin et al., 2004) and rodent (Bixby et al.,
2002; Etchevers, 2011; Ishii et al., 2012; Maurer et al., 2007; Pfaltzgraff et al., 2012;
Stemple and Anderson, 1992) NC cells in vitro have been established, characterization
of the cultured NC cells is limited to validation of cell identity and differentiation potential.
However, reproducible landmarks that define the temporal progression of differentiation
towards a particular cell fate in vitro have not been previously characterized. Since
50

directed differentiation of NC cells in vitro occurs over several days, delineating temporal
differences could enhance the experimental dynamic range for assessing the impacts of
genetic or environmental manipulations of the cultured cells. Therefore, our aim was to
establish a culture system of the NC that will enable future investigations assessing how
genetic or environmental perturbations may facilitate or impede NC cell differentiation
along various cell lineages.
Previous reports suggest a difficulty in long-term maintenance of murine NC cells
in culture, prompting the development of murine NC cell lines. Two murine NC cell lines
have been previously established (Ishii et al., 2012; Maurer et al., 2007). One cell line,
O9-1, was clonally-derived from cranial NC isolated from Wnt1cre; R26R/EYFP
transgenic mouse embryos (Ishii et al., 2012). The second cell line, JoMa1, was
established from clonally-derived trunk NC immortalized with the oncogene, c-myc
(Maurer et al., 2007). Although established cell lines do overcome the obstacle of longterm maintenance, one inherent drawback is the phenotypic instability that occurs over
time in culture (Geraghty et al., 2014; Ishii et al., 2012; Rao and Anderson, 1997). In
addition, the O9-1 cells have diminished differentiation capacity as they lack the ability to
give rise to neurons. Furthermore, it is not possible to directly compare cranial and trunk
NC cell behavior using these cell lines because they were derived from different genetic
backgrounds and are propagated under different conditions. Therefore, to conduct our
temporal analysis of in vitro NC differentiation, we optimized conditions for propagating
primary murine cultures of cranial and trunk NC cells.
Here we have established methods for primary murine NC cell culture that
maintains both self-renewal capabilities and broad differentiation potential over an
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extended period of time. Furthermore, we present a detailed characterization of cranial
and trunk NC cells in culture, including the molecular and morphological changes that
occur as the cells differentiate along the neuronal, glial, and chondrogenic lineages over
time. Specifically, we compared directed differentiation of cranial and trunk NC cells
isolated from Sox9cre; R26R/EYFP transgenic mouse embryos using fluorescence
activated cell sorting (FACS). Through our characterization, we have defined reproducible
benchmarks that track the progression of differentiation in vitro, many of which mimic welldocumented changes described during these processes in vivo. In addition, since we
isolated the cranial and trunk NC cells from the same embryos, we were able to directly
compare differentiation within the two cell populations. This enabled us, in some cases,
to detect subtle differences in cell morphology and behavior as cells differentiated. By
establishing a chronological baseline for how the primary cranial and trunk NC cells
differentiate under normal conditions, this culture system provides a platform for future
investigations assessing how genetic manipulation or exposure to environmental toxins
might disrupt the timing of NC differentiation.

Results
Cranial and trunk NC cells maintain expression of genes associated with NC cell
identity and self-renewal in vitro over time.
Primary cranial and trunk NC cells were separately isolated from E9.5 mouse
embryos on the basis of Sox9 reporter gene expression. Cranial tissues were dissected
rostral of the otic vesicle, excluding the pharyngeal arches and frontonasal process, and
trunk tissues were dissected between somite 8 and somite 24 to avoid isolation of the
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vagal NC (Fig. 2A, dashed lines). Cranial and trunk tissues isolated from several embryos
were separately pooled and dissociated into single cells prior to fluorescence activated
cell sorting (FACS). Sorted, EYFP-positive cells cultured in basal medium exhibited a
mesenchymal, stellate cell morphology (Figs. 2B, 2C), as previously described for NC
cells in culture (Ishii et al., 2012; Maurer et al., 2007).
Once in culture, both NC cell populations expanded relatively quickly while
maintaining their characteristic morphology. Cells were passaged every four days over a
20-day period. Although cranial NC cell growth was variable during the first four days in
culture, the cells maintained consistent growth over subsequent passages (Fig. 2D). The
trunk NC cells maintained consistent growth throughout the 20-day period (Fig. 2E). On
average, cranial and trunk NC cultures doubled approximately every 40 hours and
maintained high viability (93% ± 4.49%) based on trypan blue exclusion. Overall, the
mesenchymal, stellate cell morphology was retained as cells were passaged during the
same time period (Fig. 3A), although, we sporadically observed isolated cells exhibiting
short processes and neuronal morphology. We typically isolate approximately 9,000
cranial and 3,000 trunk NC cells/embryo. Given the average doubling times of the cells,
over 7 million cranial and 5 million trunk NC cells can be obtained from an average litter
size of 9 embryos after just three passages (12 days in culture; Appendix A). Thus, Sox9positive NC cells isolated and cultured in this manner display a robust capacity for survival
and expansion in vitro.
Furthermore, the cultured cells retained their NC cell identity and capacity for selfrenewal over time. We used RT-qPCR to assess the relative expression of several welldescribed markers of NC cell fate, including AP-2a, Snail1, Sox9 and Sox10, and stem
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Figure 2. Isolation and growth profile for primary cranial and trunk NC cells in culture. (A) Workflow
for isolating primary NC cells via fluorescence-activated cell sorting (FACS). Cranial or trunk tissues were
dissected (dashed lines) from Sox9cre; R26R-EYFP mouse embryos at E9.5. Tissues were dissociated
into single cells and sorted via FACS. Sorted, EYFP+ NC cells were cultured in basal medium and passaged
every 4 days: (B) cranial and (C) trunk NC cells. (D, E) Doubling time for cultured cranial and trunk NC cells
was calculated over 5 passages. Average doubling time was 44 and 39 hours for cranial and trunk NC,
respectively. Neither cell population showed a statistically significant difference in doubling time across the
five passages (repeated measures one-way ANOVA). All cells are derived from Sox9cre; R26R-EYFP mice
and express EYFP (green). Values represent mean ± SEM (n=3). Scale bars: (A) 200µm; (B, C) 100µm.
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cell-like marker, Nestin. Expression analysis was performed using RNA extracted from a
sampling of the cultured cranial or trunk NC cells every four days, as cells were passaged
over a 20-day period (Fig. 3A). Using this approach, we found that neither cell population
exhibited a statistically significant change in the relative expression of these genes across
the various time points (Figs. 3B, 3C). Together with the growth profile and morphological
observations of the cultured cells, these results indicate that NC cell identity and selfrenewal capacity is maintained as cells are expanded over a three-week period.

Figure 3. Maintenance of gene expression associated with NC cell identity and self-renewal.
(A) Workflow for quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR) analysis. RNA
was extracted from a sampling of cells at each passage. Expression of NC cell markers (AP2a, Snail1,
Sox9, Sox10), and stem cell-like marker (Nestin), were assessed every four days as cells were passaged
over 20 days in culture. The cultured NC cells displayed a mesenchymal morphology at each time point
across three independent cell isolates. Neither the cranial (B) nor the trunk (C) NC cells showed a
statistically significant change in the relative expression of these genes across 5 passages (two-way
ANOVA). All cells are derived from Sox9cre; R26R-EYFP mice and express EYFP (green). Values
represent mean ± SEM (n=6; three independent cell isolates carried out in duplicate). Scale bar: 50µm.
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Cranial and trunk NC cells differentiate into multiple NC derivatives in vitro.
A hallmark of NC cells in vivo is their ability to give rise to a diverse range of cell
types including ectodermal and mesoectodermal derivatives (Le Douarin, 1982).
Therefore, we tested the ability of cultured Sox9-positive cranial and trunk NC cells to
produce various cell types when exposed to lineage specific differentiation conditions.
Our results show that both cell populations could be induced to generate a broad array of
NC cell derivatives in vitro, including neuronal cells (Figs. 4A, 4B, Appendix B), glial cells
(Figs. 4C, 4D), smooth muscle cells (Figs. 4E, 4F, Appendix C), chondrocytes (Figs. 4G,
4H, Appendix D), adipocytes (Figs. 4I, 4J, Appendix D), and melanocytes (Figs. 4K, 4L,
Appendix D). For consistency, differentiation potential was assessed after passaging the
cells three times (12 days in culture), however, we have been successful in inducing
differentiation of ectodermal and mesoectodermal derivatives at both earlier and later
passages as well (data not shown).
To ensure that differentiation into mesoectodermal derivatives was not due to
inadvertent expansion of mesodermal cells, we tested for the expression of canonical
mesodermal markers, T (brachyury) and Tbx6. We did not detect expression of either
marker in cultured cranial or trunk NC cells (Appendix E). Together, these data
demonstrate that the cultured Sox9-positive cranial and trunk NC cells maintain a broad
differentiation potential in vitro, as would be expected from this multipotent cell population.
Expanding on these findings, we next sought to establish reproducible benchmarks
exhibited by the primary cranial and trunk NC cells as they differentiated towards the
neuronal, glial and chondrogenic cell fate in vitro over time.
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Figure 4. See next page for legend.
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Figure 4. Differentiation potential of cultured primary cranial and trunk NC cells. Both cranial and
trunk NC cells gave rise to known NC derivatives when grown under conditions reported to induce lineagespecific differentiation. Representative images of differentiated cells: neuronal cells (A, B; TUJ1, red; 4 days
in differentiation medium containing NT3 and NGF), glial cells (C, D; GFAP, red; 8 days in differentiation
medium containing BMP2 and LIF), smooth muscle cells (E, F; aSMA, orange; 7 days in differentiation
medium containing FCS), chondrocytes (G, H; Alcian blue staining; 6 days (G) and 14 days (H) in
differentiation medium containing TGF-b3), adipocytes (I, J; Brightfield, Inset: Oil red O staining; 14 days
in Adipogenic Medium from STEMCELL Technologies), and melanocytes (K, L; Tyrosinase, brown; 10 days
in differentiation medium containing ET3). All cells are derived from Sox9cre; R26R-EYFP mice and
express EYFP (green). Cells were expanded for 3 passages (12 days in culture) prior to differentiation.
Differentiation into each of the derivatives was consistent across replicates (n=6; duplicate cultures from
each of three independent cell isolates). Scale bars: (A – D) 50µm; (E – L) 100µm.

Cranial and trunk NC cells exhibit reproducible, temporal changes in morphology
and behavior during neuronal differentiation in vitro.
Neuronal differentiation was characterized by assessing the expression of neuronspecific class III b-tubulin (TUJ1) and ELAV-like RNA binding proteins (HuC/D) at several
time points along the 8-day differentiation process (Figs. 5 and 6). Robust expression of
both markers was observed as early as 2 days in neuronal differentiation medium (Figs.
5A, 5B; 6A, 6B). In addition, there was an observable decrease in soma size in
differentiated cells, as illustrated in cultures immunostained with TUJ1 (Figs. 5A, 5B).
Specifically, TUJ1-negative cells displayed a stellate, mesenchymal morphology (Figs.
5A’, 5B’; white lines), similar to the morphology seen in undifferentiated cells shown
previously (Figs. 2B, 2C). In contrast, TUJ1-positive cells exhibited neuronal-like
morphology with a compacted soma (Figs. 5A’’, 5B’’; cyan lines), as well as the extension
of neuritic processes.
Neuritic outgrowth continued in both cell populations as differentiation progressed
through Day 4 (Figs. 5C, 5D) and Day 6 (Figs. 5E, 5F), however under these culture
conditions, we observed clear differences in cell aggregation. After 4 days in
differentiation medium, TUJ1-positive cells derived from the trunk NC began to coalesce
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in distinct regions, forming dense aggregations (Figs. 5D, Appendix B, arrowheads).
Similar coalescence was not observed in TUJ1-positive cells derived from the cranial NC
until Day 6. In addition, the aggregates formed by cranial NC were more loosely formed
and amorphous (Fig. 5E, arrowheads) compared to those observed in cultures of trunk
NC. Aggregates observed at Day 6 in cranial NC resembled those observed at Day 2 in
cells derived from the trunk NC (Fig. 5B, cyan dashed box). The loose aggregation of
TUJ1-positive cells and moderate neuritic outgrowth, remained characteristic of the
cranial NC-derived cells as differentiation progressed through Day 8 (Figs. 5G, Appendix
B). This was in stark contrast to the aggregates formed from trunk NC-derived positive
cells, which were more compact and well-defined at Day 6 (Figs. 5F, 6F) and Day 8 (Figs.
5H, 6H, Appendix B) and displayed extensive neuritic outgrowth. The changes in
morphology and timing of aggregation were consistently observed over multiple replicates
(n=8) from several different cell isolates (n=4). Therefore, these characteristics can all be
used to assess the temporal progression of neuronal differentiation in vitro.
Another difference detected in neurons derived from trunk NC was the localization
of ELAV-like RNA binding proteins HuC and HuD. After 4 days in differentiation medium,
HuC/D was localized to the soma and neuritic processes in most of the cranial NC-derived
cells (85.89 +/- 13.12%; Figs. 6C, 6C’, 6C’’; arrowheads; quantified in Appendix F). In
comparison, HuC/D expression was observed in the soma in trunk NC-derived cells, and
mostly absent from the neuritic processes (8.51 +/- 12.91%; Figs. 6D, 6D’, 6D’’;
arrowheads; quantified in Appendix F). Differential HuC/D localization persisted through
Day 8 (6E, 6F, 6G, 6H). This axial difference suggests that HuC/D is not necessary for
neuritic outgrowth during trunk NC-derived neuronal differentiation. Having the ability to
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Figure 5. See next page for legend.
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Figure 5. Temporal progression of neuronal differentiation in cultured cranial and trunk NC cells.
Neuronal differentiation was assessed at various time points via immunostaining for TUJ1, a neuronspecific class III b-tubulin. Robust expression of TUJ1 was observed at Day 2 (A, B). Higher magnification
of boxed regions show an observable decrease in soma size when comparing TUJ1-negative cells
displaying a mesenchymal morphology (A’, B’; white lines) and cells positive for TUJ1 that display a
neuronal-like morphology (A’’, B’’; cyan lines). Neuritic outgrowth continued through Day 4 in both cell
populations (C, D). In addition, in trunk NC-derived cells, TUJ1-positive cells formed discrete aggregates
(D; arrowhead), however similar aggregation was not observed in cells derived from the cranial NC at this
time point. By Day 6, the difference in aggregation between the cell populations became more apparent (E,
F). While TUJ1-positive aggregates derived from the trunk NC were tightly compacted (F), TUJ1-positive
aggregates derived from the cranial NC were loosely formed (E; arrowheads). At Day 8, TUJ1-positive cells
derived from the cranial NC maintained a similar phenotype as seen in Day 6 (G). In contrast, TUJ1-positive
cells derived from the trunk NC displayed enhanced aggregation, coupled with extensive neuritic outgrowth
(H). Phenotypic characteristics of the cells at each time point were consistently observed (n=6; duplicate
cultures from each of three independent cell isolates). All cells are derived from Sox9cre; R26R-EYFP mice
and express EYFP (green). Red staining = TUJ1. Scale bars: 50µm.

detect such differences allows further investigation to determine the specific role of
HuC/D, and other RNA binding proteins, during neuritogenesis in the peripheral nervous
system.

Cranial and trunk-derived NC cells differentiated in culture display distinct
morphological transitions characteristic of glial differentiation in vivo.
The temporal progression underlying glial differentiation was determined utilizing
the expression of glial fibrillary acidic protein (GFAP, Fig. 7; Jessen and Mirsky, 1984).
After 4 days, robust GFAP expression could be seen in both cranial and trunk NC cells
(Figs. 7A, 7B), with most cells displaying a stellate, mesenchymal morphology
comparable to undifferentiated cells shown previously (Figs. 2B, 2C). After 10 days in
glial differentiation medium, the cells exhibited a more diversified range of cell
morphologies. Specifically, some of the GFAP-positive cells displayed flattened, sheetlike processes (Figs. 7C, 7D; asterisks), similar to those formed by Schwann cell
precursors, while other cells had adopted an elongated, spindle-like morphology (Figs.
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Figure 6. See next page for legend.
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Figure 6. Cultured cranial and trunk NC cells exhibit differential HuC/D localization during neuronal
differentiation. Neuronal differentiation was assessed at various time points via immunostaining for
HuC/D, a pan-neuronal marker recognizing neuron-specific RNA binding proteins. Robust HuC/D
expression was observed after 2 days in differentiation medium (A, B). By Day 4, a difference in HuC/D
localization in neuritic processes between the cell populations was observed (C, D; arrowheads). Higher
magnification of boxed regions show HuC/D localized to the soma and neuritic process of cells derived from
the cranial NC (C’, C’’; arrowheads), however HuC/D expression was only observed in the soma of cells
derived from the trunk NC, and absent from the neuritic processes (D’, D’’; arrowheads). Differences in
HuC/D localization between the cell populations persisted through Day 8 (E – H). Phenotypic
characteristics of the cells at each time point were consistently observed (n=6; duplicate cultures from each
of three independent cell isolates). All cells are derived from Sox9cre; R26R-EYFP mice and express EYFP
(green). Red staining = HuC/D. Scale bars: (A – D; E – H) 50µm; (C’, C’’, D’, D’’) 25µm.

7C, 7D, arrowheads), indicative of immature Schwann cells. By Day 14, most GFAPpositive cells derived from either cell population displayed an elongated morphology, with
extension of bipolar processes (Figs. 7E, 7F). Moreover, flattened, sheet-like processes
noted at earlier time points were only observed sporadically throughout the cultures at
Day 14. Similar observations were also made using a marker of Schwann cell
differentiation, Erb-B2 Receptor Tyrosine Kinase 3 (Erb-B3, Riethmacher et al., 1997;
Appendix G).
The transition from flattened, sheet-like processes to elongation of bipolar
processes is considered a hallmark of differentiation during Schwann cell development
(Dong et al., 1999; Jessen et al., 2015; Maurer et al., 2007; Thaxton et al., 2011). In vivo,
further maturation is dependent on environmental context as immature Schwann cells will
either become a myelinating or non-myelinating Schwann cell depending on the size of
the associated axon. In absence of peripheral axons, we conclude that the primary cranial
and trunk NC cells are able to give rise to immature Schwann cells in vitro. Moreover,
changes in cell morphology over the 14-day differentiation time course were highly
consistent between cultures (n=6) derived from different cell isolates (n=3). Therefore,
the temporal transition in cell shape, specifically between 10 and 14 days in differentiation
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Figure 7. Primary cranial and trunk NC cells display distinct morphological transitions during the
temporal progression of glial differentiation in vitro. Glial differentiation was assessed via
immunostaining for glial fibrillary acidic protein (GFAP) after 4, 10 or 14 days in differentiation medium.
GFAP-positive cells were observed in both cranial and trunk NC cell populations at Day 4 (A, B). By Day
10, some of the GFAP-positive cells extended flattened, sheet-like processes (C, D; asterisks) while the
other GFAP-positive cells displayed an elongated, spindle-like morphology (C, D; arrowheads). After 14
days, most GFAP-positive cells in both populations exhibited an elongated, bipolar morphology and cells
extending flattened, sheet-like processes were only occasionally observed (E, F). Phenotypic
characteristics of the cells at each time point were consistently observed (n=6; duplicate cultures from each
of three independent cell isolates). All cells are derived from Sox9cre; R26R-EYFP mice and express EYFP
(green). Red staining: GFAP. Scale bars: 100µm.
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medium, could act as a reproducible gauge of differentiation towards the glial cell fate in
vitro. We further conclude that both the primary cranial and trunk NC cells exhibit a similar
capacity to differentiate into glial cells, and that differentiation occurs along a similar
temporal progression.

Cranial NC-derived chondrocytes form distinct nodules and secrete measurable
cartilage matrix proteins when cultured as a micromass.
Cranial NC-derived chondrogenic differentiation was assessed by documenting
changes in protein expression and cell morphology at several time points over a 2-week
differentiation window. These characteristics were determined utilizing expression of
Type II collagen (Col2a1), an established marker of articular chondrocyte differentiation
(Lefebvre et al., 1997), as well as Alcian blue staining, a common dye used to stain the
acidic glycosaminoglycans and sulfated glycoproteins secreted by chondrocytes during
chondrogenesis (Mello and Tuan, 1999; Paulsen et al., 1988; Paulsen and Solursh,
1988). In vivo, chondroprogenitors initially exhibit a stellate, mesenchymal morphology,
and subsequently transition to a cuboidal shape as differentiation progresses (reviewed
in Woods et al., 2007). In addition, they begin to produce cartilage matrix proteins,
including Col2a1, and highly sulfated proteoglycans, such as aggrecan (reviewed in
Woods et al., 2007). The production of cartilage matrix proteins promotes aggregation,
which results in the formation of chondrogenic condensations, a hallmark of overt
differentiation (reviewed in Hall and Miyake, 2000). In vitro, we demonstrate that our
cultured cells undergo similar transitions in cell morphology, condensation, and cartilage
matrix secretion as described for chondrogenic progenitors in vivo.
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After 4 days in differentiation medium, many of the cultured cells positive for
Col2a1 had transitioned from a mesenchymal morphology (Figs. 8A, 8A’; white lines) to
a cuboidal one (Figs. 8A, 8A’’; cyan lines). However, at this time point, parallel cultures
displayed only faint Alcian blue staining (Fig. 8E). This suggests that early Col2a1
expression may be promoting morphological changes necessary to begin the
differentiation process, but the robust secretion of cartilage matrix proteins has not yet
occurred.
We first observed distinct chondrogenic nodules after 6 days in differentiation
medium (Figs. 8B, 8F; arrowheads). Nodules could be visualized using both Col2a1 and
Alcian blue staining, indicating that cartilage matrix proteins were being produced and
secreted. Furthermore, the timing of nodule formation was consistent across multiple
replicates (n=6) from several distinct cell isolates (n=3).
By Day 8, cartilage matrix-producing chondrocytes were observed extending from
the nodules (Figs. 8C, 8G; arrows), a phenotypic characteristic which became more
prominent as differentiation progressed through Day 14 (Figs. 8D, 8H; arrows). Higher
magnification of boxed regions in Figures 8C and 8D show chondrocytes which appeared
to align and form chains of cells that emanate from the nodules at Day 8 (Fig. 8C’, cyan
lines) and Day 14 (Fig. 8D’, cyan lines).
Based on our observations, increases in nodule number and cartilage matrix
accumulation over time can serve as a measurable benchmark of chondrogenic
differentiation in vitro. Lower magnification views at Day 6 revealed that chondrogenic
nodule formation occurred in localized regions of the cultures (Fig. 8I). However, by Day
14, nodules were observed throughout the cultures (Fig. 8J). Further quantification of
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temporal changes in nodule number and cartilage matrix accumulation were analyzed in
Alcian blue stained cultures. Consistent with our histological observations, our results
showed a statistically significant increase in both nodule number (Fig. 8K) and cartilage
matrix accumulation (Fig. 8L) over time when compared to the undifferentiated cells.
Together, these data reveal several reproducible characteristics that define the temporal
progression of cranial NC-derived chondrogenic differentiation in vitro, including the
timing of detectable Alcian blue staining, nodule formation and secretion of cartilage
matrix proteins.

Discussion
In this chapter, we demonstrate a reliable method for establishing a robust in vitro
model system of the mammalian NC. We successfully isolated primary cranial and trunk
NC cells from E9.5 mouse embryos by FACS, using Sox9 as marker. Once in culture,
both NC cell populations expanded relatively quickly while maintaining NC cell identity
and stem cell-like properties, even as they were passaged over the course of a 3-week
time period. We have also shown that our cultured cells can be reproducibly differentiated
into a multitude of NC derivatives, including neuronal cells, glial cells, smooth muscle
cells, chondrocytes, adipocytes and melanocytes. Based on our characterization of
differentiation markers, cell morphology and cell behavior, we also established
reproducible benchmarks that define the temporal progression of NC differentiation into
neurons, glia and chondrocytes. This allowed us to detect similarities and differences
between the cranial and trunk NC cells as they transitioned through intermediate stages
of differentiation, comparable to those described in vivo. These temporal benchmarks
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Figure 8. Cranial NC-derived chondrocytes form distinct nodules and produce cartilage matrix in
vitro over time. Cell morphology and cartilage matrix production were analyzed at various time points via
immunostaining for Type II collagen (Col2a1) (A – D), and Alcian blue staining (E - J). After 4 days in
differentiation medium, Col2a1-positive cells displayed a cuboidal morphology (A). Higher magnification of
boxed region highlights the difference between Col2a1-negative cells displaying a mesenchymal
morphology (A’; white lines) and cells positive for Col2a1 that display a cuboidal morphology (A’’; cyan
lines). At this same time point, parallel cultures showed faint Alcian blue staining (E). By Day 6, Col2a1-
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positive cells began to form chondrogenic nodules that stained positive for Alcian blue (B, F; arrowheads).
At later stages of chondrogenic differentiation, chains of chondrocytes producing cartilage matrix could be
seen emanating from the nodules (C, D, G, H; arrows). Higher magnification of boxed regions shows
chondrocytes which appear aligned, forming chains of cells that emanate from the nodules at Day 8 and
Day 14 (C’, D’; cyan lines). In addition, the number of chondrogenic nodules increased over time. (I, J) In
order to obtain a representative field of view of the entire culturing surface, four images from overlapping
fields of view were aligned and stitched using the open source Hugin software (d’Angelo, 2007). Nodules
were first observed in distinct regions of the well at Day 6 (I), but by Day 14, had spread throughout the well
(J). Boxed regions in I and J correspond to the higher magnification images in F and H, respectively.
Quantification of chondrogenic nodule number (K) and cartilage matrix accumulation (L) further
demonstrates the increase in nodule formation over time. Experiments were repeated from three
independent cell isolates, each in duplicate. Each dot represents one technical replicate, grouped by
biological isolate. Black horizontal line indicates grand mean across replicates. *p < 0.05, ****p < 0.0001
vs. undifferentiated cells (two-way ANOVA). All cells are derived from Sox9cre; R26R-EYFP mice and
express EYFP (green). Magenta staining = Col2a1. Scale bars: (A – H) 100µm; (I, J) 1mm.

constitute a valuable addition to existing criteria for assessing the impacts of genetic or
environmental perturbations on the timing of NC differentiation.
Our method for isolating murine NC cells via FACS differs from previously
established protocols in which NC cells are collected after emigrating from neural tube
explants dissected at E8.5. At E8.5, isolating premigratory NC cells via FACS alone does
not yield enough cells to establish successful growth in culture. Using Wnt1 as a marker,
FACS has been used to further select NC cells isolated from E8.5 neural tube explants
and expanded in culture (Ishii et al., 2012). Although Wnt1 is commonly used as a marker
for selecting the NC (Druckenbrod and Epstein, 2005; Ishii et al., 2012; Pfaltzgraff et al.,
2012; Wong et al., 2006), Wnt1 is expressed throughout the cranial dorsal neural tube
where it is a marker for both NC and non-NC derivatives (Lewis et al., 2013; McMahon
and Bradley, 1990; Pietri et al., 2003). This makes it difficult to specifically isolate cranial
NC cells directly from the embryo by FACS using Wnt1 as a marker. In contrast, our
method isolates Sox9-positive NC cells from specific tissues dissected at E9.5, where
Sox9 is a well-established marker for both premigratory and migratory NC cells (Cheung
and Briscoe, 2003). In addition, by isolating primary NC cells at this later developmental
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time point, we were able to consistently isolate enough purified NC cells to establish
successful cultures without the need for an intermediate in vitro expansion step prior to
selection (Ishii et al., 2012).
We also demonstrate that the cultured primary cranial and trunk NC cells can be
induced to differentiate into a broad range of NC derivatives (Fig. 4). As previously
described, the cultured cells can give rise to a larger repertoire of derivatives than would
be expected from the same cells in vivo, when exposed to appropriate differentiation
factors. For example, cultured trunk NC cells grown under conditions which simulate the
endogenous microenvironment during differentiation could give rise to chondrocytes (Ido
and Ito, 2006; Maurer et al., 2007; McGonnell and Graham, 2002) and adipocytes (Billon
et al., 2007), albeit with less efficiency compared to the cranial NC. This innate ability to
generate multiple cell fates suggests that at least some NC cells possess an inherent
plasticity concerning fate determination that can be influenced by exposure to the
appropriate environmental cues.
Moreover, while the cultured NC cells were able to produce all the differentiated
cell types tested, we also observed subtle, but reproducible differences in the extent of
differentiation between the cranial and trunk NC. For instance, melanocyte differentiation
appeared more robust in trunk NC cultures, while chondrogenic differentiation appeared
more robust in cranial NC cultures. The subtle variations in the extent of differentiation
observed between cranial and trunk NC could indicate an intrinsic difference in the way
these two populations respond to environmental cues. Alternatively, these differences
may reflect mixtures of progenitors with varying differentiation potential as has been
described previously (Morrison et al., 1999; Stemple and Anderson, 1992). In support of
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this

explanation,

recent

studies

have

revealed

that

a

large

majority

of

premigratory/migratory murine trunk NC cells are multipotent, both as single cells, and as
a population (Baggiolini et al., 2015). However, the number of derivatives formed by each
single cell varied, consistent with the premise that NC cells exhibit diverse multipotent
potentials.
Distinguishing how cell intrinsic factors and cell environment contribute to the
broad, but varied, differentiation potential of NC cells is critical to understanding
embryonic development and NC-related diseases. Gene regulatory networks governing
NC specification, migration and differentiation demonstrate that NC specifier genes can
play multiple roles over the course of NC development (recently reviewed in Martik and
Bronner, 2017). For example, Sox9 plays important roles in premigratory and migratory
NC, and is also a key regulator of chondrogenic differentiation in cranial NC. Although we
demonstrate broad potential for differentiation of Sox9-positive NC cells, it is possible that
our primary cultures may select for a population of cells that have a special propensity for
Sox9-dependent differentiated cell types. Alternatively, it is possible that Sox9, which is
co-expressed broadly in migrating NC cells with other NC specifiers, is later re-expressed
in a more limited population during differentiation. We anticipate the isolation and
expansion methods we have described could also be applied to embryos from the broad
array of NC reporter lines (recently reviewed in Debbache et al., 2018). Genomic and
proteomic analyses of NC cells isolated based on expression of different NC specifiers
may help determine if expression of different specifiers select for distinct subpopulations
with variations in differentiation potential.
Our comparison of cranial and trunk NC isolated from the same animals has also
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enabled us to detect axial differences in behavior, morphology and protein localization
during the differentiation process. One of the most significant axial differences we noted
was in the ability of cells to aggregate during neuronal differentiation. While we observed
aggregation in both cell populations, the neurons derived from the trunk NC formed
distinct cell aggregates sooner in culture that were more compact and well-defined
compared to the cranial NC, suggesting that they have a greater propensity for
aggregation (Figs. 5, Appendix B). In vivo, aggregation is a common behavior observed
between the cranial and trunk NC during gangliogenesis, however there are inherent
differences in cell-environment interactions during this process. While the dorsal root
ganglia arise exclusively from the trunk NC, neurons in the cranial ganglia are largely
derived from placodal ectoderm in the head with contributions from the NC (D’AmicoMartel and Noden, 1983). To date, the specific signals involved in regulating interactions
between NC and placodal ectoderm involved in cranial ganglion assembly are still under
investigation (Kurosaka et al., 2015). Future studies may exploit the differences we
observe in vitro between cranial and trunk cultures by using genomic and proteomic
analyses to identify cell intrinsic factors that contribute to gangliongenesis at each axial
level in vivo.
Another difference we detected was in the cellular localization of the HuC/D RNA
binding proteins in neurons derived from cranial or trunk NC. While HuC/D was present
in the soma and neurites of neurons derived from cranial NC, it was present only in the
soma of neurons derived from trunk NC (Fig. 6). This suggests that axonal trafficking or
local translation within peripheral axons arising from neurons in the head and trunk may
be governed by different mechanisms. In vertebrates, HuC and HuD proteins bind to AU-
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rich regulatory sequences in the 3’ UTR of target gene transcripts, leading to mRNA
stability (reviewed in Dêschenes-Furry et al., 2006). Overexpression of HuC or HuD
accelerates neurite outgrowth in cultured PC12 cells (Akamatsu et al., 1999, Anderson et
al., 2000), E19 rat cortical neurons and retinoic acid-induced embryonic stem cells
(Anderson et al., 2001), and stabilizes growth-associated mRNAs localized to the growth
cones of PC12 cells (Smith et al., 2004). Given that we observe HuC/D in neurites of
neurons derived from cranial NC, but not from trunk NC, it is possible that another type
of RNA-binding protein stabilizes growth-associated mRNAs in the trunk NC. Our culture
model provides a means for isolating neurites from the different populations in order to
address this possibility. In addition, these cultures may also be used to screen
pharmacological agents that promote or disrupt these same processes.
A unique contribution of the current study is our temporal characterization of
differentiation along the neuronal, glial, and chondrogenic lineages. Through this analysis,
we reproducibly identified distinct intermediate stages during differentiation that mimicked
those previously described in vivo. We envision future studies that will elucidate gene
regulatory changes that accompany these transitions, which could identify cell intrinsic
drivers of stage-specific progression along differentiation pathways. Such drivers would
serve as important targets for screening potential therapeutic agents useful in stem cell
therapies. For example, agents that promote condensation of cells during chondrogenic
differentiation may be useful for improving the efficiency of direct programming protocols,
enabling more effective generation of resting chondrocytes that could be used to combat
the progression of cartilage degeneration associated with osteoarthritis, or restore head
and facial tissues disrupted in craniofacial syndromes. In addition, our temporal
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characterization of differentiation in vitro provides a basis for more comprehensive testing
of industrial compounds, personal use products, and therapeutic drugs for developmental
toxicity. Although whole animal testing remains the standard for assessing developmental
toxicity, the cost and time involved in in vivo testing has resulted in a large backlog of
compounds to be tested (Woodruff et al., 2011; Mitro et al., 2015). In vitro assays that
include intermediate endpoints in neuronal, glial, and chondrogenic differentiation could
serve as a valuable preliminary screen to prioritize compounds for further in vivo analysis.
Another potential application of this culture system is to examine cell intrinsic
mechanisms of NC differentiation in the context of various mouse models of human NCrelated disorders. Disruption of NC development underlies many pediatric syndromes and
has been associated with deletions in multiple genes affecting various aspects of NC
development. In many neurocristopathies, patients with identical deletions present with
widely disparate symptoms or with varying severity of symptoms (reviewed in Noack Watt
and Trainor, 2014). This suggests that a critical interplay between genetic and
environmental factors can contribute to the severity of NC-related disorders. In vitro
methods, such as ours, enables the characterization of cell intrinsic contributions of
specific mutations, which can subsequently be assessed in the context of controlled
environmental manipulations. For example, the LgDel mouse model of chromosome
22q11 deletion syndrome displays many of the hallmarks of the pediatric syndrome
including dysphagia (Karpinski et al., 2014). These mice display defects in both cranial
nerve development and orofacial morphology, suggesting an impact of the deletion on
neuronal and chondrogenic development. However, in vivo, it is difficult to separate the
direct effects of the deletion on each tissue from the potential of the neural defect to
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secondarily impact orofacial development. Furthermore, the ability to partially rescue of
the phenotype by manipulation of retinoic acid synthesis suggests the potential for
environmental disrupters to further modify the effects of the deletion. In vitro analysis of
differentiation along both the neural and chondrogenic lineages could help to distinguish
the direct impact of the deletions on differentiation of each lineage separately, while
providing a platform to investigate environmental contributions.
In accordance with our primary objectives, we have developed methods for
effective isolation, expansion, and directed differentiation of murine NC cells. With this
method, we are able to reliably obtain enough cells for biochemical analyses, such as coimmunoprecipitation and ChIP-seq, after only a short expansion in culture, thus
advancing our ability to elucidate novel protein-protein and protein-gene interactions that
regulate NC growth and differentiation. Additionally, since we isolate both cranial and
trunk NC cells from the same embryos, this culture system offers a foundation to tease
apart the intrinsic and extrinsic factors that contribute to cell fate acquisition in an axial
level-specific manner. Finally, we established reproducible benchmarks that define the
temporal progression of neural and chondrogenic differentiation in vitro. These
benchmarks significantly enhance our ability to determine how subtle alterations in the
timing of differentiation due to genetic mutation or toxicological exposures contribute to
NC-related birth defects and disorders.
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CHAPTER IV

Chronological transcriptomic analysis of cranial neural crest cell
differentiation along neurogenic and chondrogenic lineages

Abstract
Abnormal cranial neural crest (NC) development can result in a broad spectrum of
congenital malformations, many of which are often associated with pediatric syndromes.
As multipotent progenitors, cranial NC cells contribute to a diverse array of ectodermal
and mesoectodermal cell types, from neurons and glia of the peripheral nervous system
to the cartilage and bone of the face. To transition from a progenitor state to a specific
cell type, developing cranial NC cells must undergo a sequential series of time-sensitive
changes in morphology and behavior driven by concurrent changes in gene expression.
However, we currently have a limited understanding of the molecular programming
underlying the progression through the intermediate stages of cranial NC differentiation
along a specific lineage. Recently, we established a murine culture system modeling
cranial NC cell differentiation along the neurogenic and chondrogenic lineages.
Systematic characterization of the cultured cells identified reproducible timelines for
changes in cell shape, protein expression and aggregation behavior that mimic the
progression of neurogenic and chondrogenic differentiation in vivo. Using this culture
system, we have delineated transcriptional changes that accompany the transition of
cranial NC cells to (1) intermediate progenitors, and (2) differentiated peripheral neurons
or cartilage matrix-producing chondrocytes. Our results reveal that the temporal
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progression of differentiation toward either cell fate is governed by both shared and
lineage-specific gene expression patterning that together drive distinct, yet partially
overlapping biological processes and pathways. In addition, we have identified distinct
transcriptional signatures indicative of the intermediate state, as well as candidate
transcriptional regulators that potentially coordinate cell fate acquisition in a stepwise and
time-sensitive manner. Together, these data provide a platform for further investigation
into the hierarchical, cell-intrinsic circuitry contributing to the plasticity and developmental
potential of the cranial NC, and serve as a valuable tool for discovering the molecular
targets of genetic and environmental factors that lead to cranial NC-related birth defects
and disorders.

Introduction
Disruption of cranial neural crest (NC) cell development can manifest as a wide
variety of human congenital birth defects, including craniofacial skeleton malformations,
and facial or trigeminal nerve hypoplasia, but can also contribute to predisposition to
aggressive types of cancer, such as melanoma and neuroblastoma. Of these, craniofacial
abnormalities alone account for one-third of all birth defects and are a leading cause of
infant mortality (Gorlin et al., 1990). Despite their prevalence, the etiology underlying
many cranial NC-related defects remains poorly understood. Contributing to the diversity
of anomalies is the ability of the cranial NC to give rise to both ectodermal cell types, such
as sensory ganglia and peripheral glia, and mesoectodermal cell types, including the
cartilage, bone, and connective tissues of the face. Proper formation of these derivatives
is mediated by a dynamic, multistep process that involves temporal changes in cell
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morphology and behavior, both of which play a crucial role in determining cell typespecific function. However, despite their critical contribution to the developing vertebrate
head, little is known about the genetic programming that explicitly governs the temporal
progression of cranial NC differentiation. Specifically, there is limited information
regarding the molecular mechanisms governing the initial transition toward a specific cell
type, and the subsequent progression through the intermediate stages of differentiation
in that cell type. This gap in knowledge impedes our understanding of how genetic
perturbations or environmental toxins may impact the process of differentiation as it
unfolds during embryonic development. Elucidation of the dynamic intrinsic programming
that governs the temporal progression of cranial NC differentiation will provide a platform
for discovering novel molecular targets of genetic and environmental factors that lead to
cranial NC-related malformations.
In order to understand the complex molecular programming regulating cranial NC
differentiation, it is necessary to obtain a global representation of the transcriptional
changes that occur as cranial NC transition toward a specific cell fate. Over the last
decade, cumulative information gathered from genome-wide analyses and gene
perturbation studies across various vertebrate models has led to the assembly of a
putative GRN for the different phases of cranial NC cell development: specification,
migration, and differentiation (reviewed in Martik and Bronner, 2017). The overall GRN is
characterized by a cascade of regulatory modules for each phase that combines our
current understanding of the signaling and transcriptional inputs shown to drive activation
of downstream gene batteries. To date, most of the information compiled focuses on the
regulatory logic controlling cranial NC specification and migration. Although modules for
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lineage-specific differentiation have been formulated, the information is limited to the
terminally differentiated state. Consequently, this static, endpoint assessment of cranial
NC diversification lacks pertinent information regarding the progression through the
intermediate stages of cranial NC differentiation toward a particular cell fate in a stepwise
and time-sensitive manner. Disruption or mis-wiring of the temporal circuitry leading to
either accelerated or delayed cranial NC differentiation may contribute to the formation of
cranial NC-related defects. Introducing a temporal dimension into our current
understanding of the GRNs driving differentiation would enable development of improved
strategies for diagnosing and treating patients with structural and functional deficits
resulting from perturbation of this process.
Advances in high-throughput genomic sequencing technologies have provided the
opportunity to assess the dynamically changing regulatory landscape controlling cranial
NC differentiation, thus increasing our resolution of the current GRNs. However, the
mammalian cranial NC is a transient, rare population of cells and the intermediate stages
of differentiation toward a specific cell fate are difficult to isolate and assess in vivo.
Recently, we have established a primary murine culture system modelling the temporal
progression of cranial NC differentiation along the ectodermal (neurogenic) and
mesoectodermal

(chondrogenic)

lineages

(Replogle

et

al.,

2018).

Detailed

characterization of the cultured cells identified reproducible timelines for stepwise
changes in morphology and behavior that mimic those described during neurogenesis
and chondrogenesis in vivo. Importantly, having the ability to capture these intermediate
stages of differentiation allows us to determine the precise transcriptional programming
that governs cranial NC cell fate acquisition in a stepwise and time-sensitive manner.
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Taking advantage of this culture system, we set out to determine the specific
transcriptional signatures associated with the intermediate stages of neurogenesis or
chondrogenesis in the cranial NC. Specifically, we utilized RNA-seq to identify temporal
changes in gene expression that accompany cultured cranial NC cells as they transition
to (1) intermediate progenitors, and then (2) differentiated peripheral neurons or cartilage
matrix-producing chondrocytes. We chose to focus our studies on these two lineages
based on their relevance to human cranial NC-related malformations, but also because
we observed similar changes in cell shape and aggregation formation during the
differentiation process in vitro, that are also known to occur in vivo. For instance, during
neurogenesis in the developing peripheral nervous system, migratory NC cells are
directed into discrete streams, which promotes aggregation and subsequent
differentiation characterized by soma compaction and extension of neuritic processes
(reviewed in Marmigère and Ernfors, 2007). We observed the same cell shape changes
in neurons derived from the cultured cranial NC, coupled with aggregation and neuritic
outgrowth over time (Replogle et al., 2018). During limb bud morphogenesis in vivo,
mesenchymal progenitors will transition first to chondroprogenitors, which display a
cuboidal morphology, then produce various cartilage matrix proteins, thus promoting
condensation which is crucial for further differentiation and maturation of the
chondrocytes (reviewed in Bobick et al., 2009). We observe similar transitions in cell
shape and condensation in our cultured cranial NC cells as they differentiate into cartilage
matrix-producing chondrocytes over time (Replogle et al., 2018). The apparent similarities
in cellular changes between these two distinctly different cell fates raises the intriguing
possibility that there may be a degree of overlapping programming shared between
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neurogenesis and chondrogenesis, at least during the initial stages of cranial NC
differentiation. Deciphering transcriptional relationships mediating the formation of
peripheral neurons and chondrocytes in the developing head, may provide crucial insight
into the mechanisms that contribute to multisystemic phenotypes often associated with
cranial NC-related disorders.
In this chapter, we present a comprehensive analysis of gene expression changes
detected at early and late time points over the course of neuronal and chondrogenic
differentiation in the cranial NC. Significantly, we detected distinct transcriptional
signatures corresponding to the intermediate neuroprogenitor or chondroprogenitor state.
To our knowledge, our study is the first to systematically profile the transient, intermediary
cells associated with peripheral gangliogenesis or chondrogenesis in the cranial NC.
Moreover, comparison of the transcriptional signatures between the two cell fates
revealed a combination of both common and lineage-specific gene expression modules
that together govern distinct, yet partially overlapping biological processes and pathways
mediating the progression toward a differentiated state. We also discovered putative
transcriptional regulators that potentially drive the stage-specific transitions during the
differentiation process. Elucidation of these temporally dynamic, stage-specific gene
modules represents a crucial first step in elaborating upon the current GRNs underlying
the progression of differentiation along the neurogenic or chondrogenic lineages in the
cranial NC.
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Results
Temporally-clustered transcriptional signatures reveal common and lineagespecific programming
In order to identify transcription profiles indicative of the intermediate state we
utilized RNA-seq to assess changes in gene expression that accompanied cultured
primary murine cranial NC cells as they differentiated over time into either neurons or
chondrocytes. Transcriptomic comparisons were carried out at two specific time points
relative to the undifferentiated cranial NC (Day 0). Cells at the earlier time points, Day 2
for neurogenesis and Day 4 for chondrogenesis, represent a target population of transient
intermediates progressing toward a differentiated state. Cells at the later time points, Day
6 for neurogenesis and Day 14 for chondrogenesis, represent a population enriched for
differentiated cells (Fig. 9, Appendix H). These time points were chosen as they
correspond to well-characterized lineage-specific changes in morphology and behavior
that define the progression of neurogenic or chondrogenic differentiation, both observed
in vitro, and reported in vivo.
Our overall transcriptomic analysis revealed lineage-specific changes in the
expression of over a thousand transcripts in at least one time point relative to their
expression in the undifferentiated cranial NC. However, to determine if the differentially
expressed (DE) transcripts followed a temporally dynamic pattern of expression across
the time points, we identified the timing of their peak expression over the course of
neurogenesis or chondrogenesis. Peak expression was determined by comparing
transcript counts of individual transcripts in each sample against the mean derived from
all biological replicates across all time points. Transcripts were then grouped based on
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the temporal patterning of Z-scores using K-means clustering. This enabled detection of
several distinct clusters of transcripts that displayed peak expression at each one of the
time points assessed for both neuronal and chondrogenic differentiation (Fig. 10A)
Specifically, we identified a subset of transcripts with peak expression in the intermediate
cells, potentially playing a role in driving the transition from multipotent cranial NC cell
toward either lineage. We also observed a subset of transcripts that displayed peak
expression in both populations at time points corresponding to a mature, differentiated
state. As expected, lineage-specific markers were present in these data sets, including
the transcriptional regulators Ascl1 and NeuroD1 for neurogenesis, and Sox9 and Runx1
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for chondrogenesis. Finally, we observed a subset of transcripts that displayed peak
expression in the undifferentiated cranial NC, and were subsequently downregulated over
time. Together, these clusters represent distinct modules of gene expression that control
the progression through the various stages of diversification toward these two specific
cell fates.
One surprising, but not completely unexpected finding was that 420 DE transcripts
were shared between neurogenesis and chondrogenesis. Of the those identified, 183
transcripts (43.6%, Appendix I) were commonly upregulated, and 237 transcripts (56.4%,
Appendix J) were commonly downregulated as the cranial NC cells progressed through
these differentiation processes. The shared expression of these transcripts may be
connected to subtle similarities in cellular changes that we observed during neuronal or
chondrogenic differentiation in our culture system. Notably, cranial NC cells directed
toward either lineage will first reduce cell size, then form aggregations over time, and this
progression was coupled with robust differentiation (Replogle et al., 2018). To determine
which biological processes were enriched in each of these groups we performed gene
ontology (GO) analysis. We detected 12 biological processes that were commonly
controlled either through upregulation or downregulation of gene expression (Figs. 10B,
10C). Consistent with the shared behaviors we observed over the course of differentiation
in vitro, we found many of the processes to be associated with cellular and cytoskeletal
reorganization, as well as those related to cell-cell and cell-matrix interactions (Fig. 10B).
Moreover, commonly downregulated transcripts were predominantly associated with cell
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Figure 10. Differentially expressed transcripts cluster temporally to reveal common and lineagespecific differentiation programs. (A) Summary of RNA-seq data generated from cells isolated at time
points corresponding to the intermediate state (early time points) and differentiated state (late time points)
relative to the undifferentiated cranial NC. Differentially expressed transcripts demonstrate stage-specific
gene expression patterning during neurogenic (shades of orange) or chondrogenic differentiation (shades
of purple). Of these, the expression of 420 transcripts was shared between neurogenesis and
chondrogenesis, where 183 transcripts were commonly upregulated, and 237 transcripts were commonly
downregulated over the course of differentiation. (B, C) GO analysis of commonly upregulated (B) and
downregulated (C) transcripts showed enrichment for 12 distinct biological processes. Number of
transcripts associated with each biological process is noted.

cycle progression and cell proliferation (Fig. 10C). Interestingly, cross-referencing these
transcripts against the Mouse Genome Informatics (MGI) Human Disease database
revealed a subset of genes implicated in congenital birth defects and human genetic
diseases, including microcephaly, Alport syndrome, Bloom syndrome, Charcot-MarieTooth disease, and increased cancer susceptibility. Together, these findings indicate that
there is a degree of overlapping programming that is shared between these two cell fates
that drive similar morphological and behavioral changes over the course of differentiation.
In addition, reducing the expression of genes associated with cell cycle progression is
consistent with the idea that in order to achieve a differentiated state, progenitor cells
must first suppress programming associated with maintenance of stem cell-like
properties, such as self-renewal. We further conclude that differentially expressed
transcripts not found in common between the two processes are likely to be ones driving
the fate-specific differentiation programs.

Temporal gene expression patterning drives stage-specific biological processes
and pathways over the course of neuronal differentiation in the cranial NC.
To specifically interrogate gene expression patterning and associated biological
processes over the course of neurogenesis in the cranial NC, we focused our analysis on
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DE transcripts identified at early (Day 2) and late (Day 6) time points relative to their
expression in the undifferentiated cultures (Day 0). Our transcript list was further refined
by excluding the 420 transcripts found in common with chondrogenesis, thus revealing
2,672 DE transcripts specifically associated with the progression of neurogenesis. Peak
expression of these transcripts was again used to generate temporal clusters using Kmeans clustering analysis. We detected 5 different clusters of transcripts, each of which
exhibited a distinct pattern of peak expression corresponding to the time points assessed
(Fig. 11A). For instance, 187 DE transcripts (70.0%) displayed peak expression explicitly
at Day 2, and were subsequently downregulated in the differentiated peripheral neurons.
Since this time point represents the intermediate state, the genes expressed in this cluster
may be those promoting commitment to the neuronal cell fate by driving the initial
transition from a multipotent state toward a differentiated one. In comparison, we
identified 1,596 DE transcripts (59.7%) that displayed peak expression at Day 6,
corresponding to differentiated peripheral neurons. Interestingly, closer analysis revealed
two discrete patterns of expression for the DE transcripts in this category: one
representing transcripts that gradually increased as the undifferentiated cells progressed
toward the differentiated state (602 DE transcripts; 22.5% of the total transcripts), and
another characterized by an apparent downregulation of expression in the intermediate
cell population, followed by peak expression in the differentiated neurons (994 DE
transcripts; 37.2% of the total transcripts). These differences in gene expression
signatures accentuate two separate programs working together to promote lineage
restriction,

one

that

contributes to

the gradual transition

from

intermediate

neuroprogenitor to differentiated neuron, and one that is involved in maintenance of the
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terminally differentiated state. The remaining 889 DE transcripts (33.3%) were grouped
across two clusters, both of which displayed peak expression in the undifferentiated cells,
remained highly expressed through the intermediate state, but showed marked reduction
of expression in the differentiated neurons. Since the overall pattern of expression was
very similar between these two groups, the transcripts in these clusters were merged prior
to downstream analysis. Taken as whole, our results delineate the temporally dynamic
genetic program driving the progression through the intermediate and differentiated
stages of neurogenesis in cranial NC, and highlight specific subsets of genes that may
be crucial for the initial transition along the ectodermal lineage, as well as those potentially
required for commitment and maintenance of the differentiated state.
We next queried the temporally clustered transcripts for evidence of stage-specific
biological processes and pathways that underlie the progression of neuronal
differentiation in the cranial NC. Our results revealed that diversification along the
neurogenic lineage is mediated by a chronological series of distinct, but partially
overlapping biological events, which together delineate the stepwise transition toward a
neuronal cell fate (Fig. 11B). As expected, many of the transcripts with peak expression
in the differentiated state were enriched for biological processes and pathways known to
be associated with nervous system development and maturation, including neuronal
projection organization, synapse formation, and neurotransmitter release. In addition,
transcripts that were specifically downregulated over time were primarily involved in cell
cycle progression, DNA replication and DNA repair, a gene signature indicative of
differentiated cells.
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Figure 11. Temporally dynamic gene expression modules govern stage-specific biological process
and pathways over the course of neuronal differentiation in the cranial NC. (A) Temporally clustered
transcripts reveal distinct gene expression modules corresponding to the intermediate and differentiated
stages of neurogenesis. Transcripts within each cluster display stage-specific enrichment of biological
processes underlying the progression of differentiation. Expression heatmap was produced from Z-scores
(calculated using transcript per millions [TPM] estimates) of 2,672 differentially expressed transcripts with
adjusted p values <0.01. Mean normalized transcript counts were generated for each transcript across all
samples at all time points. Each row represents a single transcript. Each column represents one of the
three biological replicates for each time point. Red and blue indicate standard deviation above and below
the mean, respectively. GO analysis was used to determine enrichment of biological process associated
with cluster-specific transcripts. (B) Stage-specific enrichment of biological pathways associated with
temporally clustered transcripts. Color scale represents adjusted p values. Circle size represents number
of transcripts associated with each biological process, where the specific value appears within each circle.

There were also several biological processes that emerged as potentially defining
features associated with the progression towards a neuronal phenotype. Notably,
pathways involved in actin cytoskeletal reorganization were significantly enriched in the
intermediate cell population, and subsequently downregulated in the differentiated cells.
In our culture system we observed soma compaction to be one of the earliest events
associated with acquisition of a neuronal morphology (Replogle et al., 2018). Therefore,
the genes associated with this process may be those contributing to cell remodeling
needed to reduce cell size, and also promote initial axon sprouting (reviewed in
Compagnucci et al., 2016). Transcripts found associated with the intermediate state were
also enriched in pathways corresponding to ECM organization. In vitro studies have
shown that lineage specification in mesenchymal stem cells (MSCs) can be solely
directed by extracellular matrix elasticity or “stiffness” to produce a range of derivatives
from neurons to bone (Engler et a., 2006; Swift et al., 2013), suggesting an important
contribution of microenvironment composition in influencing cell fate decisions.
Accordingly, pathways involved in cell adhesion were enriched in transcripts that
gradually peaked in expression in the differentiated state, potentially playing a role in
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facilitating cell-cell and cell-ECM interactions that promote aggregation, and further
maturation of the neurons.
We further identified circadian entrainment as a significantly enriched pathway
associated with transcripts that were downregulated in the intermediate cell population,
but upregulated in the differentiated neurons. In the mammalian brain, the
suprachiasmatic nucleus (SCN) of the hypothalamus is recognized as the master
regulator of circadian rhythm, although locally generated rhythmicity can be synchronized
in peripheral tissues by external cues in order to coordinate cell-type specific gene
expression (recently reviewed in Astiz et al., 2019). However, this process has not been
previously investigated in the cranial NC or its derivatives. Additionally, we observed
pathways associated with cilium assembly and intraflagellar transport enriched in
transcripts exhibiting the same trend, suggesting a temporal dependence on primary cilia
assembly and signaling in both NC development and peripheral neurogenesis.
Interestingly, NC-specific perturbation of cilium function results in aberrant NC patterning
and development (reviewed in Chang et al., 2015), however the specific role of primary
cilia in neurons derived from the cranial NC is not well understood. Furthermore,
misregulation of the transcripts identified in this particular cluster have been implicated in
a number of ciliopathies, such as Bardet-Biedl syndrome and Kartagener's syndrome. In
addition, we detected many transcripts in a cluster-wide analysis associated with various
neurological and neurodevelopmental disorders, as well as neurodegenerative disease.
Taken together, our data demonstrates that temporal changes in transcriptional
programming govern stage-specific biological processes corresponding to the
progression of peripheral gangliogenesis in the cranial NC.
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Temporal gene expression patterning drives stage-specific biological processes
and pathways over the course of chondrogenic differentiation in the cranial NC.
Similar trends in temporal gene expression patterning were evident as cultured
cranial NC cells transitioned along the chondrogenic lineage. Exclusion of the transcripts
found in common with neurogenesis enabled detection of 910 DE transcripts specifically
associated with the early (Day 4) and late (Day 14) time points of chondrogenesis, with
respect to their expression in the undifferentiated cultures (Day 0). These transcripts were
then grouped based on their pattern of peak expression, revealing 3 specific clusters (Fig
12A). In one cluster we observed 356 DE transcripts (39.1%) that were downregulated in
the undifferentiated cultures, but exhibited peak expression in the intermediate cell
population, and remained highly expressed as differentiation continued. It is possible that
transcripts within this cluster are those that not only bias cranial NC cell fate decisions
toward the mesoectodermal lineage, but reinforce the initial programming necessary to
promote a chondroprogenitor state. We also identified 282 DE transcripts (31.0%) that
displayed peak expression specifically in differentiated cells found within the
chondrogenic nodules, and therefore are likely contributing to maturation and
maintenance of the cartilage matrix-producing chondrocytes. Lastly, we detected 272 DE
transcripts (29.9%) with peak expression in the undifferentiated cranial NC cells that
displayed a gradual downregulation as the cultures differentiated into chondrocytes over
time, thus contributing to refining the transcriptional programming that promotes the
overall differentiation process. Comparable to our observations during neurogenesis,
these data demonstrate that the temporal progression of chondrogenic differentiation in
the cranial NC is mediated by stage-specific gene expression modules, which together
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drive the stepwise transition from multipotent cranial NC progenitor toward a specialized
differentiated cell type.
Subsequent GO analysis of the cluster-specific transcripts identified key biological
processes and pathways corresponding to structural and behavioral changes known to
mediate the progression through the intermediate stages of chondrogenesis (Fig. 12B).
Of note, processes associated with cellular reorganization, cell motility, and cellular
homeostasis were found to be enriched in transcripts that were initially upregulated in the
intermediate cells, but remained highly expressed as differentiation progressed. Some of
the same processes were also enriched in transcripts displaying peak expression in the
differentiated cells consistent with continued involvement of these gene products during
chondrocyte maturation. Moreover, we observed cell-cell communication, regulation of
signal transduction, and pathways associated with ECM organization and collagen
formation to be significantly enriched in the differentiated cells. We also detected
enrichment of transcripts associated with hypoxia-inducible factor 1 (HIF1) signaling and
circadian rhythm in the differentiated chondrocytes. While both of these pathways have
been implicated in regulating endochondral ossification during mesoderm-derived
skeletogenesis (Amarilio et al., 2007; Takarada et al., 2012), neither have been
investigated for their cell autonomous regulation specifically in cranial NC-derived
chondrocytes that form the craniofacial skeleton. Lastly, as expected for differentiated cell
types, transcripts that were downregulated over time were found to be involved with cell
cycle progression, DNA replication and DNA repair, similar to as seen during
neurogenesis.
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Figure 12. Temporally dynamic gene expression modules govern stage-specific biological
processes and pathways over the course of chondrogenic differentiation in the cranial NC. (A)
Temporally clustered transcripts reveal distinct gene expression modules corresponding to the intermediate
and differentiated stages of chondrogenesis. Transcripts within each cluster display stage-specific
enrichment of biological processes underlying the progression of differentiation. Expression heatmap was
produced from Z-scores (calculated using transcript per millions [TPM] estimates) of 910 differentially
expressed transcripts with adjusted p values <0.01. Mean normalized transcript counts were generated for
each transcript across all samples at all time points. Each row represents a single transcript. Each column
represents one of the three biological replicates for each time point. Red and blue indicate standard
deviation above and below the mean, respectively. GO analysis was used to determine enrichment of
biological process associated with cluster-specific transcripts. (B) Stage-specific enrichment of biological
pathways associated with temporally clustered transcripts. Color scale represents adjusted p values. Circle
size represents number of transcripts associated with each biological process, where the specific value
appears within each circle.
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The processes and pathways identified correlate with well-described, sequential
changes in cell shape and condensation behavior that occur in chondroprogenitors as
they progress toward a differentiated state, both in vivo and in vitro. First, cytoskeletal
reorganization leads to acquisition of a cuboidal morphology, which in turn promotes
cellular organization, including dynamic changes in nuclear shape and intercellular
location of organelles. Stabilization of this new cellular equilibrium triggers an increase in
cell-cell and cell-ECM interactions, as well as ECM deposition, all of which are necessary
for subsequent condensation of the dispersed cells, ECM establishment and ECM
maintenance. Importantly, disruption of either morphogenic process inhibits overt
chondrogenic differentiation (Ray and Chapman, 2015). Along those lines, many DE
transcripts identified in our chondrogenic signatures have been implicated in human
genetic diseases and syndromes characterized by multi-symptom phenotypes, including
facial dysmorphism. Importantly, we have also identified circadian rhythm and hypoxia
signaling as potentially novel pathways involved in this process. While mechanisms
underlying these two pathways have been shown to regulate mesoderm-derived
skeletogenesis, they have not been investigated specifically for their role in regulating
chondrogenic differentiation in the cranial NC. Thus, our analysis provides new avenues
for exploration into the similarities and differences in these mechanisms and how they
might be applicable to cartilage formation in the developing head. Moreover, we conclude
that the temporal progression of chondrogenesis in the cranial NC is governed by
dynamically changing gene expression modules, which drive distinct, yet partially
overlapping biological processes and pathways important for proper formation of the
craniofacial skeleton.
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Stage-specific transcriptional regulators drive the temporal progression of
neurogenesis and chondrogenesis in the cranial NC.
Our transcriptomic analysis revealed both common and unique gene expression
signatures that together promote the transition and subsequent lineage-specific
differentiation in the cranial NC in a stepwise and time-sensitive manner. Not surprisingly,
many of the gene sets corresponded to biological processes and pathways expected to
underlie the progression toward each cell fate. Others were novel, and warrant further
investigation in the context of cranial NC. In addition, we identified several reoccurring
processes and pathways that were shared between neurogenesis and chondrogenesis,
including cell motility, cell-cell and cell-ECM interactions, ECM organization and circadian
rhythm. While many of the associated transcripts were found to be commonly expressed
between the two cell fates, we also detected distinct suites of genes for each process that
were expressed in a lineage-specific manner. This suggests a potential interplay between
common and unique transcriptional programming in mediating the gradual shift toward
fate commitment, possibly through regulatory interactions between transcription factors
found in each program.
To address this, we next wanted to determine the key regulators responsible for
driving the dynamic changes in transcriptional programming over the course of
neurogenesis or chondrogenesis. By comparing our transcriptomic data to a recently
published catalog of known human transcription factors (Lambert et al., 2018), we were
able to compile a list of 198 transcription factor-encoding transcripts that displayed
differential expression at any time point during the differentiation process (Fig. 13A). Of
these transcripts, 18 (9.1%) were found to be either commonly upregulated or
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downregulated over the course of differentiation (Fig. 13B). Interestingly, we identified
Klf9 and Pura as commonly upregulated genes associated with circadian rhythm
(Petsakou et al., 2015; Spörl et al., 2012), suggesting an important role for these
regulators in driving this process in both neurogenesis and chondrogenesis. Consistent
with previous observations, many of the commonly downregulated transcripts encoded
gene products involved in controlling stem cell renewal (Tead2) or proliferation (Mxd3,
Foxm1, Mybl2, Dach1). Unexpectedly, only two C2H2 zinc finger proteins, Zbtb16 and
Zbtb20, have been reported to play dual roles in regulating cell fate decisions along
ectodermal and mesoectodermal lineages. In fact, many of the commonly identified
factors are only known to modulate differentiation toward one fate or the other. Moreover,
very few have been investigated in the context of the cranial NC, highlighting new
avenues of exploration to uncover the function of these transcriptional regulators in
governing lineage-specific cell fate acquisition.
The remaining transcripts were unique to neurogenesis and chondrogenesis,
respectively, and displayed temporal expression pattering similar to that seen when
assessing peak DE transcript expression for either time course as a whole (Figs. 13C,
13D; Appendix K, Appendix L). Representatives from each cluster revealed potential
drivers of the stage-specific gene expression modules. Notably, for neurogenesis, only
two definitive transcriptional regulators were detected in the cluster displaying peak
expression in the intermediate stage: Pa2g4 and Six4.
Pa2g4, also known as ErbB3-binding protein, regulates global gene expression
through its repression of SUV39H1-mediated histone H3K9 trimethylation, and the gene
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Figure 13. Stage-specific transcriptional regulators associated with common and lineage-specific
transcriptional programming. (A) Transcription factor-encoding transcripts demonstrate stage-specific
gene expression patterning over the course of neurogenic (shades of orange) or chondrogenic
differentiation (shades of purple). (B) 18 transcriptional regulators were shared between neurogenesis and
chondrogenesis, where 9 were commonly upregulated, and 9 were commonly downregulated over the
course of differentiation. (C, D) Temporally clustered transcripts reveal transcriptional regulators uniquely
associated with the intermediate and differentiated stages of neurogenesis (C, 125 transcripts) or
chondrogenesis (D, 55 transcripts). Each row represents a single transcript. Each column represents one
of the three biological replicates for each time point. Red and blue indicate standard deviation above and
below the mean, respectively. GO analysis was used to determine enrichment of biological process
associated with cluster-specific transcripts. bHLH, basic helix-loop-helix; bZIP, basic leucine zipper; C2H2
ZF, Cys2-His2 zinc finger; DBD, DNA-binding domain; HMG/Sox, sex-determining region Y-related,
high mobility group-box.

encoding DNMT1, a DNA methyltransferase (Ko et al., 2019). Loss of Pa2g4 in mice
results in neuron apoptosis and significant brain malformations (Ko et al., 2019). Pa2g4
has also been identified as a downstream regulator of sympathetic neuronal proliferation,
survival and differentiation in response to neuregulin signaling (Kwon and Ahn, 2010).
Interestingly, DNMT1 appears in our list of transcripts that are downregulated in
differentiated cells, indicating that Pa2g4-mediated repression of DNMT1, and other
epigenetic modifiers, may be important for initiating a cascade of gene regulatory changes
that ultimately promote neuronal cell fate in the cranial NC.
More specific to cranial peripheral neuron development is Six4, a member of the
Six-class homeobox gene family. Six4 is highly expressed in developing trigeminal
ganglia in an overlapping pattern with Six1, and mice deficient for both transcription
factors displayed aberrant gangliogenesis characterized by reduced sensory neuron
number and increased apoptosis (Konishi et al., 2006). Early trigeminal sensory neurons
are derived from a mixture of NC and placodal cells, and therefore Six4, as well as other
Six factors, are promising candidate regulators mediating the intermediate step of
peripheral neurogenesis in the developing head.
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As expected, many canonical drivers associated with differentiation along the
neuronal lineage were found to be upregulated in the differentiated cells, including
NeuroD1, NeuroD4, Fos, Jun and Ascl1. We also identified Clock, a fundamental
circadian regulator, exhibiting peak expression in the differentiated neurons. In addition,
two other circadian-associated factors, Dbp and Egr1, were detected, but their expression
was specifically downregulated in the intermediate cell population, and upregulated in the
differentiated neurons. While Clock and its interacting partner, Arntl (also known as
Bmal1), are most well-described for their rhythmic regulation of target gene expression,
Dbp participates in forming a feedback loop that stabilizes the oscillations within a
particular period length (Yoshitane et al., 2019). Egr1 was also shown to modulate
oscillatory period length, and Egr1 null mice exhibit defects in daily Clock:Bmal1-induced
rhythmicity, as well as altered body temperature regulation (Riedel et al., 2018). This
suggests that modulating the length of circadian oscillations may be important for
differentiated peripheral neurons. In addition, it is an example of how potential interactions
between multiple transcriptional regulators with different gene expression patterns might
coordinate to control a specific cellular output.
Several transcripts encoding regulators of cilium assembly, including Rfx3, Rfx4
and Foxj1, were also detected as being downregulated in the intermediate cells, but
upregulated in differentiated neurons. Both Rfx transcription factors and Foxj1 are
expressed during early brain development, and cooperatively regulate a number of genes
associated with different aspects of cilia biogenesis ranging from formation of the basal
body and axoneme to components of intraflagellar transport machinery (reviewed in
Choksi et al, 2014). Moreover, NC-specific ablation of ciliary function in mice resulted in
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a loss of cell polarity, failure to respond to hedgehog signaling, and altered ventral
forebrain morphogenesis (Schock and Brugmann, 2017). This study predicted that the
changes in cilia-mediated cell polarity within the NC negatively influenced overall
neuroectoderm morphology, thus resulting in defective forebrain formation. Identification
of these transcriptional regulators in our data supports the need for further investigation
into the cell intrinsic contribution of ciliogenesis during neuronal differentiation in the
cranial NC, potentially providing insight into how misregulation of this process during
peripheral neurogenesis might also impact overall brain morphogenesis.
Rounding out the stage-specific regulators for neurogenesis were those that were
downregulated over time. Not surprisingly, many of these transcripts were associated with
cell cycle progression and stem cell maintenance. We also detected TFAP2c and Snail2
in this cluster, suggesting that these NC specifiers are not needed for maturation of
neurons derived from the cranial NC. Interestingly, we identified a number of transcripts
encoding regulators with known roles in mesodermal differentiation, indicating an
important role for proper suppression of competing programs in order to realize robust
neuronal differentiation.
For chondrogenesis, we identified several transcription factors that were
significantly upregulated in the intermediate cells that have been implicated in MSC
differentiation, including Glis3, Stat5a, Hivep3 and the vitamin D receptor, Vdr (Fig. 12D).
In addition, we identified Hif3a, a hypoxia-inducible factor, as an important regulator of
the intermediary step in the progression. The HIF family of transcription factors, which
also includes Hif1a and Epas1 (also known as Hif2a), is known to control gene expression
associated with robust ECM synthesis in human articular chondrocytes in response to
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low oxygen levels (Lafont et al., 2007; Markway et al., 2015). Interestingly, we identified
Epas1 as a commonly upregulated transcript, and genes involved in the HIF1 signaling
pathway were found to be enriched in differentiated chondrocytes. Together, these data
accentuate an interplay between shared and early lineage-specific programming in
mediating downstream hypoxia-induced gene expression associated with the progression
of chondrogenic differentiation.
We also detected several transcriptional activators and repressors involved in
regulating the later stage of chondrogenesis. Surprisingly, 9 of the 20 transcripts
upregulated specifically in the differentiated cells encode canonical transcriptional factors
associated with circadian rhythm, emphasizing a significant role for this process in
differentiating chondrocytes derived from the cranial NC. In support of these findings, a
recent study showed that Bmal1, a master clock transcription factor, is crucial for
controlling postnatal growth of cranial cartilage elements, as Bmal1-deficient mice have
smaller, shorter mandibles due to decreased calcification (Yu et al., 2020). Circadian
control of mandibular cartilage development was found to be regulated by Hedgehog
signaling, however the precise mechanism of circadian regulation in cranial NC cells over
the course of chondrogenic differentiation has not been specifically investigated.
Peripheral circadian clocks found in various adult human and mouse limb
cartilages are known to be important for regulating cartilage homeostasis, and
dysregulation of rhythmicity leads to matrix degradation and osteoarthritis-like damage
(Dudek et al., 2016; Gossan et al., 2013). We predict that similar mechanisms for
controlling cartilage homeostasis are operating in differentiating chondrocytes derived
from the cranial NC. Consistent with this idea, we detected downregulation of Notch
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signaling effectors, Hes5, Hes1 and Hey1, in our chondrogenic cultures over time. Initial
decreases in expression of these transcriptional repressors is required in order to promote
chondrogenic maturation (Karlsson et al., 2007), and subsequent upregulation over time
promotes a hypertrophic state, characterized by reduced Sox9 expression and cartilage
matrix degradation (Rutkowski et al., 2016). While it is not known if these effectors lie
downstream of the circadian rhythm pathway, these studies indicate that their timely
downregulation not only contributes to the overall progression of chondrogenesis, but
helps to coordinate the balance between cartilage matrix production and degradation
needed for maintaining a stable chondrogenic phenotype.

Discussion
As a stem cell-like population with the capacity to give rise to a plethora of diverse
cell types, the cranial NC serves as an excellent model for addressing essential questions
regarding the complex intrinsic mechanisms regulating cell fate determination.
Diversification of the cranial NC is a highly dynamic process involving sequential
morphological and behavioral transformations that gradually unfold as an embryo
develops over time. Underlying these cellular changes is a highly regulated,
transcriptional program that guides cranial NC progenitors through a series of decisions
ultimately leading to acquisition of a specific cell fate. However, the precise genetic control
mediating the initiation of fate-specifying programming, and how it changes as cranial NC
cells gradually transition toward a specific differentiated state remains poorly understood.
In this chapter, we demonstrate that stage-specific transcriptional modules
facilitate the progression through the different phases of neurogenesis or chondrogenesis
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in the cranial NC. Each module drives distinct, yet partially overlapping biological
processes and pathways that accompany gradual differentiation into either peripheral
neurons or cartilage-matrix producing chondrocytes. Closer analysis revealed
commonalities in gene expression patterning corresponding to shared cellular and
behavioral changes observed between the two cell fates, both in vivo and in vitro, in
addition to unique lineage-specific programming. In accordance with our goal, we
delineated specific transcriptional signatures corresponding to the intermediate
neuroprogenitors or chondroprogenitor state. Significantly, we also identified candidate
transcriptional regulators that dictate the timing of this progression in vitro, including those
that may contribute to early commitment toward either lineage, as well as those that
promote maturation of the differentiated state. Elucidation of the temporally-regulated
gene modules governing cranial NC differentiation enables discovery of novel molecular
targets of genetic and environmental factors that might contribute to cranial NC-related
malformations, as well as development of potential therapeutic treatments.

Shared transcriptional programs underlie lineage-specific outcomes.
One significant finding of our transcriptomic analysis was the existence of both
common and lineage-specific gene expression signatures that appear to work together in
a stepwise and time-sensitive manner to promote differentiation toward a neuronal or
chondrogenic cell fate in the cranial NC. For instance, many of the transcripts identified
to be commonly regulated between the two cell fates were associated with cellular and
cytoskeletal reorganization, as well as cell-cell and cell-matrix interactions. As cranial NC
cells differentiated over time, we observed continued enrichment of these shared
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processes, however the corresponding transcripts were unique for each cell type, and
their expression changed in a stage-specific manner. We predict that the transcripts
corresponding to these shared biological processes are regulating similar changes in cell
shape and aggregation potential observed during differentiation both in in vitro and in
vivo. Specifically, acquisition of a bipolar neuronal morphology, and the transition to a
cuboidal chondroprogenitor, are characterized by an initial reduction of cell size, and both
peripheral neurons and chondrocytes are known to coalesce to form aggregations as
differentiation progresses. Recent studies have implicated regulation of cytoskeletal
dynamics as important influencers of cell fate determination (Chen et al., 1997; Mammoto
et al., 2011; Mammoto and Ingber, 2009; McBeath et al., 2004), and highlight signaling
pathways involving Rho family of small GTPases as key regulators of changes in cortical
cytoskeleton architecture that occur during neurogenesis and chondrogenesis (GonzalezBillault et al., 2012; Ray and Chapman, 2015). Interestingly, cytoskeletal rearrangement
is not only necessary for controlling cell shape, but also plays crucial roles in modulating
organelle localization, and intracellular transport, as well as interactions between cells
and with their microenvironment, such as those involved in formation of focal adhesions,
adherens junctions or actin bridges (reviewed in Mammoto and Ingber, 2010). Cell-cell
and cell-ECM interactions are crucial for mediating proper coalescence of both
developing cranial ganglion and chondrogenic mesenchyme in the head, and disruption
of adhesion-mediated mechanisms results in disorganized cranial ganglion assembly
(Shaiu and Bronner-Fraser, 2010), and inhibition of chondrogenic condensation (Ray and
Chapman, 2015), respectively. In that light, the mechanisms controlling reduction in cell
size and aggregation capabilities in both neurons and chondrocytes may be more closely
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linked than previously appreciated. Finally, changes in cytoskeletal architecture facilitate
the direct association between cell membrane and nucleus, which has been shown to
influence downstream gene expression, and transcription factor availability, in a cell-type
specific manner (Mammoto et al., 2011; Percipalle, 2013; Swift et al., 2013; Wang et al.,
2009). Given this information, our results reveal a crucial role for proper expression of
genes associated with cytoskeletal dynamics during the earliest stages of differentiation
in the cranial NC. In addition, they provide insight into how commonly regulated
transcripts, which appear to be important for two very different cell fates, can potentially
coordinate subsequent lineage-specific outcomes. Future studies that manipulate the
expression of these genes early in the differentiation process, and then assess
downstream changes in gene expression, morphology and behavior will be able to
determine their precise contribution to the formation of these derivatives in the cranial NC.
The expression pattern of transcripts associated with circadian rhythm and
entrainment represent another example of the interplay between common and lineagespecific programming during neurogenesis and chondrogenesis. While circadian rhythm
is an evolutionarily conserved biological feature found in most cells, it has not been
directly investigated in the context of the cranial NC or in the formation of its derivatives.
In mammals, a global 24-hour circadian cycle is established through the central
pacemaker located in the SCN of the hypothalamus, which translates external stimuli,
such as light/dark input from the retina, into temporal signals that are then communicated
to other clocks within the brain, and peripheral tissues. Tissue-specific peripheral clocks
can be further modulated or entrained by other external cues (known as zeitgebers),
including hormones, exercise, stress, drugs, and food entraining factors, such as glucose
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and insulin. At the level of the single cell, circadian clocks are responsible for generating
oscillatory

expression patterns

through cell-autonomous

transcription-translation

feedback loops involving canonical clock components, Bmal1, Clock, Per and Cry.
Integration of the master feedback loop with others creates an endogenous circadian
network that has the ability to control rhythmic chromatin transitions (Ripperger and
Schibler, 2006), as well the expression of over 40% of murine protein-coding RNA, and
over a thousand non-coding RNAs in a tissue-specific manner (Zhang et al., 2014).
Additionally, the timing underlying the expression of an oscillatory transcript is typically
synchronized with the biological pathway involving its gene product, highlighting a timedependent relationship between the peak expression of circadian-regulated transcripts
and pathway output (Panda et al., 2002).
In our study, we identified several transcripts associated with circadian rhythm to
be shared during neurogenesis and chondrogenesis, but we also observed a distinct suite
of transcripts that seemed to propagate this process in a lineage-specific manner. We
predict that the commonly regulated transcripts provide the foundation needed for initial
establishment of the circadian clock in differentiating cranial NC cells, but then the
circadian transcriptional profile is tailored as cells diversify into either peripheral neurons
or cartilage-matrix producing chondrocytes in order to orchestrate cell-type specific
function. For instance, synchronizing environmental signals throughout the systemic
circadian network is achieved through the autonomic nervous system and the endocrine
system, and coordinated communication is crucial for driving a wide range of
physiological and behavioral responses, including sleep cycles, feeding behavior,
metabolic function, body temperature regulation, and hormone release (reviewed in Xie
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et al., 2019). Since cranial NC-derived ganglia in the head are a component of the
autonomic nervous system, establishment of circadian rhythmicity during differentiation
may be governing the transcriptional programming necessary for integrating SCN output
in order to facilitate synchronization of other peripheral clocks. In support of this, the
transcripts enriched over the course of neuronal differentiation were those known to be
associated with clock-to-clock synchronization, including GABA and glutamate sensors
(Moore et al., 1993; Liu et al., 2000; Meijer and Schwartz, 2003), and modulators of the
adenosine monophosphate/adenosine triphosphate (AMP/ATP) ratio (Lamia et al., 2009).
Interestingly, the AMP/ATP ratio is also an indicator of the cell's metabolic state, and
AMP-dependent activation of AMP kinase (AMPK), which acts as a central sensor of
metabolic signals in many cell types, including neurons, has also been implicated in
regulating nutrient-mediated clock entrainment in the liver (Lamia et al., 2009), suggesting
a relationship between metabolic homeostasis and circadian rhythm that warrants further
exploration in the context of cranial NC differentiation.
In contrast, circadian rhythm in articular chondrocytes is known to play important
roles in maintaining cartilage homeostasis and integrity by controlling the delicate balance
between ECM synthesis and degradation. Accordingly, mouse models exhibiting a loss
of key clock genes, such as Bmal1, have ectopic ossification of cartilage, reduced bone
growth, altered bone volume and increased susceptibility to inflammatory joint diseases
such as osteoarthritis and rheumatoid arthritis (Dudek et al., 2016; Gossan et al., 2013;
Yu et al., 2020). Unexpectedly, we found that nearly half of the transcriptional regulators
exhibiting peak expression in differentiated chondrocytes were associated with control of
circadian rhythm, indicating a significant role for clock-related gene regulation in the
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cranial NC during chondrogenic differentiation. In addition, we observed enrichment of
glucagon and IGF1 signaling pathways over the course of chondrogenic differentiation.
Recently, both serum glucagon and IGF1 levels were identified as novel factors in the
entrainment of the circadian clock in the liver (Ikeda et al., 2018), thus suggesting a
potentially novel role for these same factors in entrainment of the chondrogenic clock
during cranial NC-derived chondrogenesis. When taken as a whole, the results of our
transcriptomic analysis reveal key differences in circadian requirements between
neurogenesis and chondrogenesis, but also highlight circadian-controlled maintenance
of cellular homeostasis as a potential similarity underlying the differentiated state. We
envision future studies using targeted genetic approaches to assess the definitive roles
of both commonly regulated circadian transcripts, particularly Klf9 and Pura, and lineagespecific ones, will advance our understanding of the rhythmic mechanisms that not only
control cell fate acquisition, but maintenance of the differentiated state during
neurogenesis and chondrogenesis in the cranial NC.

Lineage-specific biological processes coordinate gene expression associated with
progression of differentiation, and the maintenance of the differentiated state.
Having the ability to detect environmental stimuli, like microenvironment or
signaling pathway outputs, and then translate that information to achieve a cell-type
dependent physiological or behavioral response is crucial for proper cell fate acquisition.
Accordingly, our analysis also pinpointed transcripts associated with ECM organization,
cilium assembly and hypoxia signaling as potential integrators of extrinsic cues involved
not only in the stepwise progression of differentiation in a cell-type dependent manner,
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but the continued maintenance of the differentiated state. Interestingly, we observed ECM
organization as a shared biological process between neurogenesis and chondrogenesis,
however each cell type displayed a unique combination of transcripts, which likely
contribute to differences in microenvironment composition that promotes lineage
specification. This is consistent with several studies demonstrating that the physical
attributes of extracellular matrices, such as composition, concentration and elasticity, can
have a direct effect on fate specification (Engler et al., 2006, Swift et al., 2013; Yang et
al., 2016). Matrix elasticity can be mimicked in vitro using either collagen-coated
polyacrylamide gels or hydrogels engineered to exhibit a range of matrix flexibilities.
Subsequently, naïve MSCs exposed to identical media conditions will differentiate into
neurons when grown on softer matrices, and osteoblasts when grown on more rigid
matrices. Elasticity-directed differentiation was disrupted upon the addition of instructive
medium that conflicted with the matrix stiffness, suggesting that synchrony in
microenvironment and instructive cues is crucial for robust differentiation into a particular
cell type. Interestingly, variations in matrix mechanisms were found to influence focal
adhesion structure and cytoskeletal dynamics through non-muscle myosin II (Engler et
al., 2006), as well as nuclear lamina stabilization via mechanical stress-induced changes
in lamin-A levels (Swift et al., 2013). In both cases, these mechanical signals facilitated
changes in transcriptional and proteomic profiles that enhanced lineage-specific
differentiation, thus emphasizing a significant role for the combined effect of ECM
composition, cytoskeleton remodeling, nuclear membrane stability, and cell-ECM
interactions in coordinating gene expression outcomes associated with cell fate
acquisition.
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Enrichment of transcripts associated with cilium assembly were detected in both
undifferentiated cranial NC cultures, and differentiated peripheral neurons. Primary cilia
are essential for reception and internal processing of outputs from multiple molecular
signaling pathways, including Hedgehog, WNT and Notch signaling (Bangs and
Anderson, 2017; Reiter and Leroux, 2017; May-Simera et al., 2017; Pala et al., 2017).
Once the axoneme of a cilium is established, signaling components are transported along
microtubules via intraflagellar transport, allowing the cilium to act as a cellular antenna.
Primary cilia are typically extended in quiescent cells and are found in most cell types,
including NC cells and many PNS derivatives, although the specific role of primary cilia
in neurons derived from the cranial NC has not been previously investigated. Interestingly,
transgenic mouse mutants exhibiting a loss of cilia specifically in the NC failed to respond
to hedgehog signaling emanating from the ventral forebrain, and this resulted in disruption
of cell polarity in both NC cells and ventral forebrain neuroectoderm (Schock and
Brugmann, 2017). These findings suggest a crucial role for reciprocal signaling between
NC and surrounding tissues during brain development. Future work focusing on how cilia
interpret molecular signals in order to direct downstream cellular outputs mediating tissue
morphogenesis, and the specific contribution of ciliated cranial ganglia to this process,
may provide insight into the etiology underlying ciliopathies.
Lastly, we detected stage-specific expression of transcripts associated with the
hypoxia signaling pathway specifically during chondrogenesis. Hypoxia-inducible factors
are key mediators of the cellular response to limiting oxygen conditions, responsible for
activating

transcriptional

programming

associated

with

tissue

protection

and

homeostasis. Cartilage is an avascular tissue, and therefore chondrocytes are inherently
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adapted to hypoxic conditions. In this context, stabilization of HIFs trigger enhanced ECM
deposition, as well as increased Sox9, Col2a1 and aggrecan expression, all of which is
associated with a robust articular chondrocyte phenotype (Murphy and Polak, 2004;
Robins et al., 2005; Lafont et al.,2007). In addition, chondrogenic nodules formed during
the initial stages of chondrogenic differentiation in developing limb buds were found to be
hypoxic (Schipani et al., 2001; Amarilio et al., 2007), suggesting a similar environmental
condition, and requirement for HIF signaling, in chondrocytes derived from the cranial NC.
During skeletogenesis in vivo, condensing chondrocytes will first maintain a prehypertrophic state, characterized by continued ECM deposition and maintenance, but
they will eventually transition toward a terminal hypertrophic state, which results in ECM
degradation, calcification and bone formation. In our transcriptomic analysis, we observe
Hif3a as an early regulator of hypoxia-induced gene expression that persists through the
later stages of differentiation. Interestingly, progressive increases in Hif3a expression in
healthy human articular chondrocytes in vivo or differentiated MSCs in vitro, was found
to be associated with low levels of hypertrophic markers, Col10a1 and MMP13. In
contrast, human articular cartilage harvested from patients with osteoarthritis, exhibited
low levels of Hif3a, and high hypertrophic gene expression (Markway et al., 2015). We do
not detect expression of Col10a1 or MMP13 in our cultured chondrocytes indicating that
they have not progressed toward a hypertrophic state, and therefore represent resting,
pre-hypertrophic chondrocytes. In this light, it is possible that hypoxia-induced gene
expression may help to preserve cartilage homeostasis through maintenance of the
resting chondrogenic state, partly by regulating the timing of hypertrophy.
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New paradigm for diversification along the ectodermal or mesoectodermal lineages
in the cranial NC.
When taken together, the results of our transcriptomic analysis suggest a new
paradigm for cranial NC diversification along the ectodermal or mesoectodermal lineages
in which specific cell fate acquisition is mediated by two, partially overlapping
transcriptional programs (Fig. 14). The first is a cell type-independent program commonly
initiated in the cranial NC progenitor cells undergoing neuronal or chondrogenic
differentiation. Significantly, we identified transcripts associated with cytoskeletal
reorganization, cell-cell and cell-ECM interactions, and circadian rhythm to be shared
between developing neurons and chondrocytes. These processes have been implicated
in regulating cellular changes corresponding to those observed early in the differentiation
process for both cell types, however they also have the potential to directly influence
downstream gene expression in a lineage-specific manner. Accordingly, transcripts
associated with common programming may be instrumental in establishing an overall
differentiation-competent state, thus providing an intrinsic foundation from which
intermediate neuroprogenitors or chondroprogenitors can elicit lineage-specific
physiological or behavioral outputs in response to external cues.
Subsequently, the progression through the intermediate state toward a
differentiated one is mediated by a second, cell type-dependent program, characterized
by distinct, stage-specific gene expression modules that appear to work synergistically
with the common programming to control the precise cellular changes required for
function of either peripheral neurons or pre-hypertrophic chondrocytes. Of note, we
identified unique transcripts associated with ECM organization, cilium assembly and

113

Neurogenic differentiation
Peripheral
neurons

Cranial
NC cells

Neuroprogenitors

Cell-cell adhesion

Chondrogenic differentiation
Chondroprogenitors

Pre-hypertrophic
chondrocytes

Cell-cell adhesion and
Hypoxia

Cytoskeletal changes
------ Circadian rhythm -----ECM

ECM

------ Cilium assembly -----Cellular homeostasis

Cell cycle progression
DNA repair
Mesodermal cell fate

Cell cycle progression
DNA repair
Hypertrophic state

Figure 14. Schematic representation of cranial NC diversification along the neurogenic and
chondrogenic lineages. The transition from multipotent, cranial NC progenitor (green cells) to a
differentiated peripheral neuron (red cells) or pre-hypertrophic chondrocyte (blue circles) is mediated by
two partially overlapping programs. The first, a cell type-independent program (yellow), is commonly
initiated in progenitor cells as they begin to transition toward neuroprogenitor (pink cells) or
chondroprogenitor (light blue cells) state. Enriched biological processes corresponding to the commonly
regulated transcripts are associated with shared morphological and behavior changes known to occur in
the early stages of the differentiation along either lineage. Transcripts associated with the common
programming likely promote an overall differentiation-competent state, which lays the intrinsic foundation
Cell
cycle progression
Cell
cycle progression
for subsequent
lineage-specific differentiation. The second program is characterized by
stage-specific
gene
DNA
repair
DNAare
repair
expression modules that are unique to each cell fate. Transcripts associated with this program
enriched
Mesodermal cell fate
Hypertrophic state
for biological processes capable of driving the transition through the intermediate stages of differentiation,
but are also the continued maintenance of the differentiated state. Robust differentiation is achieved through
cooperation of both programs in a stepwise and time-sensitive manner, as well as concurrent
downregulation of competing programs (blue arrows), such as those involved in self-renewal, conflicting
cell fates, or progression toward alternative fates. Temporal dynamics of stage-specific biological process
and pathways are represented by each bar. Colors denote common (yellow) or lineage-specific
programming for neurogenesis (shades of purple) or chondrogenesis (shades of magenta).

hypoxia response over the course of either neurogenesis or chondrogenesis. One
common feature underlying the mechanisms corresponding to these processes is the
inherent ability to sense and integrate external inputs to produce transcriptional outputs
that would influence cell type-specific function. In that light, these processes may not only
play an important role in mediating the temporal progression of differentiation by
translating spatiotemporal cues into stage-specific changes in gene expression, but
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potentiate the maintenance of the differentiated state. Finally, robust differentiation is
achieved through concurrent suppression of competing programs, including those
associated with stem cell-like properties, such as self-renewal and DNA repair, those that
promote conflicting fate programs, or those that propagate inevitable states of maturation
outside the scope of our culture system.
Our results provide strong evidence that cranial NC diversification along the
neurogenic or chondrogenic lineage is mediated through gradual coordination of both
common and lineage-specific programming, as well as concurrent downregulation of
competing cell fate modules. These findings are similar to a recent study which observed
that increased synchronization of fate-specific programming and concurrent repulsion of
competing non-relevant programming promoted gradual biases favoring either the
ectodermal or mesoectodermal lineage in pre- and post-migratory murine cranial NC cells
(Soldatov et al., 2019). In addition, they support the idea that determination of a specific
cell fate is coordinated, rather than stochastic, and mediated through the interplay
between intrinsic programming and extrinsic signals which together promote gradual
shifts toward commitment (Soldatov et al., 2019; Hu et al., 1997). However, identification
of common programming shared between neurogenesis and chondrogenesis challenges
the current view of differentiation where acquisition of a particular cell fate is thought to
be achieved upon activation of a single, mutually exclusive lineage-specific program.
Consequently, this model does not account for potential overlap in transcriptional
signatures as multipotent, cranial NC progenitor cells transition toward a differentiated
state, nor their potential contribution to the developmental progression. Our findings
support the incorporation of this shared module into the overall model of cell differentiation
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in the cranial NC, thus expanding the depth and complexity of the transcriptional logic
controlling the formation of these derivatives in the developing embryo.
Nevertheless, one limitation to our transcriptomic approach is that the populations
captured at the early time points for both neurogenesis and chondrogenesis likely
represent a mixture of cells transitioning toward a differentiated state, and those that may
never differentiate, even when grown in an instructive environment. Our stringent criteria
for denoting significant changes in differential gene expression revealed pertinent
programming mediating the intermediate steps. However, it is also possible that subtle,
yet equally relevant changes remain undetected in our analysis due to the heterogeneity.
A logical future approach would be to employ single-cell RNA-seq to catalog cell-to-cell
variation in transcriptional profiles over the course of neuronal or chondrogenic
differentiation. Similar analyses have been used to elegantly capture spatiotemporal
biasing in early cell fate choices toward the ectodermal or mesoectodermal lineages in
FACS purified pre- and post-migratory murine cranial and trunk NC cells in vivo (Soldatov
et al., 2019). One caveat to this approach for assessing differentiation in vivo is that
computational reconstruction of single-cell data only predicts lineage relationships, and
our current interpretation of these data are largely founded on information derived from
non-cranial NC sources. However, in vitro studies utilizing single-cell profiling at multiple
time points over the course of directed differentiation would enable identification of distinct
changes in gene expression that are coupled with observable morphological, cellular and
behavioral transformations characteristic of neuroprogenitors or chondroprogenitors, as
well as other intermediate stages, during cranial NC diversification. These findings would
not only provide a higher resolution map of the molecular programming identified in this
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study, but contribute to more accurate interpretation of subsequent in vivo single-cell
assessment.
The findings of our transcriptomic analysis represent a crucial first step in
establishing a comprehensive regulatory network detailing the temporally dynamic
genetic program that directs the transitions through the intermediate stages of
differentiation in the cranial NC. Our immediate next step would be to utilize our culture
system to validate the results of our transcriptomic analysis via RT-qPCR, and a
combination of conventional and novel immunolabeling techniques, such as SABER
(Kishi et al., 2019). SABER allows for multiplexed amplification of signals from oligobased fluorescent in situ hybridization (FISH) probes targeting up to 17 different
transcripts simultaneously with high resolution. Such a technique would not only allow for
visual confirmation of the distinct temporal gene expression patterns we observed at the
level of the single cell in vitro, but it can also be applied in vivo as well, allowing
incorporation of spatial patterning of the DE transcripts in the context of the developing
mouse embryo. In addition, targeted manipulation of the transcripts identified would
illuminate how disruption of the programming might accelerate or delay the progression
of cranial NC cell differentiation, thus contributing to cranial NC-related defects and
disease.
The ultimate long-term goal of this work would be integration of our findings into
the current GRNs underlying cranial NC diversification. Significantly, our transcriptomic
analysis has identified several candidate regulatory factors that may coordinate changes
in gene expression over the course of cranial NC differentiation, however differential
expression alone is not enough to definitively establish their regulatory role during these
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processes. It is important to recognize that transcription factor activity may be influenced
by a number of variables, including chromatin accessibility, interaction with various cofactors, and/or binding partners, as well as post-translational modification. In addition,
recent studies demonstrate that gene regulatory programs directing changes in cell state,
such as those associated with lineage specification, are controlled through the
combinatorial binding of transcription factors and chromatin regulators to distal gene
enhancers (Attanasio et al., 2013; Velasco et al., 2017). Therefore, to truly incorporate
this information we must first decipher the shared cis-regulatory modules that drive stagespecific gene expression during neuronal and chondrogenic differentiation in the cranial
NC. To achieve this, we intend to use ATAC-seq (Buenrostro et al., 2013) in order to
identify transcriptionally accessible regions of chromatin that correspond to putative DNA
regulatory sequences (promoters, enhancers, and insulators) in cultured cranial NC cells
as they transition through the intermediate stages of neurogenic and chondrogenic
differentiation. Motif analysis enrichment would be performed to determine transcription
factor binding sites within the temporally clustered enhancers, thus uncovering key
transcriptional regulators mediating each step of the differentiation process. We would
also expect to decipher co-regulatory binding sites within temporally clustered enhancer
sequences which, when coupled with our temporal gene expression profiles, would
enable identification of combinatorial transcriptional activity controlling the stepwise,
lineage-specific gene expression changes as cranial NC cells transition toward the
neurogenic or chondrogenic cell fate. Similar approaches have been used to identify key
transcriptional regulators driving the stepwise progression of optic nerve regeneration in
zebrafish (Dhara et al., 2019), as well as those involved in direct programming of human
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embryonic stem cells (hESCs) into motor neurons (Velasco et al., 2017). It is expected
that data from these combined temporal analyses could be used to build a high resolution,
comprehensive roadmap of the unique lineage-specific regulatory mechanisms driving
cranial NC differentiation.
The temporal, transcriptomic data presented in this chapter serves as an excellent
resource for further exploration into the dynamic intrinsic control of the progression of
neurogenic and chondrogenic differentiation in the cranial NC. Interrogation of the stagespecific transcriptional modules elucidated both expected and novel biological processes
and pathways that govern the initial transition and subsequent transformation through the
intermediate stages of differentiation. We also uncovered unique transcriptional
signatures indicative of the intermediate stages, as well as putative transcriptional
regulators that mediate the progression, including those that may contribute to early
commitment toward either lineage, and those that promote maturation of the differentiated
state. Significantly, our results suggest a crucial interplay between common and lineagespecific programming over the course of differentiation in the cranial NC. We expect that
future studies using targeted genetic manipulation of the genes associated with each
program may yield insight into how they work together in a stepwise and time-sensitive
manner to coordinate appropriate downstream physiological and behavioral responses
during differentiation. In that light, our findings provide a valuable platform for discovering
previously unknown mechanisms underlying a range of cranial NC-related malformations
including, but not limited to, craniofacial defects and neuroblastoma. We expect the
findings of such studies will enhance our understanding of the etiology underlying the
pleiotropic structural and functional anomalies that often accompany pediatric syndromes
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arising from defects in the cranial NC. Finally, assessing how genetic mutations or
developmental exposure to environmental toxins impact the temporal regulation of cranial
NC differentiation would enable discovery of novel molecular targets of genetic and
environmental factors that might contribute to cranial NC-related malformations. This
information would not only facilitate the development of effective therapeutic
interventions, but also strategies for prevention with the long-term goal of reducing the
overall incidence of cranial NC-related defects in the population.
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CHAPTER V

General Discussion

Summary of key findings and future directions
The work that comprises this dissertation provides several tools for uncovering the
specific mechanisms that govern the progressive acquisition of cell fate in the NC. In order
to investigate the temporal regulation of this process we established a robust in vitro
model system of mammalian cranial and trunk NC cell differentiation. We demonstrate
reproducible methods for isolation and long-term expansion of both primary cranial and
trunk NC cells obtained from the same animals. Both populations maintained their
multipotency in culture, as demonstrated by their ability to be directly differentiated into
neurons, glia, melanocytes, chondrocytes, adipocytes and smooth muscle cells.
Characterization of directed differentiation along the neural and chondrogenic lineages
revealed reproducible, temporal benchmarks indicative of the intermediate stages
underlying the progression. Using this culture system, we explicitly interrogated cranial
NC cells to uncover the dynamic gene expression changes that occur over the course of
neurogenesis and chondrogenesis. Our analysis revealed that cranial NC cell
diversification toward either fate is mediated through gradual coordination of both
common and lineage-specific programming, as well as concurrent suppression of
competing

cell

fates.

We

further

identified

distinct

transcriptional

signatures

corresponding to the intermediate state, as well as putative regulators that govern the
overall progression in a stage-specific and time-sensitive manner.
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Lineage-specific transcriptional signatures that delineate the intermediate stage of
differentiation in the cranial NC.
The current GRNs describing NC cell diversification lack specific modules that
represent the progression through the intermediate stages of differentiation toward a
particular cell type. One significant finding of the work presented was the identification of
key candidate transcriptional activators and repressors that control the transition from
multipotent progenitor to an intermediate neuroprogenitor and chondroprogenitor state.
Upon validation, and functional assessment, these regulators would represent a new
module in hierarchical regulation of NC cell development (Fig. 15).
Notably, for neurogenesis, we specifically identified Pa2g4 and Six4, both of which
regulate gene expression associated with sensory neuron survival (Ko et al., 2019;
Konishi et al., 2006; Kwon and Ahn, 2010). As a direct repressor of the methyltransferase
DNMT1, and suppressor of SUV39H1-mediated histone H3K9 trimethylation (Ko et al.,
2019), Pa2g4 may play a crucial role in promoting global changes in chromatin
accessibility, thereby promoting activation of downstream genes associated with sensory
neuron development. Targeted manipulation of Pa2g4 in our cultures, followed by RNAseq would clarify which genes might be under the control of Pa2g4-mediated activation,
and therefore crucial for the initial transition toward the sensory neuron cell fate. A similar
approach could be used to determine downstream gene targets of Six4. Six1/Six4deficient mice displayed aberrant gangliogenesis due to increased apoptosis (Konishi et
al., 2006), however the loss of Six1/Six4 was not specific to the cranial NC. Six factors
are expressed in placodal cells, which also contribute to trigeminal ganglion formation.
Therefore, such analysis would shed light on the specific effect of Six4 in the cranial NC
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Figure 15: Incorporation of putative transitional and intermediate modules into the current GRN for
neural crest cell differentiation. Transcriptional regulators that are shared between neurogenesis and
chondrogenesis comprise a novel Transitional module (yellow). Commonly upregulated and downregulated
transcription factors mediate the initial transition toward either cell fate by driving shared cellular and
behavioral changes observed during the earliest stages of differentiation along either the neuronal or
chondrogenic lineage, and may play similar roles in driving the transition toward other cell fates, as well.
Intermediate modules for neurogenesis (red arrow) and chondrogenesis (dark blue arrow) include novel
transcriptional regulators that specifically control the progression through the intermediate neuroprogenitor
or chondroprogenitor state. Regulators found within intermediate modules likely drive downstream gene
expression batteries associated with robust lineage-specific differentiation and maturation.
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during neurogenesis.
For chondrogenesis, the transcription factors upregulated in the intermediate stage
were those known to play roles during MSC differentiation, as well as Hif3a and Epas1,
which are associated with hypoxia-induced signaling. In healthy human articular
chondrocytes, Hif3a and Epas1 control robust ECM synthesis and a stable prehypertrophic phenotype, characterized by high Sox9 expression, and low levels of
hypertrophic markers Col10a1, and MMP13 (Lafont et al., 2007; Markway et al., 2015).
We do not detect significant Sox9 expression, or Alcian blue-positive ECM synthesis in
our cultures until the differentiated cells condense to form chondrogenic nodules, which
have been described as a hypoxic environment (Amarillio et al., 2007; Schipini et al.,
2001). Therefore, it is possible that expression of Hif3a and Epas1 in the intermediate
cells may be the first step in establishing a robust response which allows chondrocytes
to adapt to low oxygen conditions at the later stages of differentiation. Consistent with
this, we observe enrichment of additional genes associated with the HIF1 signaling
pathway in the differentiated cells found within chondrogenic nodules.
Even though the cultured chondrocytes used in this study were grown under
normoxic conditions, we were able to detect enrichment of transcripts associated with
hypoxia-related signaling. Therefore, our culture system serves as a tool to further
investigate the role of hypoxia-induced gene expression during chondrogenesis in the
cranial NC. Moreover, growing cultures in the presence of low oxygen tension using a
hypoxia chamber may uncover hypoxia-related mechanisms or factors involved in the
progression of chondrogenic differentiation that are not readily detectable under
normoxia. Together, these findings would inform future strategies for improving

124

chondrogenic culture conditions, enabling advancement of stem-cell based therapies to
treat congenital and acquired craniofacial deformities, such as craniofacial tissue repair.

Enriched biological processes and pathways reveal potential mechanisms of cell
fate determination in the cranial NC
The results of our analysis further revealed common and lineage-specific
programming that governs distinct, but partially overlapping biological processes and
pathways that may have important roles to play in cell fate determination in the cranial
NC. While this work provides a snapshot into the cell intrinsic mechanisms that direct
differentiation over time, diversification in vivo is also dependent on spatial and temporal
extrinsic factors, such as paracrine and autocrine signaling molecules, ECM composition,
and physical interaction with surrounding tissues. However, how migratory NC cells
integrate this information in order to activate downstream gene expression modules
associated with a particular cell fate is not well understood. We hypothesize that common
programming shared between developing peripheral neurons and chondrocytes poises
the cells to sense and respond to various environmental contexts in a lineage-specific
manner. A question then becomes: what are the mechanisms by which a common
regulatory program can drive a cell type-specific differentiation response?
In our study, we found that common transcriptional signatures were associated
with cytoskeletal reorganization, changes in cell-cell and cell-ECM interactions and
circadian rhythm (Fig. 15). We also detected lineage-specific gene expression associated
with these processes as the cells progressed toward a differentiated state. The interplay
between these two programs in driving the shared processes is consistent with our
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observations that a reduction in cell size, and aggregation formation were some of the
earliest changes displayed by differentiating cranial NC cells, no matter their future fate.
We predict that the mechanisms underlying these early cellular changes are crucial for
determining downstream lineage-specific outcomes.
Consistent with this idea a recent study investigating the timing of skeletal element
formation in the developing avian head found that cytoskeletal rearrangement associated
with changes in cell shape were required for condensation formation, and overt
chondrogenic differentiation (Ray and Chapman, 2015). Cytoskeletal remodeling was
facilitated by RhoA/ROCK-driven actomyosin contractions and non-muscle myosin II
(NMII)-mediated changes in cell cortex tension. Disruption of F-actin remodeling,
RhoA/ROCK-driven actomyosin contractility or NMII-generated tension via treatment with
Cytochalasin D, ROCK inhibitor Y27632, or Blebbistatin, respectively, prevented overt
differentiation, as indicated by a loss of Sox9 expression, dysregulated TGFβ/SMAD2,
BMP2, and FGF signaling, and a lack of condensations. This illustrates a direct
connection between changes in cytoskeletal architecture and the regulation of
downstream gene expression, at least concerning Sox9, and signaling dynamics
associated with robust chondrogenic differentiation.
Accordingly, we predict that global disruption in cell shape changes as the cells
begin to transition toward either the neurogenic or chondrogenic fate would inhibit
differentiation. However, we would also expect that targeted manipulation of specific
factors associated with cytoskeletal organization identified in our study would have a
differential impact on neuronal and/or chondrogenic differentiation depending on whether
they were detected in the common or lineage-specific programming. We identified Ezrin
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as a possible regulator of cytoskeletal dynamics in both peripheral neurons and
chondrocytes. Ezrin regulates membrane tension by linking the plasma membrane to the
actomyosin cortex, and by switching between active and inactive states it can impact
cellular morphology (Doherty and McMahon, 2008). Activated Ezrin results in increased
tension, and cell spreading, while the inactive form promotes cell contraction, and the
conformational switch in activity is mediated through Rho kinase signaling (Matsui et al.,
1998). Since Ezrin was found in common between the two cell fates we would expect that
inhibition of Ezrin activity would impact both neurogenesis and chondrogenesis during
development. Importantly, by identifying potential cytoskeletal regulators that are shared
between both cell types, our analysis enables discovery of genes that may contribute to
multisymptom phenotypes often associated with cranial NC-related disorders.
It is also possible that the regulators found within the common programming are
conserved across other NC cell derivatives. For instance, we observed that cranial and
trunk NC cells undergoing glial differentiation exhibited distinct morphological
transformations over time. For both cell populations, NC cells initially displayed flattened,
sheet-like morphology but transitioned toward an elongated, bipolar morphology,
indicative of immature Schwann cells, as differentiation progressed. Therefore, it would
be advantageous to conduct a temporal transcriptional analysis for gliogenesis, as we
have described for neurongenesis and chondrogenesis. This would not only enable
identification of regulators that control the distinct morphological transitions, but also
provide insight into the overall transcriptional programming that governs the progression
toward a glial cell fate.
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One potential mechanism for transducing actomyosin-mediated mechanical forces
into regulatory signals that direct lineage-specific gene expression would be through
modulation of nuclear stability and stiffness. In the study referenced above, Ray and
Chapman (2015) found that temporal cytoskeletal remodeling not only impacted overall
cell morphology, but the shape of the nucleus and cell-cell/cell-ECM interactions, as well.
At first, they observed irregularly-shaped cells transforming to a characteristic cuboidal
chondrocyte morphology. This change was coupled with increased F-actin homogeneity,
and a significant decrease in nuclear circularity, resulting in a similarly cuboidal nuclear
shape. Then, as the chondrocytes condensed, their overall morphology, and nuclear
shape, relaxed to become more rounded. Concurrently, they observed increased focal
adhesion formation, thus fixing the condensing cells to extracellular substrate. Several
studies have shown that external mechanical forces, such as those associated with
morphological transformation, can lead to nuclear deformation and altered levels of
euchromatin and heterochromatin (Bank and Gruenbaum, 2011; Stephens et al., 2018;
Swift et al., 2013). Since higher order chromatin structure is partly controlled through its
attachment to the nuclear periphery (Guelen et al., 2008; Harr et al., 2015), it is possible
that subtle changes in cellular mechanics can have a significant impact on overall
chromatin accessibility and enhancer-promoter interactions that regulate transcriptional
programming during differentiation.
Changes in the tensile forces due to cytoskeletal reorganization and modulation of
ECM adhesion are propagated into the nucleus through the nuclear lamina via Lamin-A
(Swift et al., 2013). Nuclear lamins are intermediate filaments that comprise a meshwork
found just inside the nuclear envelope, and are responsible for regulating nuclear stability
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(De Vos et al., 2011). Varying levels of Lamin-A were shown to enhance tissue-specific
differentiation in vitro, and this effect was mediated by matrix elasticity. Higher levels of
Lamin-A were induced in cells grown on stiffer matrices, and this was associated with cell
spreading and bone formation. In contrast, softer matrices were correlated with low
Lamin-A levels, and were associated with adipocyte formation, which display a more
rounded phenotype.
Interestingly, we detected upregulation of the gene for Lamin-A/C (LMNA) in the
intermediate chondroprogenitors, indicating a viable role for this mechanism in promoting
chondrogenic differentiation in the cranial NC. In contrast, Lamin-A expression was not
found to be differentially expressed over the course of neurogenesis. This is consistent
with studies that have shown that MSCs grown on softer matrices preferentially give rise
to neurons (Engler et al., 2006), and therefore Lamin-A suppression may be necessary
in order to drive cranial NC cells toward a neuronal cell fate. Characterizing Lamin-A
dynamics and changes in nuclear stabilization over the course of differentiation would
provide insight into the differential role of mechanotransduction during lineage
specification in the cranial NC. Future temporal analyses utilizing chromatin capture
techniques, coupled with RNA-seq and ATAC-seq, could uncover how changes higher
order chromatin architecture due to mechanical forces generated upon morphological
transformation are correlated with dynamic changes in chromatin landscape and gene
expression, thus potentiating acquisition of a particular cell fate. We would expect these
aspects to be unique to each cell type, and therefore dysregulation of these processes
could result in either delayed or ectopic differentiation, thus contributing to the etiology
underlying cranial NC-related birth defects and disorders.
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Outside the cell, extracellular matrices play an integral role in promoting lineage
diversification

by

acting

as

an

instructive,

mechanical

switch

that

initiates

mechanotransduction pathways (Engler et al., 2006, Swift et al., 2013; Yang et al., 2016).
Matrix elasticity alone can direct naïve MSCs toward a neuronal or chondrogenic cell fate,
yet there are many unanswered questions regarding the precise composition,
concentration and organization of matrices that these cells are exposed to during
differentiation, and how they together mediate robust differentiation.
Our transcriptional analysis revealed specific suites of genes associated with ECM
organization that were uniquely expressed in either differentiating peripheral neurons or
chondrocytes. These transcripts were significantly enriched in the intermediate stage and
then continued to be expressed in the differentiated cells. We predict that gradual
expression of these transcripts over time serves two purposes. First, they promote
aggregation of the intermediary cells by providing a scaffold that fixes the cells spatially,
which in the developing embryo would contribute to position and patterning of the future
tissue or structure. Second, by bringing the differentiating cells in close contact, ECM
composition facilitates cell-cell communication that triggers downstream transcriptional
events, including expression of genes necessary for continued production and
reorganization of the ECM. By continuing to tailor the surrounding microenvironment in a
cell type-specific manner, the cranial NC cells could promote robust differentiation by
stabilizing the programming associated with a distinct cell fate. We expect that closer
examination of the genes associated with ECM organization identified in this study will
greatly contribute to our understanding of how the microenvironment drives lineage
diversification in the cranial NC.
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Interestingly, stabilization of matrix-mediated lineage-specific programming may
be achieved through regulation of circadian rhythm. A recent study found that ECM
stiffness can directly influence circadian dynamics (Yang et al., 2017). Here, mammary
epithelial cells cultured on extremely stiff matrices displayed dampened circadian
rhythmicity, but softer matrices promoted a 7-fold increase in the amplitude of the
oscillations. Differences in circadian activity were found to be associated with vinculin, a
tension sensing adhesion molecule that is downstream of the Rho/ROCK signaling
pathway. This raises the intriguing possibility that a similar interplay between
mechanotransduction and circadian rhythm may be occurring during neuronal and
chondrogenic differentiation in the cranial NC.
In our analysis we identified key differences in circadian transcriptional signatures
between differentiated peripheral neurons and chondrocytes, and hypothesize that
circadian-controlled gene expression plays a role in maintaining cellular homeostasis,
albeit in two different ways. In differentiated neurons the transcripts identified were
associated with clock synchronization and metabolic homeostasis, while circadian
rhythm-related transcripts in differentiated chondrocytes have been implicated in
regulating the balance between cartilage synthesis and degradation. Given that ECMmediated mechanotransduction has the potential to direct downstream gene expression
changes, it is possible that the microenvironment may play a previously unappreciated
role in tailoring circadian dynamics to coordinate lineage-specific physiological and
functional output, thus promoting maintenance of the differentiated state. Regulation of
circadian rhythm is often studied in the context of ageing, and disease, such as
osteoarthritis. Therefore, future studies focusing on discovering the chemical and
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biomechanical inputs that govern circadian dynamics, and the downstream clockcontrolled genes that regulate neuronal or chondrogenic differentiation, will be able to
clarify the contribution of this process to cranial NC cell development. In addition,
information gathered from these studies may be directly applicable to understanding the
pathogenesis of circadian-related disease progression, thus enabling development of
potential therapies and strategies for disease prevention.

Concluding remarks
Our primary murine culture system modeling NC cell differentiation provides a
powerful tool for investigating the cell intrinsic mechanisms that coordinate the
progression of cell fate acquisition. Given their broad contribution to a range of tissues,
disruption of NC cell development can result in pleiotropic structural and functional
anomalies. The well-characterized differentiation timelines described in this work
constitute a temporal baseline for assessing how genetic or environmental disruptions
may facilitate or impede NC differentiation, thus contributing to these defects. In addition,
our transcriptomic analyses enable discovery of novel genes that may contribute to
multisymptom phenotypes often associated with cranial NC-related disorders. Future
studies can build on this work by interrogating cranial or trunk NC undergoing
differentiation toward other cell fates, such as the gliogenic or melanogenic lineages.
Such information would broaden our understanding of the similarities and differences in
programming that govern NC cell diversification, as well as their potential contribution to
NC-related defects and disorders, thus enabling development of novel therapeutic
interventions, and strategies for prevention.
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Appendix A: Cell numbers and doubling rates for biological replicates
SUPPLEMENTARY INFORMATION
Biological isolates
Pregnant Number of
dams
embryos
3
28
2
18
1
7
average
8.83

Cranial NC
Total cells
recovered
2.77E+05
1.20E+05
7.50E+04

Cells per
embryo
9.89E+03
6.64E+03
1.07E+04
9.08E+03

Doubling
rate
(hours)
44.6
42.9
44.9
44.1

Trunk NC
Cells per
Total
embryo number of
by P3
cells by P3
8.69E+05 2.43E+07
6.97E+05 1.25E+07
9.14E+05 6.40E+06
8.37E+05 7.39E+06

Total cells
recovered
7.26E+04
5.19E+04
3.00E+04

Cells per
embryo
2.59E+03
2.88E+03
4.29E+03
3.25E+03

Doubling
rate
40.0
42.6
32.6
38.4

Cells per
Total
embryo number of
by P3
cells by P3
3.81E+05 1.07E+07
3.12E+05 5.62E+06
1.96E+06 1.37E+07
5.89E+05 5.20E+06

TableFigure
3. Cell
numbers and doubling rates for biological replicates. Each primary
S1. Cell numbers and doubling rates for biological replicates. Each primary
isolate consisted of cells pooled from 1-3 litters of embryos (7-28 embryos total)
depending
how many
females
setfrom
up for
were carrying
E9.5 embryos
isolate on
consisted
of cells
pooled
1-3 breeding
litters of embryos
(7-28 embryos
total) on the
day of dissection. Method: “Doubling rate” was determined using an online doubling time
depending
on2006).
how many
females
up for breeding
were carrying
E9.5 embryos
on the
calculator
(Roth,
“Cells
per set
embryo”
was calculated
by dividing
the total
number of
cells day
recovered
at
isolation
by
the
total
number
of
embryos.
“Cells
per
embryo
by P3
of dissection. Method: “Doubling rate” was determined using an online doubling time
(hours
in
(passage 3)” was calculated using the doubling rate formula (cells per embryo x 2
culturecalculator
(288)/doubling
(Roth,rate)
2006).
“Cellsnumber
per embryo”
was calculated
dividing
the total number
of
). “Total
of cells
by P3” forbyeach
experiment
was calculated
by multiplying “number embryos” by “cells per embryo by P3”. Average number of
cells recovered at isolation by the total number of embryos. “Cells per embryo by P3
embryos per litter was calculated by dividing the total number of embryos recovered from
in
the three
biological
(53) the
by doubling
the totalrate
number
litters
Average
per
(passage
3)” wasreplicates
calculated using
formulaof
(cells
per (6).
embryo
x 2(hours“Cells
embryo” and “Doubling rate” were calculated by taking the average of the three biological
culture (288)/doubling rate)
). “Totalper
number
of cellsby
byP3”
P3” for
each
experiment
wascalculated
calculated by
replicates.
Average “Cells
embryos
was
calculated
was
using the
(hours
in
culture
(288)/average
doubling
doubling
rate formula (average cells per embryo x 2
multiplying “number embryos” by “cells per embryo by P3”. Average number of embryos
rate)). Average “Total number of cells by P3” was calculated by multiplying “average
per embryos”
litter was calculated
by dividing
numberby
of P3”.
embryos recovered from the three
number
by “average
cellsthe
pertotal
embryo
biological replicates (53) by the total number of litters (6). Average “Cells per embryo” and
“Doubling rate” were calculated by taking the average of the three biological replicates.
Average “Cells per embryos by P3” was calculated was calculated using the doubling rate
formula (average cells per embryo x 2(hours

in culture (288)/average doubling rate)

). Average “Total

number of cells by P3” was calculated by multiplying “average number embryos” by
“average cells per embryo by P3”.
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Appendix B: Wide field comparisons of neuronal differentiation in cultures
derived from cranial and trunk NC.

Figure 16.
S2. Wide
Wide field
field comparisons
comparisons of
Figure
of neuronal
neuronal differentiation
differentiation in
in cultures
cultures derived
derived
from cranial and trunk NC. Neuronal differentiation of cranial- and trunk-derived NC
from was
cranial
and trunk
NC. and
Neuronal
differentiation
of cranial-medium
and trunk-derived
NC
cells
observed
after four
eight days
in in differentiation
containing NT3
and NGF. Differentiation was assessed by immunostaining for TUJ1, a neuron-specific
cells was
observedInafter
and eightthe
days
in in of
differentiation
medium
NT3
class
III b-tubulin.
orderfour
to visualize
extent
differentiation
within containing
the cultures,
we
obtained overlapping, high resolution images spanning the entire culture well. (A-D) TUJ1
and NGF. Differentiation
was assessed
immunostaining
for NC
TUJ1,
a neuron-specific
immunostaining.
(A’-D’) EYFP
expressionby(lineage
tracer in the
cells).
(A”-D”) Higher
magnification, merged images of the boxed regions in A-D’ (TUJ1, red; EYFP, green).
class III were
b-tubulin.
In order
visualize
thethe
extent
of source
differentiation
within (Preibisch
the cultures,
Images
aligned
and to
stitched
using
open
Fiji software
et we
al.,
obtained overlapping, high resolution images
157spanning the entire culture well. A-D: TUJ1

2009). Cells with neurites are observed throughout cultures from both cranial and trunk
NC, however, aggregation of neurons is more prevalent in neurons derived from trunk NC
at both time points. At day 4, individual neurons extending neurites were observed
throughout the cranial NC culture (A, A”), while trunk NC-derived neurons are observed
both singly and in small loosely formed aggregates (C, C”). By day 8, loose aggregates
of cranial NC-derived neurons can also be observed (examples indicated by arrowheads
and boxed region in B, and as magnified boxed region in B”), however, aggregates
formed by trunk NC-derived neurons are more compact and well-defined with extensive
neuritic outgrowth (examples indicated by arrowheads and boxed region in D, and
magnified boxed region in D”). Scale bars: (A-D and A’-D’) 2 mm; (A”-D”) 100 μm.
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Appendix C: Wide field comparisons of smooth muscle differentiation in cultures
derived from cranial and trunk NC.

Figure 17.
S3. Wide
Wide field
field comparisons
comparisons of
of smooth
smooth muscle
Figure
muscle differentiation
differentiation in
in cultures
cultures
derived from cranial and trunk NC. Smooth muscle differentiation of cranial- and trunkderivedNC
from
cranial
and trunkthroughout
NC. Smooth
of cranialand trunkderived
cells
was observed
themuscle
culturedifferentiation
after seven days
in differentiation
medium containing FCS. Differentiation was assessed by immunostaining for alpha
derived muscle
NC cellsactin
was(αSMA).
observedInthroughout
the culture
seven
days in differentiation
smooth
order to visualize
the after
extent
of differentiation
within the
cultures, we obtained overlapping, high resolution images spanning the entire culture
medium
containing
FCS. Differentiation
was
assessed
by immunostaining
alpha
well.
(A, B)
αSMA immunostaining,
(A’, B’)
EYFP
expression
(lineage tracer for
in the
NC
cells). Images were aligned and stitched using the open source Fiji software (Preibisch et
smooth
muscle
actinHigher
(aSMA).
In order to visualize
extent
differentiation
within
the
al.,
2009).
(A”, B”)
magnification,
merged the
images
of of
the
boxed regions
in A-B’
(αSMA, orange; EYFP, green). Images were aligned, stitched and pseudocolored using
cultures,
we obtained
overlapping,
highetresolution
spanning
the
open source
Fiji software
(Preibisch
al., 2009).images
Scale bars:
(A, Bthe
andentire
A’, B’)culture
2 mm;
(A”, B”) 100 μm.
well. A, B: aSMA immunostaining, A’, B’: EYFP expression (lineage tracer in the NC
cells). Images were aligned and stitched using the open source Fiji software (Preibisch et
al., 2009). A”, B”: Higher magnification, merged images of the boxed regions in A-B’
(aSMA, orange; EYFP, green). Images were aligned, stitched and pseudocolored using
the open source Fiji software (Preibisch et al., 2009). Scale bars: (A, B and A’, B’) 2 mm;
(A”, B”) 100 µm.
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Appendix D: Wide field comparisons of chondrogenic, adipogenic, and
melanogenic differentiation in cultures derived from cranial and trunk NC.

Figure S4. Wide field comparisons of chondrogenic, adipogenic, and melanogenic
Figure 18. See next page for legend.
differentiation in cultures derived from cranial and trunk NC. Differentiation of
160

Figure 18. Wide field comparisons of chondrogenic, adipogenic, and melanogenic
differentiation in cultures derived from cranial and trunk NC. Differentiation of
cranial- and trunk-derived NC cells into chondrocytes, adipocytes and melanocytes was
observed throughout the cultures (A, B: chondrocytes (blue) detected by Alcian blue
staining after 14 days in differentiation medium containing TGF-β3; C, D: adipocytes (red)
detected by Oil red O staining after 14 days in Adipogenic Medium from STEMCELL
Technologies; and E, F: melanocytes (brown) detected based on tyrosinase activity after
10 days in differentiation medium containing ET3). In order to visualize the extent of
differentiation within the cultures, we obtained overlapping, high resolution images
spanning the entire culture well. Images were aligned and stitched using the open source
Hugin software (d’Angelo, 2007). Higher magnification images of the boxed regions are
shown in the insets. Scale bars: 2 mm; insets, 100 μm.
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Appendix E: Mesodermal markers are not detected in cultured cranial
and trunk NC cells.

Figure
S5. Mesodermal
markers
are notcranial
detected
intrunk
cultured
Figure 19. Mesodermal
markers
are not detected
in cultured
and
NC cranial and t
cells. Cultured NC cells were compared with whole E9.5 embryos for the expression of
cells.Brachyury
Cultured NC
were compared
whole E9.5
a pan-mesodermal marker,
(T), cells
or a marker
for axial with
mesoderm,
Tbx6,embryos
using for the expr
reverse transcriptase PCR. NC markers, Snail and Sox9, and housekeeping gene,
a pan-mesodermal
marker, Brachyury
(T), or ahowever,
marker for
axial mesoderm, Tb
GAPDH, served as positive
controls. A representative
gel is shown;
identical
results were obtained from three independent biological samples.
reverse transcriptase PCR. NC markers, Snail and Sox9, and housekeepi

GAPDH, served as positive controls. A representative gel is shown; however,

results were obtained from three independent biological samples. Method: P

carried out on cDNA prepared from RNA isolated from cultured cranial or trunk

three passages, or from whole E9.5 mouse embryos as described in the metho
primers:

Tbx6

(5'-

TGAAGATCGCAGCCAATCCC-3',

TGAAAAGCGGCAGGGTGTAG-3'); Brachyury (T) (5'-CCAGCTCTAAGGAAC

3', 5'- AAAGAACTGAGCTCCCAGCC-3'); Snail1 (5'-CTGCACGACCTGTGGAA
GCCTGGCACTGGTATCTCTT-3');

Sox9

(5'-AGTCGGTGAAGAACGGACAA

CCCTCTCGCTTCAGATCAACT-3'); GAPDH (5'-GCTCATGACCACAGTCCATG
GTTGGGATAGGGCCTCTCTTG-3').
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Appendix F: Neuritic expression of HuC/D is more prevalent in neurons derived
from cranial NC when compared to those derived from trunk NC.

Figure S6.
20. Neuritic
Neuritic expression
expression of
of HuC/D
HuC/D is
is more
more prevalent
prevalent in
in neurons
neurons derived
derived from
from
Figure
cranial NC when compared to those derived from trunk NC. Images of neurons
differentiated
fromcompared
cranial to
andthose
trunk-derived
NCtrunk
and NC.
subjected
HuC/D
cranial
NC when
derived from
Method: to
Images
of
immunofluorescence staining for experiments described in Fig. 5 were quantified with
respect to
the percentage
neuronsand
extending
HuC/D NC
positive
neurons
differentiated
fromof cranial
trunk-derived
and neurites.
subjectedFive
to images
HuC/D
were obtained from differentiated cultures in each biological replicate. Cells with neurites
were identified in the staining
green channel
(EYFP). These
cells were
then
assessed
for HuC/D
immunofluorescence
for experiments
described
in Fig.
5 were
quantified
with
expression in the red channel to calculate the percentage of neurons with HuC/D in
processes.
Each
image wasofanalyzed
two blinded
sets
respect
to the
percentage
neurons separately
extending by
HuC/D
positiveobservers,
neurites. and
Fiveboth
images
of observations are displayed in the graph. The Grubbs test was used to eliminate outliers
in theobtained
cranial and
trunk
data sets from
eachinobserver,
resulting
in elimination
of two
points:
were
from
differentiated
cultures
each biological
replicate.
Cells with
neurites
(1) trunk, isolate 2, observer 1 and (2) trunk, isolate 1, observer 2. Two-way ANOVA
analysis
with Tukey’s
multiple
testing
correction
no significant
effects
of
were
identified
in the green
channel
(EYFP).
These determined
cells were then
assessed for
HuC/D
observer or isolate, but a significant effect between cranial and trunk NC (p<0.0001). Each
dot represents
onered
observation
one image
is color-coded
by biological
replicate
expression
in the
channel toof calculate
theand
percentage
of neurons
with HuC/D
in
and observer as indicated. Black horizontal line indicates grand mean across replicates.
processes. Each image was analyzed separately by two blinded observers, and both sets
of observations are displayed in the graph. The Grubbs test was used to eliminate outliers
in the cranial and trunk data sets from each observer, resulting in elimination of two points:
(1) trunk, isolate 2, observer 1 and (2) trunk, isolate 1, observer 2. Two-way ANOVA
analysis with Tukey’s multiple testing correction determined no significant effects of
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Appendix G: Primary cranial and trunk NC cells express Schwann cell marker,
ErbB3, during glial differentiation.

Figure S7. Primary cranial and trunk NC cells express Schwann cell mark

Figure 21. Primary cranial and trunk NC cells express Schwann cell marker, ErbB3,
during glial differentiation. Schwann cell differentiation of cranial- and trunk-derived NC
during
glial after
differentiation
Schwann
cell
differentiation
of cranialand tru
cells
was observed
4, 10 or 14 days. in
differentiation
medium
containing BMP2
and
LIF. Differentiation was assessed by immunostaining for ErbB3, a receptor tyrosine
kinase enriched in Schwann cell. ErbB3-positive cells were observed in both cranial and
NC cells was observed after 4, 10 or 14 days in differentiation medium conta
trunk NC cell populations at Day 4 (A, B). By Day 10, some of the ErbB3-positive cells
extended flattened, sheet-like processes (C, D; asterisks) while the other ErbB3-positive
cells
displayed
an elongated, spindle-like
morphologyby
(C, immunostaining
D; arrowheads). Afterfor
14 ErbB3,
days,
and
LIF. Differentiation
was assessed
a recep
most ErbB3-positive cells in both populations exhibited an elongated, bipolar morphology
and cells extending flattened, sheet-like processes were only occasionally observed (E,
enriched
in Schwann
cell.
ErbB3-positive
wereobserved
observed in both
F).kinase
Phenotypic
characteristics
of the cells
at each
time point were cells
consistently
(n=6; duplicate cultures from each of three independent cell isolates). All cells are derived
from
Sox9cre;
mice andat
express
staining:
ErbB3. of
Scale
trunk
NC R26R-EYFP
cell populations
Day EYFP
4 (A,(green).
B). ByRed
Day
10, some
the ErbB3-po
bars: 100μm.

extended flattened, sheet-like processes
(C, D; asterisks) while the other Erb
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cells displayed an elongated, spindle-like morphology (C, D; arrowheads). Aft

Appendix H: Enriching for intermediate and differentiated cell populations over
the course of neurogenesis and chondrogenesis.
C

A
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Intermediate
cells
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FSC-A

B
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D

Differentiated
neurons
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FSC-A

Enriching for differentiated chondrocytes at Day 14

Before

E

After

Darkfield

Darkfield

Figure 22. See next page for legend.
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Figure 22: Enriching for intermediate and differentiated cell populations over the
course of neurogenesis and chondrogenesis. Cranial NC cells were grown in neuronal
differentiation medium for two and six days. FACS purification was used to enrich for
intermediate neuroprogenitors or differentiated neurons distinguished by cell size. (A)
Intermediate neuroprogenitors, corresponding to the larger cell population (black
polygon), were isolated from cells grown for two days in neuronal differentiation medium.
(B) Differentiated neurons, corresponding to the smaller cell population (black polygon),
were isolated from cells grown for six days in neuronal differentiation medium. Cells
collected and cultured from both populations appeared healthy and reattached to the
culture dish, however, after one day in differentiation medium, the isolated differentiated
neurons appeared stressed and were not extending neurites in contrast to the isolated
intermediate cells (not pictured). (C) Many of the intermediate cells grown in neuronal
differentiation medium for two days following FACS purification began to extend neurites.
(D) Most of the differentiated neurons grown in neuronal differentiation medium for two
days following FACS purification extended short, fine neuritic processes that appear as a
TUJ1-positive halo around the cell body. Chondrogenic nodules (arrowheads) were
individually picked from chondrogenic cultures at Day 14, and dissociated for downstream
analysis. Representative images showing cultures before and after nodule selection. Red
staining = TUJI. Blue staining = DAPI labelled nuclei. Scale bars: (C, D) 50 μm; (E) 200
μm.
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Appendix I: Commonly upregulated transcripts over the course of
neurogenesis and chondrogenesis.
Table 4. Commonly upregulated transcripts over the course of neurogenesis and
chondrogenesis.
Ensembl transcript ID
ENSMUST00000043313.14
ENSMUST00000146468.3
ENSMUST00000006669.5
ENSMUST00000107044.9
ENSMUST00000002305.8
ENSMUST00000006697.16
ENSMUST00000027297.10
ENSMUST00000027477.14
ENSMUST00000070256.8
ENSMUST00000047786.5
ENSMUST00000029766.8
ENSMUST00000003870.14
ENSMUST00000004756.13
ENSMUST00000070478.3
ENSMUST00000030915.10
ENSMUST00000053355.5
ENSMUST00000032201.7
ENSMUST00000046212.1
ENSMUST00000102823.9
ENSMUST00000034992.7
ENSMUST00000020586.6
ENSMUST00000208605.1
ENSMUST00000090379.6
ENSMUST00000038562.8
ENSMUST00000163230.7
ENSMUST00000151894.8
ENSMUST00000022875.6
ENSMUST00000020497.13
ENSMUST00000163832.7
ENSMUST00000045557.9
ENSMUST00000127492.1
ENSMUST00000039522.7
ENSMUST00000093852.4
ENSMUST00000032203.8
ENSMUST00000117077.7
ENSMUST00000086559.6
ENSMUST00000161017.7
ENSMUST00000051293.7
ENSMUST00000102813.1
ENSMUST00000121288.1
ENSMUST00000102549.9
ENSMUST00000109349.8

Mouse gene symbol
Nmnat2
Lgals3
Pdk1
Plekhb1
Kdm7a
Itih3
Plekhb2
Ngef
Kcnq3
March4
Bcar3
Mxi1
Wwox
Sdc3
Morn1
Creg2
Ret
Slc16a1
Ttc39b
Nt5e
Slc22a4
Map6
Usp53
Spsb1
Cd200
Pfkp
Ank
Aldh1l2
Gbe1
Slc7a5
Map6
Apobr
Zbtb16
A2m
Slc7a2
Slc41a1
Kif26b
Gpr146
Cfap157
Fam167a
Nipal3
Dbndd2
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ENSMUST00000005829.12
ENSMUST00000050958.8
ENSMUST00000086465.5
ENSMUST00000020500.13
ENSMUST00000094456.9
ENSMUST00000238946.1
ENSMUST00000000608.7
ENSMUST00000025830.8
ENSMUST00000047889.12
ENSMUST00000077902.4
ENSMUST00000156673.1
ENSMUST00000094569.10
ENSMUST00000067444.9
ENSMUST00000027741.11
ENSMUST00000024988.14
ENSMUST00000173287.7
ENSMUST00000002073.12
ENSMUST00000163060.1
ENSMUST00000089332.4
ENSMUST00000034230.6
ENSMUST00000020399.5
ENSMUST00000038188.13
ENSMUST00000032342.2
ENSMUST00000028815.14
ENSMUST00000163623.2
ENSMUST00000058981.2
ENSMUST00000118317.7
ENSMUST00000040914.2
ENSMUST00000026617.12
ENSMUST00000067854.9
ENSMUST00000032272.12
ENSMUST00000031446.6
ENSMUST00000102911.9
ENSMUST00000160719.7
ENSMUST00000028080.11
ENSMUST00000036070.14
ENSMUST00000219435.1
ENSMUST00000023099.7
ENSMUST00000218362.1
ENSMUST00000097425.9
ENSMUST00000091288.12
ENSMUST00000113457.8
ENSMUST00000019734.10
ENSMUST00000009789.14
ENSMUST00000112747.1
ENSMUST00000060251.7
ENSMUST00000014990.12

Ampd3
Tmie
Adora1
Appl2
Snph
Aqp4
Gm2a
Apba1
Atp1b2
Gfap
Als2cl
Nfasc
Gfap
Xpr1
C3
Adamtsl3
Ltbp2
Hr
Col8a1
Cx3cl1
Cpm
Limch1
Mgp
Slc23a2
Nedd9
Lxn
Hipk1
Hist1h1c
Phkg1
1600014C10Rik
Adipor2
Tmem132b
Slc44a1
Mfap3l
Nebl
Fam107a
Chchd10
Slc38a2
Ttc9
Fndc1
Prnp
Col4a3
Cyb561
P4ha1
Spp1
Higd1a
Tppp3
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ENSMUST00000112748.7
ENSMUST00000099396.2
ENSMUST00000000058.6
ENSMUST00000009435.11
ENSMUST00000191805.6
ENSMUST00000027726.13
ENSMUST00000048116.14
ENSMUST00000165027.8
ENSMUST00000089959.6
ENSMUST00000031243.14
ENSMUST00000189137.6
ENSMUST00000100635.4
ENSMUST00000029326.5
ENSMUST00000056416.8
ENSMUST00000025363.6
ENSMUST00000236652.1
ENSMUST00000031766.11
ENSMUST00000019445.5
ENSMUST00000121334.7
ENSMUST00000080145.12
ENSMUST00000031122.8
ENSMUST00000036884.2
ENSMUST00000029188.7
ENSMUST00000084412.5
ENSMUST00000046071.4
ENSMUST00000048432.5
ENSMUST00000113585.8
ENSMUST00000070070.7
ENSMUST00000209208.1
ENSMUST00000018361.9
ENSMUST00000031646.7
ENSMUST00000112933.1
ENSMUST00000049095.5
ENSMUST00000039438.8
ENSMUST00000032185.8
ENSMUST00000038791.14
ENSMUST00000046515.14
ENSMUST00000034905.8
ENSMUST00000001824.6
ENSMUST00000085412.6
ENSMUST00000027263.13
ENSMUST00000222970.1
ENSMUST00000066708.6
ENSMUST00000156876.7
ENSMUST00000009798.4
ENSMUST00000118800.7
ENSMUST00000069620.9

Spp1
Nt5dc3
Cav2
Pttg1ip
Larp1b
Cyb5r1
Slc7a1
Ifrd1
Gch1
Spp1
Trpc1
Lratd2
Sucnr1
Rbfox1
Hbegf
Rps14
Asns
Hsd17b1
Sept8
Adamts16
Gabrb1
Klf9
Ccn5
Ifitm10
Klhdc8a
Prelp
Mgll
Dnaja4
Gm19935
Pmp22
Rasl11a
Cntf
Faah
Ntrk3
Slc6a6
Gde1
Nceh1
Gclc
Folh1
Coch
Stk17b
Aspg
Dmp1
Mfsd6
Oit3
Afap1l2
Per2
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ENSMUST00000022616.13
ENSMUST00000091309.11
ENSMUST00000036653.4
ENSMUST00000016168.8
ENSMUST00000108713.7
ENSMUST00000063982.6
ENSMUST00000060989.8
ENSMUST00000046765.9
ENSMUST00000105686.2
ENSMUST00000121200.8
ENSMUST00000130310.7
ENSMUST00000098786.2
ENSMUST00000102955.10
ENSMUST00000000579.2
ENSMUST00000021390.8
ENSMUST00000020234.13
ENSMUST00000033933.6
ENSMUST00000210490.2
ENSMUST00000043098.8
ENSMUST00000164047.1
ENSMUST00000134004.2
ENSMUST00000075980.11
ENSMUST00000051301.5
ENSMUST00000030056.11
ENSMUST00000020223.7
ENSMUST00000105507.4
ENSMUST00000071986.12
ENSMUST00000018246.5
ENSMUST00000230160.1
ENSMUST00000064234.6
ENSMUST00000107893.8
ENSMUST00000106307.8
ENSMUST00000050584.9
ENSMUST00000207932.1
ENSMUST00000027863.12
ENSMUST00000080666.7
ENSMUST00000153290.7
ENSMUST00000155364.7
ENSMUST00000171970.2
ENSMUST00000114694.8
ENSMUST00000087050.6
ENSMUST00000024954.10
ENSMUST00000137948.1
ENSMUST00000002885.7
ENSMUST00000226438.1
ENSMUST00000203574.1
ENSMUST00000033333.12

Clu
Cp
Htr2a
Lbp
Epn2
Fzd5
Sorl1
Kcnk1
Slc25a33
Palld
Cpeb1
1700029J07Rik
Cetn4
Sox9
Galc
Timp3
Saraf
Igip
Gadd45a
Ifrd1
Ank
Tmem107
Pura
Tnc
Tcp11l2
Ppil6
Mia
Hist1h2bc
Clip4
Ezr
Atf5
Hivep3
Cystm1
Prss23
Atp1b1
Ndrg4
Htra1
Mpc1
Bmp6
Zbtb20
Col4a4
Epas1
Ankrd29
Epdr1
Retreg1
Gm31520
Tmem9b
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Appendix J: Commonly downregulated transcripts over the course of
neurogenesis and chondrogenesis.
Table 5. Commonly downregulated transcripts over the course of neurogenesis and
chondrogenesis.
Ensembl transcript ID
ENSMUST00000014917.7
ENSMUST00000021164.3
ENSMUST00000195957.4
ENSMUST00000023353.3
ENSMUST00000093937.2
ENSMUST00000094339.2
ENSMUST00000026461.7
ENSMUST00000088248.12
ENSMUST00000027393.7
ENSMUST00000028803.13
ENSMUST00000005607.8
ENSMUST00000060710.8
ENSMUST00000101343.1
ENSMUST00000086461.12
ENSMUST00000203220.2
ENSMUST00000034205.4
ENSMUST00000105866.2
ENSMUST00000172699.1
ENSMUST00000110621.2
ENSMUST00000052686.3
ENSMUST00000021941.7
ENSMUST00000026661.3
ENSMUST00000034830.8
ENSMUST00000130533.1
ENSMUST00000102691.10
ENSMUST00000096482.9
ENSMUST00000031838.8
ENSMUST00000104999.3
ENSMUST00000197962.1
ENSMUST00000045802.6
ENSMUST00000110382.8
ENSMUST00000119827.7
ENSMUST00000052140.2
ENSMUST00000019907.7
ENSMUST00000063531.4
ENSMUST00000110949.8
ENSMUST00000107415.7
ENSMUST00000166505.6
ENSMUST00000166117.3
ENSMUST00000070326.13
ENSMUST00000022218.5
ENSMUST00000081387.10
ENSMUST00000069334.7
ENSMUST00000030714.7

Mouse gene symbol
Dll1
Pimreg
Hgf
Mcm4
Cdc6
Peg12
Prim1
Ube2c
Bard1
Knstrn
Asf1b
Cdc25c
Mad2l1
Rfc5
Hnrnpa2b1
Cenpn
Aunip
Mex3a
Lrr1
H2afx
Mxd3
Tk1
Crabp1
Cpxm1
Cdca7
Skp2
Igf2bp3
Nrarp
Cenpa
Pclaf
Gmnn
Cdk1
Haspin
Fbxo5
Cdkn2c
Arhgap11a
Zfp618
Pabpc4l
Gen1
Ttk
Dhfr
Birc5
Dach1
Sema3a
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ENSMUST00000110057.2
ENSMUST00000026846.10
ENSMUST00000022945.8
ENSMUST00000100458.3
ENSMUST00000024736.13
ENSMUST00000018744.14
ENSMUST00000117280.7
ENSMUST00000020980.11
ENSMUST00000108324.3
ENSMUST00000237276.1
ENSMUST00000041183.6
ENSMUST00000047768.10
ENSMUST00000034815.8
ENSMUST00000022536.2
ENSMUST00000047368.7
ENSMUST00000129195.7
ENSMUST00000029270.9
ENSMUST00000024840.11
ENSMUST00000139460.1
ENSMUST00000119026.7
ENSMUST00000151815.7
ENSMUST00000022612.9
ENSMUST00000020794.5
ENSMUST00000122091.7
ENSMUST00000038194.4
ENSMUST00000229333.1
ENSMUST00000080511.2
ENSMUST00000007296.11
ENSMUST00000200543.4
ENSMUST00000071812.10
ENSMUST00000096766.11
ENSMUST00000033060.13
ENSMUST00000048374.5
ENSMUST00000084828.4
ENSMUST00000054917.11
ENSMUST00000102611.9
ENSMUST00000093321.11
ENSMUST00000018506.12
ENSMUST00000025425.6
ENSMUST00000045730.6
ENSMUST00000168479.2
ENSMUST00000024599.13
ENSMUST00000093812.4
ENSMUST00000168064.2
ENSMUST00000071750.12
ENSMUST00000023612.16
ENSMUST00000074733.10
ENSMUST00000216139.1
ENSMUST00000212426.1

Flrt3
Tyms
Shcbp1
Suv39h2
Sgo1
Shmt1
Smc2
Rrm2
Ccne2
Ska1
Meox2
Neil3
Kif23
Ska3
Mnd1
Adamts20
Ccna2
Arhgap28
Top2a
Tmem132c
Atad5
Pbk
Ska2
Zwilch
Atad2
Atad2
Hist1h1b
Pole
Adgrl2
Iqgap3
Eml4
Tead2
Cip2a
Ncapg2
Epb41
Myh10
Grb10
Kpna2
Cep192
Akap12
Nynrin
Igf2r
Cd109
Vgll3
Col12a1
Ets2
Sept11
Akap12
Mcm5
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ENSMUST00000026150.14
ENSMUST00000039949.4
ENSMUST00000058011.7
ENSMUST00000033154.7
ENSMUST00000073316.12
ENSMUST00000018005.9
ENSMUST00000027601.10
ENSMUST00000025486.8
ENSMUST00000038131.9
ENSMUST00000043296.9
ENSMUST00000108023.9
ENSMUST00000035651.5
ENSMUST00000072119.14
ENSMUST00000109140.9
ENSMUST00000049348.8
ENSMUST00000110387.3
ENSMUST00000046916.8
ENSMUST00000005365.14
ENSMUST00000105286.3
ENSMUST00000028329.12
ENSMUST00000051594.11
ENSMUST00000034278.5
ENSMUST00000146520.4
ENSMUST00000078259.7
ENSMUST00000045876.7
ENSMUST00000223907.1
ENSMUST00000023666.10
ENSMUST00000086423.5
ENSMUST00000014747.2
ENSMUST00000001566.9
ENSMUST00000030674.7
ENSMUST00000070755.12
ENSMUST00000039725.11
ENSMUST00000150006.8
ENSMUST00000029183.2
ENSMUST00000171808.7
ENSMUST00000093191.2
ENSMUST00000029170.7
ENSMUST00000044423.3
ENSMUST00000028858.7
ENSMUST00000045607.11
ENSMUST00000025965.11
ENSMUST00000052201.8
ENSMUST00000062893.11
ENSMUST00000022613.9
ENSMUST00000068225.14
ENSMUST00000029482.15
ENSMUST00000048518.15
ENSMUST00000155907.1

Arhgap19
Eme1
Mcm2
Plk1
Foxm1
Mybl2
Mcm6
Lmnb1
Rfc3
Dlgap5
Ccne1
Lrrc17
Ccnb1
Aurka
Traip
Ncaph
Ckap2
Spc25
Kera
Sapcd2
Depdc1b
Gins2
Tyms
Nsl1
BC055324
Kif20b
Chaf1b
Gm10184
Alx3
Tubb5
Sytl1
Rad54b
Exo1
Cdca2
Fam83d
Dbf4
Spdl1
Rbl1
Brip1
Bub1
Melk
Hells
Mis18bp1
Cenpe
Esco2
Nusap1
Gpsm2
Parpbp
Adamts20
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ENSMUST00000157040.7
ENSMUST00000026662.7
ENSMUST00000102744.3
ENSMUST00000012587.3
ENSMUST00000216689.1
ENSMUST00000028000.12
ENSMUST00000040912.8
ENSMUST00000028802.2
ENSMUST00000020579.8
ENSMUST00000225740.1
ENSMUST00000171929.7
ENSMUST00000053266.10
ENSMUST00000035977.8
ENSMUST00000115390.4
ENSMUST00000035495.14
ENSMUST00000021311.9
ENSMUST00000065896.8
ENSMUST00000022053.10
ENSMUST00000000028.13
ENSMUST00000038341.7
ENSMUST00000031366.11
ENSMUST00000114426.9
ENSMUST00000025562.8
ENSMUST00000040717.6
ENSMUST00000048391.14
ENSMUST00000109432.3
ENSMUST00000117396.2
ENSMUST00000059091.5
ENSMUST00000199581.4
ENSMUST00000000095.6
ENSMUST00000081314.10
ENSMUST00000024981.8
ENSMUST00000025704.2
ENSMUST00000076147.5
ENSMUST00000099349.9
ENSMUST00000025595.4
ENSMUST00000027202.8
ENSMUST00000156899.1
ENSMUST00000024851.9
ENSMUST00000053364.11
ENSMUST00000126739.1
ENSMUST00000035164.9
ENSMUST00000033310.8
ENSMUST00000082337.12
ENSMUST00000033283.9
ENSMUST00000054674.14
ENSMUST00000054607.15
ENSMUST00000017290.10
ENSMUST00000051395.8

Mest
Cbx2
Orc1
Kif11
Kif11
Nuf2
Anln
Knl1
Hmmr
Epb41l3
Cenpf
Mcm3
Ticrr
Ccnf
Fanca
Kif18b
Kif2c
Trip13
Cdc45
Bub1b
Kntc1
Tacc3
Incenp
Kif15
Clspn
Fbln1
Ncapg
Clca3a1
Hgf
Tbx2
Blm
Jpt2
Cdca5
Ackr4
Hspa12b
Fam111a
Sgo2a
Tpm1
Ndc80
Aspm
Hjurp
Topbp1
Mki67
Mdc1
Rrm1
Hjurp
Ahcy
Brca1
Prr11
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ENSMUST00000068031.7
ENSMUST00000028119.6
ENSMUST00000129466.7
ENSMUST00000013559.2
ENSMUST00000045026.3
ENSMUST00000070607.8
ENSMUST00000043294.11
ENSMUST00000231569.1
ENSMUST00000098942.5
ENSMUST00000075550.3
ENSMUST00000154332.7
ENSMUST00000093346.5
ENSMUST00000102647.9
ENSMUST00000024270.13
ENSMUST00000029679.3
ENSMUST00000125430.1
ENSMUST00000075995.6
ENSMUST00000021359.6
ENSMUST00000084296.9
ENSMUST00000112221.7
ENSMUST00000174105.7
ENSMUST00000225316.1
ENSMUST00000117299.8
ENSMUST00000178997.7
ENSMUST00000067925.7
ENSMUST00000034742.7
ENSMUST00000028948.4
ENSMUST00000072239.13
ENSMUST00000120272.7
ENSMUST00000181026.1
ENSMUST00000041045.13
ENSMUST00000222156.1
ENSMUST00000023598.14
ENSMUST00000110805.2
ENSMUST00000222761.1
ENSMUST00000144742.5
ENSMUST00000144800.1
ENSMUST00000202314.2
ENSMUST00000182402.7
ENSMUST00000139147.1
ENSMUST00000107802.7
ENSMUST00000075853.5
ENSMUST00000099985.5
ENSMUST00000067426.5
ENSMUST00000226621.1
ENSMUST00000022227.7

Top2a
Mastl
Tpm1
Igf2bp1
Spag5
Haus6
Asb4
Ttc3
Spc24
Cenph
Top2a
H2afv
Selenoh
Cdca3
Cks1b
Mad2l1
Cand2
Pole2
Cdca8
Rad51ap1
Chek1
Epb41l3
Selenoh
Tpx2
Hmgb2
Ccnb2
Gins1
Tmpo
Depdc1a
Cox4i1
H2afz
Trip13
Rfc4
Oip5
Ncapg2
Cenpa
Cthrc1
Cthrc1
2700099C18Rik
Rad54l
Trim59
Cks2
Cenpw
Cdkn3
Cdkn3
Cenpk
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Appendix K: Differentially expressed transcription factor encoding transcripts
over the course of neurogenesis.
Table 6. Differentially expressed transcription factor encoding transcripts over the
course of neurogenesis.
Ensembl transcript ID
ENSMUST00000026425.12
ENSMUST00000221541.1
ENSMUST00000043208.7
ENSMUST00000114694.8
ENSMUST00000022304.9
ENSMUST00000051301.5
ENSMUST00000202651.3
ENSMUST00000114086.7
ENSMUST00000080885.11
ENSMUST00000063116.9
ENSMUST00000014174.13
ENSMUST00000042352.10
ENSMUST00000107893.8
ENSMUST00000139064.9
ENSMUST00000141605.7
ENSMUST00000105637.7
ENSMUST00000036884.2
ENSMUST00000106307.8
ENSMUST00000210120.1
ENSMUST00000024954.10
ENSMUST00000174611.7
ENSMUST00000048934.14
ENSMUST00000061571.4
ENSMUST00000003870.14
ENSMUST00000196324.1
ENSMUST00000163727.3
ENSMUST00000030124.3
ENSMUST00000211665.1
ENSMUST00000041099.4
ENSMUST00000018842.13
ENSMUST00000105238.9
ENSMUST00000208230.1
ENSMUST00000165033.1
ENSMUST00000064795.5
ENSMUST00000127820.1
ENSMUST00000231082.1
ENSMUST00000021674.6
ENSMUST00000027649.13
ENSMUST00000098611.3
ENSMUST00000107094.1
ENSMUST00000173161.1
ENSMUST00000205980.1
ENSMUST00000109129.7
ENSMUST00000081162.5
ENSMUST00000183176.1
ENSMUST00000095388.4

Mouse gene symbol
Pa2g4
E2f6
Six4
Zbtb20
Thrb
Pura
Clock
Klf7
Dbp
Msx1
Pax5
Zmat4
Atf5
Pou6f2
Hivep3
Prdm16
Klf9
Hivep3
Dbp
Epas1
Zic4
Tbr1
Neurod4
Mxi1
Nhlh2
St18
Tal2
Zscan18
Neurod1
Lhx1
Stat2
Fosb
Egr1
Egr1
Egr2
Egr2
Fos
Nr5a2
Lef1
Jun
Rfx3
Sox6
Zfp2
Homez
Mzf1
Rfx4

q value
0.037074859
0.011229629
0.0495181
2.27E-05
9.62E-12
0.006341933
0.003385927
0.025446458
0.00143505
0.002286702
6.55E-05
0.028186784
0.000171867
0.001722898
0.000485563
0.034215109
4.57E-19
0.000232794
0.025489191
0.007117976
0.016797667
0.044821646
0.001291819
0.000120296
0.00399891
6.74E-08
0.003135712
0.002306537
2.18E-06
6.64E-05
0.027075271
0.031214601
0.01465912
0.022408227
0.005492251
0.005492251
0.003059529
0.037553714
0.023964961
0.018848301
0.023420476
0.045398148
0.000560989
0.046336946
0.017366523
0.011017416
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ENSMUST00000178174.2
ENSMUST00000207873.1
ENSMUST00000135523.4
ENSMUST00000000579.2
ENSMUST00000176383.2
ENSMUST00000089257.5
ENSMUST00000036328.8
ENSMUST00000020243.9
ENSMUST00000175965.9
ENSMUST00000109514.7
ENSMUST00000113132.8
ENSMUST00000205391.1
ENSMUST00000153369.1
ENSMUST00000057950.8
ENSMUST00000105494.7
ENSMUST00000024159.7
ENSMUST00000140030.7
ENSMUST00000122912.7
ENSMUST00000118578.8
ENSMUST00000053491.8
ENSMUST00000036215.7
ENSMUST00000206034.1
ENSMUST00000130310.7
ENSMUST00000078058.4
ENSMUST00000046870.12
ENSMUST00000216751.1
ENSMUST00000090813.5
ENSMUST00000111752.9
ENSMUST00000093852.4
ENSMUST00000188495.7
ENSMUST00000105590.7
ENSMUST00000056882.6
ENSMUST00000035608.9
ENSMUST00000129843.7
ENSMUST00000030489.8
ENSMUST00000054244.6
ENSMUST00000145088.1
ENSMUST00000049784.16
ENSMUST00000066384.6
ENSMUST00000028928.7
ENSMUST00000020982.6
ENSMUST00000128406.7
ENSMUST00000072566.4
ENSMUST00000021941.7
ENSMUST00000018005.9
ENSMUST00000103145.10
ENSMUST00000073316.12
ENSMUST00000000095.6
ENSMUST00000102923.9
ENSMUST00000163568.3
ENSMUST00000175984.1

Pou3f2
Zfp14
Sall2
Sox9
Zfhx4
Insm1
Zfhx2
Ascl1
Onecut2
Bcl11a
Pbx3
Cebpa
Nr4a3
Sall3
Scml4
Dlx2
Camta1
Csrnp3
Otx2
Pou3f1
Foxj1
Sox6
Cpeb1
Purg
Lhx9
Myb
Sp9
Cux2
Zbtb16
Myb
Esr1
Olig1
Olig2
Myt1
Tal1
Dbx2
Dlx1
Myt1l
Zic4
Gzf1
Klf11
Tfap2c
Nme2
Mxd3
Mybl2
E2f1
Foxm1
Tbx2
Aebp1
Six2
Tsc22d1

0.016982133
0.015766186
0.011231309
0.046674133
0.006679687
0.010597163
0.002689615
0.002401149
3.65E-05
8.96E-05
0.031836646
0.025625003
0.013392873
0.018055327
0.015821594
0.010882032
2.57E-05
1.00E-13
0.041849927
0.0080492
9.17E-06
0.030006111
0.013891018
0.010746307
0.009718447
0.026804145
5.65E-08
0.004533237
0.008541476
1.20E-10
1.56E-11
0.002789013
9.77E-08
6.87E-05
0.000336058
0.000562862
0.000378653
1.42E-13
2.79E-11
0.028954405
0.024282276
0.017668791
0.000467672
6.82E-06
0.009778572
0.008347907
4.39E-06
0.000265269
0.005313408
0.005042195
0.022038383
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ENSMUST00000129393.1
ENSMUST00000031017.10
ENSMUST00000112966.9
ENSMUST00000014747.2
ENSMUST00000102864.4
ENSMUST00000029462.9
ENSMUST00000052946.11
ENSMUST00000042054.2
ENSMUST00000214964.1
ENSMUST00000056924.13
ENSMUST00000072777.13
ENSMUST00000162098.8
ENSMUST00000097216.4
ENSMUST00000124268.7
ENSMUST00000022646.8
ENSMUST00000159310.1
ENSMUST00000026662.7
ENSMUST00000033060.13
ENSMUST00000137093.7
ENSMUST00000069334.7
ENSMUST00000110510.3
ENSMUST00000069536.11
ENSMUST00000070143.12
ENSMUST00000229748.1
ENSMUST00000144716.1
ENSMUST00000119223.1
ENSMUST00000076521.6
ENSMUST00000144742.5
ENSMUST00000003369.9
ENSMUST00000197962.1
ENSMUST00000023612.16
ENSMUST00000026703.5
ENSMUST00000102820.8
ENSMUST00000176971.1
ENSMUST00000187952.1
ENSMUST00000093801.9
ENSMUST00000100043.2
ENSMUST00000032768.14
ENSMUST00000005279.7
ENSMUST00000040536.5
ENSMUST00000113326.8
ENSMUST00000110835.2
ENSMUST00000208474.1
ENSMUST00000065360.4
ENSMUST00000207153.1
ENSMUST00000041183.6
ENSMUST00000023356.7
ENSMUST00000021333.4
ENSMUST00000075805.12

Smyd3
Fosl2
Lhx6
Alx3
Rel
Tbx15
Tbx20
Foxf2
Dnmt1
Plagl2
Hmga2
Shox2
Tead2
Rreb1
Nkx3-1
Hmga2
Cbx2
Tead2
Stat3
Dach1
Gli3
Tcf7l1
Zhx1
Zhx1
Lin54
E2f8
Irf6
Cenpa
Plag1
Cenpa
Ets2
Bach1
Bnc2
Bnc2
Plscr1
Plscr1
Sp5
Nr2f2
Klf5
Batf
Foxp1
Elf1
Nr2f2
Zic1
Nr2f2
Meox2
Snai2
Foxg1
Prrx1

0.013139532
0.045749144
2.94E-07
0.005563884
0.026836299
3.05E-06
0.000180055
0.000481976
0.002449328
0.002474876
8.85E-61
6.78E-05
2.23E-06
0.00169927
0.000725587
1.69E-06
0.021209482
0.007675474
0.000843998
0.023916477
0.005826814
0.033216635
0.031575319
0.031575319
0.020720846
2.42E-06
0.009893328
0.006173902
0.018375568
0.000119044
0.025721954
0.017142392
9.18E-12
0.000186192
7.12E-08
0.004409213
0.000131646
0.023978763
0.009858261
0.000640377
0.00716893
0.028562499
0.020551134
0.002356006
0.018522085
2.59E-05
0.00077003
0.000351571
0.031157801
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Appendix L: Differentially expressed transcription factor encoding transcripts
over the course of chondrogenesis.
Table 7. Differentially expressed transcription factor encoding transcripts over the
course of chondrogenesis.
Ensembl transcript ID
ENSMUST00000096430.10
ENSMUST00000112832.7
ENSMUST00000162022.7
ENSMUST00000114694.8
ENSMUST00000106307.8
ENSMUST00000103112.7
ENSMUST00000108639.7
ENSMUST00000102944.10
ENSMUST00000043637.13
ENSMUST00000043172.14
ENSMUST00000109460.7
ENSMUST00000063694.9
ENSMUST00000216150.1
ENSMUST00000023612.16
ENSMUST00000093852.4
ENSMUST00000023119.14
ENSMUST00000036884.2
ENSMUST00000107893.8
ENSMUST00000004145.13
ENSMUST00000108492.8
ENSMUST00000024954.10
ENSMUST00000128282.3
ENSMUST00000130491.2
ENSMUST00000113956.9
ENSMUST00000023673.13
ENSMUST00000139491.7
ENSMUST00000195612.1
ENSMUST00000003870.14
ENSMUST00000032194.10
ENSMUST00000032386.10
ENSMUST00000210748.1
ENSMUST00000111703.1
ENSMUST00000000579.2
ENSMUST00000047321.8
ENSMUST00000053484.7
ENSMUST00000152594.7
ENSMUST00000075159.4
ENSMUST00000046303.11
ENSMUST00000113624.2
ENSMUST00000048128.14

Mouse gene symbol
Zhx2
Rorb
Glis3
Zbtb20
Hivep3
Zhx3
Zbtb4
Creb3
Mitf
Rarg
Zhx3
Klf13
Zbtb16
Ets2
Zbtb16
Vdr
Klf9
Atf5
Stat5a
Hif3a
Epas1
Jazf1
Cebpg
Runx1
Runx1
Zbtb20
Zbtb18
Mxi1
Bhlhe40
Bhlhe41
Npas1
Bhlhe41
Sox9
Arntl
Eea1
Zbtb38
Clock
Crebl2
Rora
Zbtb7a
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q value
0.03045774
0.037690499
0.024024999
0.012944301
0.000347325
0.007380018
0.018430829
0.002321999
0.01681401
0.044180782
0.000947638
0.00079267
0.012208448
5.84E-05
1.02E-12
9.57E-13
1.53E-34
8.76E-05
0.035531961
1.43E-07
0.026372533
0.015076474
0.012429213
0.001018652
0.001647935
0.031988814
0.044222356
0.025833874
0.023204295
4.33E-07
0.012311725
7.64E-05
0.03698768
0.00079267
0.034021177
0.018512368
0.002017165
0.000130738
0.032142853
0.044136531

ENSMUST00000051301.5
ENSMUST00000211770.1
ENSMUST00000202122.1
ENSMUST00000130310.7
ENSMUST00000027974.6
ENSMUST00000144742.5
ENSMUST00000032717.6
ENSMUST00000197962.1
ENSMUST00000174672.1
ENSMUST00000021941.7
ENSMUST00000018005.9
ENSMUST00000073316.12
ENSMUST00000107801.9
ENSMUST00000061721.5
ENSMUST00000219808.1
ENSMUST00000026474.4
ENSMUST00000041183.6
ENSMUST00000155821.1
ENSMUST00000107246.1
ENSMUST00000159334.7
ENSMUST00000226960.1
ENSMUST00000231153.1
ENSMUST00000192102.1
ENSMUST00000192550.5
ENSMUST00000215916.1
ENSMUST00000161839.1
ENSMUST00000109795.1
ENSMUST00000023171.7
ENSMUST00000000095.6
ENSMUST00000176161.7
ENSMUST00000014747.2
ENSMUST00000049621.6
ENSMUST00000033060.13
ENSMUST00000026662.7
ENSMUST00000069334.7
ENSMUST00000177754.8

Pura
Arntl
Clock
Cpeb1
Atf6
Cenpa
Dbx1
Cenpa
Zfp57
Mxd3
Mybl2
Foxm1
Tead2
E2f2
Gli1
Gli1
Meox2
Nfib
Nfib
Etv1
Dzip1
Nr4a1
Hey1
Hey1
Csrnp1
Hes1
Plagl2
Hes1
Tbx2
Ebf2
Alx3
Hes5
Tead2
Cbx2
Dach1
Dnmt1

0.006126644
0.00346531
0.004380651
0.001626425
0.000920068
0.022392889
0.04109932
0.0001589
0.001273074
0.023604982
7.64E-05
4.36E-05
2.89E-05
0.001210404
0.043851212
0.031881612
0.009514586
0.000933271
0.002378571
0.000362215
0.037423673
0.045484727
0.042644997
0.024668126
0.001294471
2.23E-07
0.000140655
0.017404777
0.005778282
0.001083613
0.043167409
8.63E-08
0.000559772
0.011223377
0.00231894
0.00290074
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Appendix M: Characterization of Cabin1 during chondrogenic differentiation
in the cranial neural crest
Previous work in our lab discovered that transient reduction of Cabin1 expression
in developing zebrafish embryos resulted in a distinct phenotype characterized by a range
of developmental defects, including craniofacial deformities and abnormal cranial NC cell
migration. During T-cell activation and muscle development, Cabin1 modulates the
temporal expression of genes associated with differentiation through its interaction with a
variety of proteins, including MEF2 (myocyte enhancer factor 2; Yang et al., 2011; Youn
and Liu, 2000). One specific isoform of MEF2, MEF2C, is a well-established
transcriptional regulator of chondrogenesis (Miller et al., 2007; Verzi et al., 2007),
however it is not known if Cabin1 interacts with MEF2C in the cranial NC during the
formation of the craniofacial skeleton. We hypothesize that Cabin1 regulates
chondrogenic differentiation through its repression of MEF2C, thus inhibiting gene
expression associated with this process during cranial NC cell migration. Here we
demonstrate that Cabin1 and MEF2C directly interact in cultured cranial NC cells, and
observe a reduction in Cabin1 protein during in vitro chondrogenic differentiation. Taken
together, these observations support a novel role for Cabin1 in the cranial NC, paving the
way future investigation into the definitive role of this transcriptional repressor during
craniofacial development.
In order to determine if Cabin1 was expressed in the cranial NC we assessed
Cabin1 protein expression in undifferentiated cranial NC cells grown for three passages
(12 days in culture). Robust Cabin1 expression was observed in both the cytoplasmic and
nuclear compartments of the undifferentiated cultures (Fig. 23A). Moreover, the
expression of MEF2C, an isoform of MEF2 known to regulate chondrogenesis, was also
observed in undifferentiated cranial NC cells (Fig. 23A’). MEF2C expression was localized
to the nucleus, as we would expect for a transcriptional activator. Importantly, merged
images of Cabin1 and MEF2C protein expression reveal co-expression of Cabin1 and
MEF2C in the nucleus of the undifferentiated cranial NC cells (Fig. 23A’’), thus increasing
the possibility for a potential interaction between the two proteins.
Cabin1 is known to interact with MEF2 proteins during T-cell activation and skeletal
myogenesis (Yang et al., 2011; Youn and Liu, 2000). During these processes, the
presence of Cabin1 inhibits differentiation in general, however differentiation progressed
upon dissociation of Cabin1 from MEF2. In order to determine if Cabin1 interacts with
MEF2C in the cranial NC, we performed immunoprecipitation assays on nuclear lysate
extracted from undifferentiated cranial NC cells grown for three passages (12 days in
culture). Antibodies against Cabin1 and MEF2C were validated using immunoblotting in
the same lysates, which also served to confirm the nuclear localization of these two
proteins in the undifferentiated cultures. In support of our hypothesis, Cabin1 was
detected in the immunoprecipitation of MEF2C (Fig. 23B; red dashed boxes). Conversely,
MEF2C protein was also detected in the immunoprecipitation of Cabin1 (Fig 23C; red
dashed boxes). In both cases, Cabin1 or MEF2C proteins were detected in the flowthrough lysate. This suggests that both Cabin1 and MEF2C may also interact with other
proteins in the undifferentiated cranial NC cells as they are known to do in other cell types.
Nevertheless, these results indicate that Cabin1 and MEF2C interact in the nucleus of the
undifferentiated cranial NC cells.
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We next sought to determine how Cabin1 gene expression changed over the
course of chondrogenic differentiation, and how the expression of MEF2C-target genes
might be impacted as a result. To do this, we evaluated gene expression changes for
Cabin1, and MEF2C-target genes, Dlx6 (direct target) and Hand2 (indirect target),
between the undifferentiated cranial NC and over the course of chondrogenic
differentiation using qRT-PCR. Cabin1 expression was still detectable after 4 days in
chondrogenic differentiation, however we observed reduced Cabin1 gene expression in
RNA extracted from chondrogenic nodules at Day 14 (Fig. 23D). Dlx6 expression did not
change relative to its expression in the undifferentiated cultures, although reduced Cabin1
expression over time appeared to correlate with modest increases in Hand2 expression,
both at Day 4 and Day 14. During cartilage formation in both mice and zebrafish, MEF2C
activation results in expression of Dlx6 and Dlx5, which work cooperatively to activate
Hand2 (Miller et al., 2007; Verzi et al., 2007). We predicted that a reduction in Cabin1
expression over time would be correlated with increases in MEFC-target genes. Our
results do not support this relationship, although it does not preclude its ability to regulate
other genes during chondrogenesis that have yet to be determined.
In human naïve T cells, the ability of Cabin1 to repress MEF2 gene activation is
known to be modulated by nuclear export in response to increased calcium levels, which
promotes expression of MEF2-target gene IL-2 during T-cell activation (Pan et al., 2005).
To determine if Cabin1 localization changes during chondrogenesis, we evaluated
differences in Cabin1 nuclear localization between undifferentiated cranial NC cells and
those undergoing chondrogenic differentiation at an early (Day 4) and late (Day 14) time
point. We observed Cabin1 protein in both the cytoplasmic and nuclear compartments at
all time points tested, however Cabin1 nuclear localization decreased in cells undergoing
chondrogenesis over time (Fig. 24). Specifically, there was a statistically significant
reduction of Cabin1 in the nucleus of cells assessed after 4 days in chondrogenic
differentiation medium when compared to undifferentiated cranial NC cultures (Figs. 24B,
24B’ compared to 24A, 24A’, quantified in Fig. 24D). A similar significant decrease was
also detected in chondrocytes at Day 14 (Figs. 24C, 24C’ compared to 24A, 24A’,
quantified in Fig. 24D), although Cabin1 nuclear localization was significantly higher at
Day 14 compared to Day 4 (Fig. 24D). Most notably, we observed a marked reduction in
Cabin1 immunostaining in regions of the well containing differentiated chondrocytes
within chondrogenic nodules at this later time point (Figs. 24C, 24C’, 24C’’; arrowheads),
although we are unable to rule out the possibility that antibody penetration may not have
occurred equally across all the cells within the center of the nodules. We also noted that
the presence of nuclear Cabin1 was significantly higher at Day 14 compared to Day 4,
although it is possible that our data may represent an overestimation of the amount of
Cabin1 in the nucleus at this later time point. At Day 14, the chondrocytes within the
nodules are compacted, making it difficult to establish parameters that would definitively
distinguish each individual nuclei of these cells within the nodules without increasing
detection of artifacts/debris. Since some of the differentiated cells within the nodules were
not being assessed, it is possible that the MFI values reported for Day 14 are higher than
they would be had the analysis been able to account for those missing nuclei, or if it were
more specific to the differentiated cells within the nodules. Despite these caveats, our
results do indicate that the presence of Cabin1 in the nucleus decreases during
chondrogenesis.
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Figure 23: Cabin1 and MEF2C interact in the nucleus of undifferentiated cranial NC cells. (A, A’, A’’)
Cabin1 (A) and MEF2C (A’) were co-expressed in the nucleus of the undifferentiated cranial NC cells.
Merged image of Cabin1 and MEF2C (A’’) (B) Cabin1 (250 kDa; red dashed box) was detected in the
immunoprecipitation of MEF2C from nuclear lysate extracted from undifferentiated cranial NC cells. (C)
MEF2C (45 kDa; red dashed box) was detected in the immunoprecipitation of Cabin1 from nuclear lysate
extracted from undifferentiated cranial NC cells. (D) Expression of Cabin1, MEF2C, MEF2C-target genes,
Dlx6 and Hand2, and chondrogenic markers, Sox9 and Col2a1 were assessed in RNA extracted from
cranial NC cells after 4 and 14 days in chondrogenic differentiation medium. Only Sox9 and Col2a1 showed
a statistically significant change in relative expression between Day 4 and Day 14 when compared against
the undifferentiated cultures. (*P<0.05, Unpaired t-test). Values represent mean ± SEM from 3 independent
isolates of cranial NC. Green staining = Cabin1. Red staining = MEF2C. Blue staining = DAPI labelled
nuclei. Scale bar: 25 μm.
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Figure 24: Reduced Cabin1 nuclear localization corresponds with progression of chondrogenesis
in vitro. (A-C, A’-C’) Cabin1 protein expression in undifferentiated cranial NC cells (Day 0), and after 4 and
14 days in chondrogenic differentiation medium. Cabin1 was observed in both the cytoplasm and nuclear
compartments at all time points, however its nuclear localization decreased over time. A marked reduction
of Cabin1 was detected in regions of the cultures containing chondrogenic nodules (arrowheads) (A’’-C’’)
Higher magnification views of the boxed regions show changes in Cabin1 nuclear localization over time (D)
Quantification of Cabin1 nuclear localization in undifferentiated (Day 0), and differentiated chondrocytes
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over time. Each dot represents MFI within one nucleus, color-coded by biological isolate. Black horizontal
lines represent mean ± SEM. (****P<0.0001. Unpaired t-test was used to assess replicates at each time
point. One-way ANOVA was used to assess each replicate across time points). Red staining = Cabin1.
Blue staining = DAPI labelled nuclei. Scale bars: (A, B, A’, B’, A’’, B’’) 50 μm; (C, C’, C’’) 25 μm.
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